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ABSTRACT 
 
Introduction 
My doctoral work focuses on the disease vitiligo vulgaris.  Several treatments already exist 
however, one totally successful remedy is unavailable.  I have focused on cell-based 
technologies to refine the melanocyte–keratinocyte transplantation procedure (MKTP) that is 
currently in use.  Treating this disease is important not just for its physical but its emotional 
effects. 
Aim and objectives 
The broad aim of my doctoral work was to establish techniques to enhance the MKTP vitiligo 
treatment by developing a method for isolating melanocyte and keratinocyte cells from skin, 
co-culturing in different ratios and manipulating this by different factors. 
Methods 
A co-culture system of melanocytes and keratinocytes at different ratios (1:3, 1:5 and 1:10) 
was established.  Co-culture at different ratios was exposed to various concentrations of α-
MSH (2.5 µg/ml, 5 µg/ml and 10 µg/ml) and UVB (10 mJ/cm2, 20 mJ/cm2 and 30 mJ/cm2). 
Cells were evaluated for changes in morphology, melanin content, tyrosinase activity and the 
expression of selected markers (S100, TYRP1, TYR, pan-cytokeratin, cytokeratin 10 and 
filaggrin). 
Results 
In co-culture ratios 1:3 and 1.5 exhibited a higher population of melanocytes.  Exposure of 
cells to various concentrations of α-MSH exhibited a dose dependent response and UVB caused 
a stimulated effect on melanin and its production. 
15 
 
Discussion & conclusion 
As an in vitro study my doctoral work has provided a vital first step towards the development 
of melanocyte–keratinocyte co-cultured cell treatments for vitiligo vulgaris.  The positive rate 
of melanocytes co-cultured with keratinocytes in vitro reached the maximum on the 12th day, 
and this co-culture model may be capable of being used in the treatment of vitiligo patients.  
Future applications of my work include informing the development of three-dimensional skin 
models and exosomes technology as an improvement to the co-culture method. 
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CHAPTER ONE: INTRODUCTION TO THE STUDY 
 
1.1 Introduction and rationale for the study 
The purpose of my doctoral work was to focus on a disease called vitiligo vulgaris.  There are 
several treatments already in place for this condition, however, at present there is still not one 
totally successful remedy.  In this work, I have focussed on cell-based technologies to refine a 
treatment that is currently in use.  As of the present date, cell and stem cell technologies are at 
the cutting edge of modern science and an understanding/grasp of how to use these is 
invaluable, not only in the field of cosmetic sciences but also in many other diseases in 
existence worldwide. 
 
Developing treatments for the condition vitiligo vulgaris is important because whilst the skin 
is a primary target, other organs are also at risk, with its impact being far deeper than this. This 
condition can often have a devastating effect on the patient’s emotional health with recent 
studies indicating that it might even have implications for the affected person's physical health 
too (Mishra et al., 2014).  
 
Normal healthy skin is a vital constituent of a person’s psychological and physical welfare as 
well as being a crucial part of their sexual attractiveness, and their feelings of self-confidence 
and wellbeing (Allen, 2015).  The skin is the largest and most visible organ of the human body 
which means that any skin discolourations are highly visible and thus profoundly affect that 
person with disease (Ahmed et al., 2018). 
 
Vitiligo is a condition where light white patches develop, most commonly affecting the skin, 
but it might also develop in the hair, the eyes or inside the mouth.  It can be seen physically as 
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light-coloured or white patches in any of these areas while the amount of colour loss that occurs 
varies from patient to patient (Ghafourian et al., 2014).  This condition affects millions of 
people worldwide and it occurs in all skin types, affecting both men and women fairly 
equally.  Approximately 50% of those affected receive a vitiligo diagnosis before the age of 20 
with most patients having the disorder for the rest of their lives (Mahajan et al., 
2019).  Although the physical symptoms are currently not thought to be so detrimental, it is 
widely reported that vitiligo can be a substantial contributing factor to emotional problems such 
as low self-esteem or depression (Ahmed et al., 2018). 
 
From a physical point of view, there appears to be a strong association of vitiligo with 
autoimmune disease comprising at least 20% of vitiligo patients being affected by both, and 
this linkage between both is known as comorbid condition (Gill et al., 2016).  This can be 
demonstrated with hyperthyroid disease and alopecia areata, where thyroid disease is 15 times 
more common in vitiligo patients and alopecia areata being 31 times more common (Saleem 
and Azim, 2016). Other conditions that show a heightened prevalence in vitiligo patients 
include lupus, inflammatory bowel disease, and Sjögren’s syndrome, which presents clinically 
as dry eyes and a dry mouth. The prevalence of comorbid conditions means that everyone with 
vitiligo should be screened for them at least once a year (Gill et al., 2016). 
 
Vitiligo is a depigmentation disorder that affects 0.5-2% of the worlds’ population (Anbar et 
al., 2019).  It has been documented that historically vitiligo patients have suffered the same 
mental abuse as lepers with this going so far as sufferers being referred to as Sweta Kustha 
which means “White leprosy.”  It is devastating in all affected races but due to the strong 
contrast in dark skinned people, it is more of a problem for these people (Ezzedine et al., 2019). 
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A study was documented in India which concluded that being afflicted with vitiligo is 
associated with suffering from serious social and psychological problems, a fact that has a 
heightened risk of occurrence in affected young women and children (Sarkar et al., 2018).  Due 
to India’s status as being a very religious country where reincarnation is a popular theory, as 
described in ancient Hindu texts, many people still think that an individual suffers from vitiligo 
because they did wrong or “Guru Droh” in their previous life (Garg and Sarkar, 
2014).  Therefore, the social suffering from vitiligo of those affected is more prevalent in India 
than in other countries (Raman et al., 2013).  This is especially pronounced in young unmarried 
women due to the prevalence of arranged marriages with young women that have vitiligo 
having in some communities a minimal chance of being accepted for marriage.  The lack of 
understanding is such that even if a woman develops vitiligo after their marriage they may have 
marital problems, which might even end up in divorce (Nguyen et al., 2016). 
 
For patients suffering from vitiligo, the economic and financial costs of this disease can be 
severe due to their need to take time off work so that they can attend hospital appointments for 
treatment, such as psoralen and ultraviolet A (PUVA).  Psoralen (sor’ a len) is a natural 
furocoumarin found in the seeds of Psoralea corylifolia and other botanicals and used for their 
photosensitizing activity in the therapy of psoriasis and vitiligo. Psoralen increases the skin’s 
sensitivity to light.  The theory behind their use is that they increase the amount of light the 
skin absorbs; this lets light into the skin.  Psoralen is applied first to sensitise the skin, then 
UVA light is applied.  The mode of action of psoralens is that it is actively taken up by 
epidermal cells and intercalates into DNA. Upon exposure to ultraviolet (UV) light, psoralen 
forms cross links between DNA causing cell injury and death (Madigan and Lim, 2016). 
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Another negative implication of suffering from this disease on a patient’s employability is that 
visible lesions can also affect that person's chances of getting a job at an interview, thereby 
reducing their career choices (Lotti et al., 2018).  The psychological consequence of this 
disease is that a large proportion of patients feel distressed and stigmatized by their 
condition.  Individuals that show visible signs of being affected by vitiligo often attract undue 
attention from the general public in the form of whispered comments, antagonism and 
ostracism (Vernwal, 2017). Of particular embarrassment are lesions over the face and parts of 
the hands and feet which can result in anger and disillusionment. This often leads to depression 
due to a marked reduction in the self-image of the affected person.  Experiences such as these 
over a number of years can also reinforce the patient’s negative feelings with regard to their 
illness (Chan et al., 2013).   
 
Many of the patients can report suffering from feelings such as embarrassment which can lead 
to a low self-esteem and social isolation.   Mood disturbances, such as irritability and 
depression are particularly common in teenagers.  Social withdrawal is a particularly common 
symptom as well as emotional distress, problems with employment, substance misuse and in 
extreme cases even severe depression leading to suicide attempts (Chan et al., 2013).  Bullying 
related to this condition is associated with significant psychological trauma which can have 
long-lasting effects on the personal self-esteem of these children (Lotti et al., 2018). 
 
Children with vitiligo lesions often avoid sports or restrict such activities and they might lose 
vital days from school.  The extent of the psychological distress that these individuals suffer 
from can be dependent on the attitudes of those surrounding them, such as their parents, 
siblings, relatives, teachers, and friends.  A consequence of this disease is depression and 
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frustration which can also manifest as problems in interpersonal relations and they can often 
feel that members of their family lack in understanding or support (Chan et al., 2013). 
 
Long term therapies for vitiligo including immunosuppressive treatments and 
PUVA/narrowband UVB therapy can carry a risk of side effects such as photo aging and 
carcinogenesis which has led to the need to find new safer alternatives (Shenoi and Prabhu, 
2014).  In one published report (Whitton et al., 2015), 68% of all cases studied here reported 
adverse effects, especially so in topical treatments.  The nature of these effects included itching, 
skin thinning, telangiectasia and atrophy.  A few of the narrowband-UVB studies in this report 
(Whitton et al., 2015) caused a phototoxic reaction while PUVA treatment triggered the 
symptoms of dizziness and nausea (Whitton et al., 2015).  It is important that the psychological 
components of this disease are recognized and dealt with, so that those affected have an 
enhanced quality of life, and to improve response to treatment with counselling often helping 
to improve body image and self-esteem (Chan et al., 2013) (Lotti et al., 2018). 
 
 
1.2 Currently available treatments for vitiligo vulgaris 
Treatment of vitiligo vulgaris consists of three main options, namely medical, light based, 
surgical or a combination of all the aforementioned (Table 1).  After medical modalities, light-
based therapies are the next treatment method but the limitations of these treatments are that 
stable colourless vitiligo patches that do not have any melanocytes left or do not have any 
inducible melanocyte precursors show no response to medical modalities (Nahhas et al., 2019).  
An important note is that clear NICE (national institute for health and care excellence) 
guidelines are available for implementation of vitiligo treatment, the last date of revision of 
these was 2016 with a new review planned next in December 2021.  
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 Table 1:  Treatment algorithm for adults with vitiligo (Van Onselen, 2013) 
Adult treatment 
algorithm 
First-line Second-line Third-line 
1. Diagnosis Straightforward: 
Primary care 
diagnosis, including 
thyroid function test 
Atypical 
presentations: 
referral and 
diagnosis by a 
dermatologist 
 
2. No treatment 
            option 
Sun screens Cosmetic 
camouflage 
 
3. Topical 
treatment 
Recent onset: potent 
or very potent topical 
steroid for two 
months 
Ongoing 
treatment: topical 
pimecrolimus 
(alternative to 
topical steroid) 
Severe vitiligo: De-
pigmentation with p-
(benzyloxy)phenol 
4. Phototherapy Narrow-band 
ultraviolet B 
Psoralens and 
ultraviolet A 
phototherapy 
 
5. Systemic 
therapy 
None   
6. Surgical 
treatments 
Cosmetically 
sensitive site 
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only.  Split skin 
grafts only. 
7. Psychological 
treatments 
Should be offered to 
improve coping 
mechanisms in adults 
Cognitive 
behavioural 
therapy 
 
 
 
The options for medical treatment of vitiligo involve using immune-modulating drugs on 
patients, such as vitamin supplements (especially vitamin B12 and folic acid), azathioprine, 
cyclophosphate, levamisole and systemic corticosteroids) (Nahhas et al., 2019).  Phototherapy 
is a medical procedure which involves exposing vitiligo lesions to fluorescent lamps which 
emit UV light.  However, due to side effects, this should only be used when other treatments 
fail and UVB is emerging as the safer option.  Heliotherapy is the therapeutic use of sunlight 
and its advantages are that it is cheap but unfortunately it does carry an increased risk of ageing 
skin, sunburn and skin cancer (Lotti et al., 2018). 
 
A product called Khellin is often used to enhance the treatment of vitiligo.  Khellin is isolated 
from Khella, a Mediterranean plant and it acts as a photosensitizer which means that it acts 
directly on melanocytes to enhance proliferation and melanogenesis.  For this treatment to be 
the most effective, it must be used in combination with PUVA or narrowband-UVB.  Excellent 
repigmentation can occur within 2-4 months especially on the neck, face, upper limbs, 
abdomen and hands (Fenniche et al., 2017).  Steroids have been known to be effective in the 
treatment of vitiligo, but they have been associated with serious side effects which have led to 
the search for alternative treatments (Lotti et al., 2018).  
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The mode of action of steroids is to reduce both inflammation and the immune systems activity. 
Inflammation arises out of the body’s white blood cells protecting it against infection and 
foreign substances such as bacteria and viruses. However, there are some diseases where the 
body’s immune system does not act correctly. An outcome of this is inflammation working 
against the body's tissues thus causing unwanted damage.  Signs of inflammation include: 
redness, warmth, swelling and pain.  Steroids work by reducing the production of chemicals 
which can cause inflammation. The outcome of this is to help tissue damage to be kept as 
minimal as is possible.  In summation steroids work by reducing the activity of the immune 
system by affecting the way white blood cells work (Grennan and Wang, 2019). 
 
When the depigmentation covers more than 60% to 80% of the body, the easiest option is to 
depigment the entire skin rather than to try to repigment any remaining areas.  Depigmentation 
occurs in the opposite way to pigmentation therapies by removing any pigment in the skin 
rather than regaining it.  Before any adult is treated via the depigmentation process it is 
important that they are aware that the treatment involves the use of chemical depigmenting 
products for a long period of time.  The patient must also be aware that this treatment will 
significantly change their physiognomy as well as creating the requirement for them to take 
special precautions, for the rest of their life, when exposing themselves to the sun.  Established 
and potential depigmenting agents include: monomethyl ether of hydroquinone imiquimod, 
88% phenol solution diphencyprone, laser catechol, cryotherapy hydroquinone bis (2-
hydroxyethyl) ether, 4-methoxyphenol.  The option of using depigmenting treatments should 
only be considered when more than 50% of the body is affected or when the patches are highly 
disfiguring (Grimes et al., 2017). 
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A simple solution that does not require any sort of treatment is the use of camouflage 
creams/temporary makeup, such as creams and lotions (Kaliyadan and Kumar, 2012).  Surgical 
treatments involve the blister technique, non-cultured and cultured autologous grafts, and 
epidermal/dermal grafts.  For any individuals considering surgical treatment, it is important 
that they undergo a preoperative consultation to identify if they are suitable for it.  The criteria 
for surgical treatment are that the candidates' disease should have been stable for at least 6 
months and this is assessed by there being a lack of new or worsening lesions (Hossain et al., 
2016). 
 
For surgical treatment, the site used as a skin donor (a site on the patient's own body) is usually 
positioned on the upper lateral thigh or the gluteal region and before being used the area is 
shaved to avoid any interference.  The proximal portion of the lateral thigh is usually preferred 
as a donor site for grafting as it has a relatively more even plane and as far as cosmetic 
suitability is concerned, making it more preferable to patients (Nahhas et al., 2019). 
 
The blister technique (epidermal blister transplantation) is a surgical option, using the roofs of 
artificially created skin blisters as a source of melanocytes, to treat areas of vitiligo that are 
stable but refractory.  There are three main stages to this technique which are: creation of the 
blisters, preparing the recipient site and transplanting the blisters to the recipient site.  To create 
the skin blisters a special suction device is applied to the skin of the donor area.  The recipient 
area is then prepared for receiving the donor skin by creation of superficial erosions, of 5-6mm 
in diameter, via ablation with an Erbium-YAG laser.  The roofs of the created skin blisters are 
then removed with scissors and smooth forceps and transferred to the erosions that have been 
made in the recipient area.  To protect these transplants silicone sheets are applied to them 
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before they were covered with a standard gauze and kept in place with an adhesive bandage to 
fix them in place and stop the transplant from moving (Dellatorre et al., 2017). 
 
One particularly novel technique for the treatment of vitiligo is the replenishment of 
melanocytes by autologous melanocytes.  The advancement of culturing melanocytes means 
that it is now possible to treat large recipient areas with smaller skin samples.  In this technique 
a superficial shave biopsy is taken, melanocytes are separated from the epidermis and cultured 
in M2 medium.  For good cosmetic results, important factors to account for are the age of the 
patient, site of vitiligo and most importantly stability of vitiligo.  In stable vitiligo, autologous 
melanocyte transfer is a simple and effective treatment to quickly produce homogeneous 
pigmentation.  The disadvantage of cultured melanocytes over non-cultured melanocyte 
techniques are that they are time-consuming and labour intensive to prepare.  The benefits of 
cultured melanocytes are that they require very little donor skin and that they can be used to 
cover an area that is over 100 times the donor area (Verma et al., 2014).  The limitations of 
autologous cultured melanocytes mean that non-cultured melanocyte transfer should always be 
the first choice of technique in not so widespread vitiligo.  The use of autologous melanocytes 
when compared to cultured melanocytes produces a much better result with the non-cultured 
techniques since other techniques have various deficiencies, such as cobblestoning, pigment 
mismatch and patient discomfort (Verma et al., 2014).  
 
1.3 Significance of the study topic 
As stated in the above sections, there are several treatment options for vitiligo that are already 
available which can broadly be defined as being either medical, light based, surgical or a 
combination of all of these (Nahhas et al., 2019).  The purpose of my doctoral work was to 
develop and modify a skin cell co-culturing technique with the aim of enhancing an already 
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existing surgical grafting technique entitled the melanocyte/keratinocyte transplantation 
procedure.  Gauthier and Surleve-Bazeille were the first to introduce this technique in 1992 
and since then, it has undergone many modifications.  In recent years, the popularity of using 
the melanocyte/keratinocyte transplantation procedure (MKTP) for treating patients with 
vitiligo has shown a sharp rise.  In this technique, a type of cell grafting, a suspension of cells 
is made from a graft of donor skin and it is applied to an appropriately prepared recipient site.  
The biggest advantage of this procedure is that a graft from a relatively small area can be used 
to treat a much larger area, usually at a size ratio of 1:10 (Altalhab et al., 2019). 
 
The aim of my doctoral work was to further improve the MKTP method that relies on the 
creation of a cellular suspension from a skin graft.  The disadvantage of this method is that as 
of yet the constitution of the cellular suspension cannot be precisely defined and it was the aim 
of my doctoral work to improve upon this shortfall so that the treatment can be tailored 
appropriately to the patients’ needs rather than being one general treatment to treat all cases of 
vitiligo, regardless of variance in disease presentations. (Bassiouny and Esmat, 2018). 
 
My work is novel since at present the exact ratio of melanocytes to keratinocytes in the cellular 
suspension is not controlled and developing a method to do this was one of my aims.  Currently, 
a generic cell suspension is being used and as such the exact cellular suspension composition 
is not known, meaning it could consist of various cell types in any ratios.  In my work, I have 
extracted not only melanocyte cells but also keratinocyte cells.  Even if previous methods used 
a pure melanocyte suspension my work is an improvement of this since I have created a 
melanocyte/keratinocyte co-culture suspension.  Not only was the melanocyte-keratinocyte 
ratio controlled but a method was developed to manipulate this ratio by the factors UV light 
and hormone (ɑMSH) to create the optimal ratio as required for the treatment of patients on an 
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individual case by case basis.  The literature suggests that existing techniques prior to my study 
do not appear to do this (Tawfik et al., 2019). 
 
To create a cell suspension of known composition, it was vital that I optimized a co-culture 
media to support the growth of both melanocyte and keratinocyte cell types.  As of yet the 
availability of co-culture media is limited and they have been created for molecular biology 
rather than clinical use (Goers et al., 2014).  By creating my own co-culture media, I could be 
sure of its contents, meaning that I could also control it.  Another disadvantage of commercially 
available media is that they are not cost-effective and are in fact very expensive to purchase 
(Kumar et al., 2012).  Once I have been able to optimise my co-culture media, it was important 
that I created a method to confirm that the required cells were present, this was done by flow 
cytometry and marker analysis.  For clinical use, different melanocyte/keratinocyte ratios 
might be required for each patient depending on their needs, this was the driving force behind 
my creation of a technique to co-culture cells at different ratios, with my experimental work 
identifying that some ratios grow better in in vitro culture than others.  
 
Further fine adjustments may be made to the cellular ratio in the composition by 
chemical/environment/physical stimulants.  I chose to manipulate my cell proportions by 
exposing the cultures to the hormone alpha melanocyte-stimulating hormone (α-MSH) and UV 
light.  I chose these two factors because they are widely and easily available, as well as this 
there is a reasonable amount of published literature on them (Nguyen and Fisher, 2019).  The 
only way to measure the success of my melanocyte/cellular suspension for therapeutic work is 
via clinical trials, which is the next step after my basic scientific research work has been 
completed. 
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Figure 1: A flow diagram illustrating the steps that were undertaken for the experimental work 
of my study  
Isolate cells from skin samples and establish pure melanocyte/keratinocyte lines 
 
Create and optimize co-culture media for melanocyte/keratinocyte cells that will support the 
required cell ratios 
 
Measure melanocyte/keratinocyte ratios to ensure that the required cell ratios are being 
obtained 
 
Adjust melanocyte/keratinocyte ratios via alpha-melanocyte stimulating hormone and 
exposure to UVB light 
 (test various concentrations/ratios of both these factors to determine the optimal dose) 
 
1.4 Research questions 
Aims and broad objectives 
The broad aim of my doctoral work was to further develop the MKTP method by manipulating 
the melanocyte/keratinocyte ratios in the cellular suspension and before my study this had not 
been done.  The longer-term aim as a result of my work is that the techniques developed in my 
doctoral work will help to inform the creation of patient specific treatments for the disease 
vitiligo vulgaris. 
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Specific objectives 
1) To isolate and characterize melanocytes based on their cellular, biological and phenotypic 
properties. 
2) To isolate and characterize keratinocytes based on their cellular and phenotypic features. 
3) To establish and examine the co-culture methods for melanocytes and keratinocytes in different 
culture conditions. 
4) To manipulate and assess the co-culture methods of melanocytes and keratinocytes by exposing 
to alpha melanocyte-stimulating hormone and UV light. 
 
1.5 Structure of the thesis 
In this chapter I have provided an introduction and background to the study.  I have also provided 
 a rationale for the study as well as an explanation of the significance of the study topic.  Chapter 
two will provide a review of the current literature.  Chapter three describes the methodology and 
outlines the methods that have been used.  Chapter four will explain the results of the  
experiments that were conducted.  Chapter five will critically discuss the results of the present 
study with already available literature on the study topic.  Finally, the summary and conclusion of 
the study will be provided along with bibliography and appendices. 
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CHAPTER TWO: LITERATURE REVIEW 
 
2.1 Introduction 
In this chapter, I have built upon the introduction to the study in Chapter 1 with a more detailed 
background and context for this study.  The first part of this chapter has identified the search 
strategy that was used.  I will then provide an account of the anatomy and physiology of normal 
skin.   After this I will focus on the topic of vitiligo which will involve a critical discussion of 
what the disorder is, its prevalence, as well as a summary of the different types of vitiligo and 
its histological/clinical presentation.  After this I will then critically outline the currently 
available treatment methods. 
 
2.1.1 Search strategy 
The initial electronic searches that were used to identify relevant studies for my work consisted 
of searching selected online medical/scientific electronic databases and journals.  The first 
search took place to assess how much relevant literature was available on my topic.  Once a 
general search had been completed it was superseded by a more refined search and finally an 
inspection by eye of the indexes of a few chosen medical journals.  Hand searching was carried 
out where it was possible to obtain the reference lists of relevant studies and these were 
searched to find appropriate further trials.  Several commonly used health related electronic 
databases were identified and searched to allow for a wider range of articles to be captured as 
no one database is exhaustive.   
 
The electronic databases that were searched were: 
1. Web of science 
48 
 
This online citation indexing service gives the user admission to several databases referring to 
scientific research across a range of subjects.  
 
2. Cinahl 
A database that contains published research in healthcare but specifically for subjects related 
to the fields of nursing, allied health and biomedicine.  
 
3. Cochrane library 
A group of databases specialising in medicine and other specialties related to healthcare.  It is 
essentially a database for systematic reviews and meta-analyses, summarising and interpreting 
medical research.  This service aims to make the results of relevant healthcare trials readily 
available and it is an important tool for evidence-based medicine. 
 
4. Google scholar 
This is a web search facility which provides access to literature across a wide range of 
subjects.   
 
5. Canterbury Christ Church University (CCCU) 
This is the university's tool for accessing library resources, such as finding printed books, e-
books and articles from journals.  It can be used to find where printed books are located as well 
as identifying e-books and online journal articles.  
 
6. Science direct 
This website provides admission to over 12 million pieces of literature on research in science 
and medicine. This includes 34,000 e-books and 3,500 academic journals.   
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7. PubMed 
This free search engine accesses literature on the topics of life sciences and biomedicine.  It is 
particularly useful for identifying abstracts of relevant research topics. 
 
The following search strings were used to conduct a preliminary search using the databases 
that are mentioned above: 
1. co-culture AND melanocytes AND keratinocytes 
2. vitiligo AND melanocytes AND keratinocytes 
3. vitiligo treatment using cultured skin sheets 
 
The following additional keywords/search strings that were not involved in the original 
proposal were used later to broaden the search and identify papers of more relevance.  These 
were: 
1. Treatment of vitiligo 
2. Surgical treatment of vitiligo 
3. Medical treatments for vitiligo 
4. Autologous cultured melanocytes 
5. Ultra thin epidermal sheets 
6. Basal layer cell suspension 
7. Micropigmentation 
8. Image processing 
9. Image J 
10. Melanocyte stimulating hormone AND vitiligo 
11. Basic fibroblast growth factor AND vitiligo 
12. Interferon gamma AND vitiligo 
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13. Ultraviolet light AND vitiligo 
14. Management/treatment of vitiligo in vitro 
15. Measurement of cells in culture not suspension 
These key words/ phrases were combined to produce various search strings using the “and” / 
“or” Boolean operators. 
 
2.1.2 Primary search 
The initial search used key words one at a time and then combined them into different 
phrases.  Since a search such as the one described produced many hundreds of results it was 
decided to include parameters to narrow it down and make it easier to identify important journal 
papers.  The date limit was set from 2013 to 2019.  Papers before 2013 were discarded (unless 
the work was thought to be highly important or useful for explanatory purposes) as this field is 
very fast moving and any papers before 2013 are likely to be outdated or irrelevant.  Papers 
over five years old were also not used because there is so much literature on the field that 
including any literature from a date earlier than this would identify so many papers it would be 
impossible to read them all but any later might miss key new discoveries in the field.  Setting 
this time limit also allowed me to narrow down what was a very broad search in a manner that 
has reason and logic rather than it just being random. 
 
2.1.3 Refined search 
A secondary (refined) search using a more complex combination of the keywords/phrases 
depending on the number of hits produced by each key word was undertaken to narrow down 
and improve the accuracy/relevance of the results found. A literature search was performed to 
find abstracts and full text articles, and relevant articles were identified using a search by eye 
for the relevance of the article titles and abstracts to my study. 
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2.1.4 Appraisal 
Every piece of literature that was identified as being relevant was subject to critical analysis 
before being accepted or rejected for inclusion as evidence to enable an answer to be obtained 
to the research study objectives.  The critiquing of the research took a consistent approach and 
consistency in the way conclusions were made and how bias was removed in the appraisal 
process was achieved by the way in which the literature was analysed.  In this review, I used 
several tools to critically appraise the literature.  
 
The Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) (Moher 
et al., 2009) (www.prisma-statement.org) tool was used to assess the quality of published 
reviews. The primary function of this tool is to enhance how authors report systematic reviews 
and meta-analyses however; it can also enable the critical appraisal of qualitative studies 
(PRISMA, 2015).  CASP (Critical Appraisal Skills Programme) is another useful tool. It was 
created with the aim of assisting health care workers to acquire research skills which fulfil the 
requirements for Evidence Based Medicine (CASP, 2015) (www.casp-uk.net).  Currently eight 
critical appraisal tools are freely accessible from the CASP website.   
 
Every specific tool is accompanied by a checklist that is unique to the literature being 
examined. When the questions are answered in their predetermined order to assess the relevant 
paper it can be decided whether the evidence in the paper is important and robust enough that 
it should be included or if it should be discarded. There are three steps in the approach to using 
CASP. Firstly, the study is valid if it is judged to be unbiased based upon evaluation of its 
methodology. After this, classification of the article is based around validity via a scale of 
levels of evidence.  
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When a study is presumed to be credible the next step is to analyse its results. The first aim of 
CASP is to examine if the results are of clinical importance. The second thing is to identify 
how certain the results are.  This is achieved via the examination of statistical parameters for 
instance: p values, confidence intervals and the sensitivity analysis. CASP’s third enquiry aims 
to find if the study results are useful and if they apply to the study questions.  Each of the search 
terms provides a different classification of vitiligo, each of which will be discussed below.  A 
criticism of using the CASP and PRISMA tools are that there are limitations to the number of 
keywords which means that the search must be repeated several times to make sure that all the 
required search query keywords have been included (Tursunbayeva et al., 2016).  The next 
section of this review will examine what the disorder of vitiligo is and then classify it.  The 
CASP and PRISMA tools are extremely useful as they provide a structured way to analyse the 
literature and determine its relevance. 
 
2.2 Classification and incidence of vitiligo 
The way that vitiligo is defined is influenced by a number of factors that include medical 
diagnosis, psychosocial impact, and whether recorded as prevalence or incidence.  As 
described further in this section, several definitions are available for vitiligo.  Vitiligo has been 
defined histopathologically as the “total absence of functioning melanocytes in the lesions, 
whilst the inflammatory cells most commonly found on the edges of the lesions are CD4+ and 
CD8+ T lymphocytes” (Faria et al., 2014).  One description of vitiligo is that it is: “an acquired 
chronic depigmenting disorder of the skin resulting from selective destruction of melanocytes” 
(Ezzedine et al., 2015).  According to another definition it is: “an acquired cutaneous skin and 
less frequently hair disease characterized by declining melanocyte function and depigmentation 
with an estimated prevalence of 0.5–1% in most populations.” (Bellei et al., 2013).  Vitiligo 
was further defined as: “a common skin disorder causing depigmented macules that can impair 
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a patient's quality of life” (Komen et al., 2015).  Vitiligo is a condition where the skin's 
epidermis lacks melanin, which is due to the absence of melanocytes (Ghafourian et al., 
2014).  Vitiligo as a disorder is reasonably common but as shown in Table 2 below there are 
slightly different figures for the incidences of vitiligo ranging from 0.5% to 4%.    
 
It has been reported that the large range that exists in the reported rate of vitiligo could be 
attributed to the fact that at present consensus is lacking with regards to defining and the 
methods of assessing this disorder making rates reported differ considerably (Al Ghamdi et al., 
2012). In both lesional and non-lesional skin of vitiligo patients, increased levels of reactive 
oxygen species (ROS) were observed, accompanied with reduced levels and activity of catalase 
(Li et al., 2015). 
 
One of the latest definitions of vitiligo taken from a nature article of 2018 is: Vitiligo is defined 
as a common depigmentary disease characterized by the destruction of melanocytes in the 
epidermis (Harris, 2018).  Nature articles can be viewed as a robust body of evidence since 
publishing in high impact journals such as this one requires strong proof and noteworthy 
conclusions. Publishing an article in Nature is widely regarded as being highly prestigious and 
there are few journals that it is more difficult to publish in than this one. 
 
The Ghafourian et al. (2014) definition gives a general description of vitiligo whilst other 
studies (Patel et al., 2017) quote figures for the range of prevalence of vitiligo but sometimes 
the findings of different papers do not agree, for example they might quote a range of incidence 
of vitiligo that is much narrower than that reported in many other studies of a similar nature 
(Bellei et al., 2013).  The table below demonstrates the extent to which the reported incidence 
rate of vitiligo varies.  As mentioned previously there are several reasons for this variance 
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which includes factors such as that when it comes to defining this condition there is a lack of 
agreement as to how this should be done.  
 
Table 2: A table representing the range in vitiligo incidences reported amongst different studies 
Vitiligo 
incidence rate 
Paper Author(s) Year 
0.5 % 
(average) 
Vitiligo part 1 Tarle et al. 2013 
0.5% to 2% Vitiligo: symptoms, pathogenesis and treatment Ghafourian et 
al. 
2014 
1% to 2% Survey of dermatologists’ phototherapy practices for 
vitiligo 
AlGhamdi et 
al. 
2012 
1% to 3% Advanced treatment modalities for vitiligo Patel et al. 2012 
0.5% to 1% Concise review of recent studies in vitiligo Allam and Riad 2013 
1% to 4% The efficacy of 308 nm UV excimer light as 
monotherapy and combination therapy with topical 
khellin 4% and/or tacrolimus 0.1% in the treatment of 
vitiligo 
Bagherani 2015 
 
 
The occurrence of a disease can be defined as its prevalence or as its incidence. The meaning 
of these two terms differs since prevalence is the proportion of cases at a given time in a 
population rather than how many new cases are occurring.  The incidence gives us information 
as to how probable it is that a condition will occur during a specific period of time. In the papers 
that were referred to, the rate of incidence was used to report the occurrence of vitiligo in the 
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population.  According to Tarle et al., (2013), different countries report different figures for 
the prevalence of vitiligo for example: 0.093% in China, 0.34% on the island of Martinique, 
0.38% in Denmark, 1% in U.S. and 0.5% to 1.13% in India. 
 
Many cases of vitiligo involve children with approximately half of all affected individuals 
experiencing the start of their disease before the age of 20.  Since childhood is such an 
important time in psychological and psychosocial development it is crucial that the full extent 
of the effect of this disease as well as the means of its alleviation is understood.  As described 
in Cadmus et al. (2018), children affected with vitiligo definitely experience a decreased 
quality of life. 
 
Cadmus et al., (2018) explains that in children the psychological effect of this disease is 
greatest in those with dark skin as the patches are more striking and they have a greater 
disfiguring effect, but it is likely that this also extends to adult patients.  It could be the fact that 
vitiligo is more visible in dark skin that has led to the different figures in Tarle et al. (2013) 
and Patel et al., (2012).  Differences in visibilities of this condition might mean that those with 
light skin but who still suffer from the condition are less likely to notice and report it in 
comparison to darker skin individuals which might lead to an interpretation of different 
occurrence rates in different countries.   
 
Both men and women are affected equally by vitiligo with differences being apparent in the 
occurrence rate being down to the person's prototype and race.  Previously it was believed that 
women are affected more than their male counterparts, but recent studies have found that bias 
does not exist with regard to sex (Steiner et al., 2004; Tarle et al., 2013).  In 25% of cases the 
affected persons are children who show symptoms of the disease before they are 10 years old 
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with total variance in age being anything between 4 to 8 years.  It has even been reported that 
very early onset, which can be as young as 3 months, has been previously acknowledged 
(Boniface et al., 2017).  However, the mean onset is at an age of approximately 20 years old 
(Tarle et al., 2013). 
 
To deal with there being a lacking consensus with regards to the classification and assessment 
of vitiligo, the Vitiligo European Task Force (VETFa) was formed in 2003 with three major 
goals, which are to: 1) propose a consensus definition of vitiligo 2) design biometric tools to 
assess the severity/stability and 3) creation of consensus scoring system (Taieb and Picardo, 
2007; Akoglu et al., 2018).  The VETFa (Komen et al., 2015) (Akoglu et al., 2018) is a 
measurement tool that was established to evaluate the extent of existing depigmentation by 
using the rule of nine.  It assesses the extent of pigmentation in four regions of the body which 
are: the head and neck, the trunk, the arms and the legs.  Additionally, VETFa determines 
disease according to a scale of +1 to -1 (+1, progressive; 0, stable; -1, regressive).  
 
It has been found that VETFa was a reliable assessment of depigmentation since both inter and 
intra observer reliability was found to be high (Komen et al., 2015).  To measure interobserver 
reliability in this study three experienced dermatologists/vitiligo physicians were recruited to 
independently assess the extent of depigmentation and compare their findings. In the case of 
intra observer reliability one physician repeated the measurement two weeks after the initial 
one.  This was thought to be a reliable technique since it is unlikely that there will be a dramatic 
change in pigmentation over such a short period of time.  Using just three observers was 
considered to be more than sufficient because the dermatologists are experts in their field so if 
two or more observers agree or disagree it will provide a majority opinion that is most likely 
to be totally reliable. 
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Komen et al. (2015) is the sole paper that describes the VETFa tool.  Clinical scoring was 
performed according to the VASI score (Vitiligo area scoring index) which was originally 
described by Hamzavi et al. (2004) and later in Akoglu et al. (2018). The conclusion of this 
paper is that VASI and VETFa are reliable, but this is debatable.  The number of patients 
sampled is small with only 31 patients being assessed for interobserver reliability and 27 
patients being assessed for intraobserver reliability. The problem with a small study is that it 
reduces the reliability of the results (the statistical power) which means that it becomes more 
and more difficult to identify if a result is not a accurate representation of the actual correct 
conclusions of an entire study.  With no other studies being available and such a small number 
of patients being studied further research must be done to come to a conclusion as to the 
reliability of this tool. 
 
High prevalence rates should be considered with caution since it has been found that this tends 
to occur in some communities where inbreeding (close relatives having children together) is 
common, meaning that genetic factors are probably involved so this figure is indicative of that 
small community rather than the entire population at large.  Another example of where 
prevalence rates are unreliable comes from a study, which arrived at a figure of 8% but was 
based at a skin institute in Delhi (Kruger and Schallreuter, 2012).  Taking figures from a skin 
institute is an unreliable reflection of the actual prevalence rate because by its nature a skin 
institute will have a greater concentration of people presenting with skin disorders thus leading 
to higher figures of incidence reported.  This fact is of relevance when considering the skin 
institute of interest was in India.  By its very nature depigmented macules are more obvious in 
darker skinned individuals than their lighter skin counterparts meaning that more affected 
people will present themselves to a medical professional in a country such as India rather than 
in Europe. 
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2.3 Diversity in melanin production in human skin 
It has been stated that one of the striking phenotypic differences that exists amongst humans is 
how they have different skin colours (Hudjashov et al., 2013).  This difference is thought to be 
because of natural selection with the geographical variation patterns being believed to correlate 
to the latitudinal differences that exist in the annual UV radiation level.  It is thought that the 
optimal level of skin pigmentation is a balance between having skin that is dark enough to 
protect cells from UV radiation but light enough to allow vitamin D formation. 
 
At a chemical level it is explained that the occurrence of such a range of pigmentation being 
present in the hair, skin and eyes of humans can be mostly a result of the diversity of pH in 
melanosomes (Wakamatsu et al., 2017).  For instance, an acidic pH is the factor that inhibits 
the production of melanin, particularly the process of eumelanogenesis. It has also been 
explained that the later part of eumelanogeneis after the dopachrome stage can be significantly 
suppressed by an acidic pH (Ito et al., 2014).  Pheomelanin production is thought to be the 
result of when tyrosine is oxidised by tyrosinase to form cysteinyldopa isomers, crucially 
cysteine is present.  These isomers are oxidised further via benzothiazine intermediates.  
 
The way in which these stages are being controlled by pH has not yet been identified. The 
outcomes of scientific analysis found that the presence of cysteine was required for 
pheomelanin production either from dopa or tyrosine by tyrosinase and this was greatest at pH 
values of 5.8-6.3, whilst eumelanin production was suppressed at pH 5.8. The inference that 
can be gained from these results is that mixed melanogenesis is chemically shifted to more 
pheomelanic states at a weakly acidic pH (Wakamatsu et al., 2018). 
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2.4 Physical and emotional consequences of vitiligo  
Vitiligo might not be life threatening but the appearance of chalky white lesions in various 
places and sizes can give rise to social stigma and leave sufferers vulnerable to psychological 
problems, in particular low self-esteem. This is particularly true of dark-skinned individuals 
where lesions stand out in stark contrast to “normal” healthy skin.  Several studies on this topic 
arrive at the same conclusion: the psychological symptoms attributed to vitiligo and the impact 
that this has on the patient’s quality of life is not to be taken lightly (Eves et al., 2005) (Leeuw 
et al., 2010). Vitiligo shows no preference for sex and it affects both adults and children of 
either gender in the same way (Kruger and Schallreuter, 2012), but women and girls tend to 
present more commonly due to greater prevailing social implications for them than for men 
(Ezzedine et al., 2015).  
 
The consequence of this disorder is that emotionally the patients may suffer with symptoms 
including stress, depression, low self-esteem and have a tendency towards suicidal thoughts 
(Paul, 2011).  The psychosocial impact of this condition cannot be ignored, especially for those 
with darker/tanned skin where the disorder is more obvious.  This condition is also particularly 
difficult for those individuals where highly visible areas such as the face or hands, and in 
children who might be teased or bullied when they reach school age (Whitton et al., 2015).  
 
Quality of life studies have indicated that psychosocial problems that result from vitiligo are 
as significant as those found in patients with eczema and psoriasis (Bilgic et al., 2010) (Hameed 
et al., 2005).  AlGhamdi and Kumar (2011) (this is an older paper but for the purposes of this 
study the results it presents are significant) have quantified the number of people affected by 
side effects of this disorder as depression (10%), suicidal thoughts (10%), sleep disturbances 
(20%) and anxiety (3.3%).   
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A study was presented where the relationship between bullying and skin disorders was 
observed (Magin, 2013).  The term bullying is given to aggressive behaviour or/and intent to 
harm another, an action that might be carried out repeatedly over a period of time.  A defining 
feature of bullying is that the victim finds it difficult to defend themselves due to the presence 
of an imbalance of power.  One feature of bullying is that it is often appearance related which 
would therefore make it surprising if bullying was not associated with skin diseases.  Studies 
have found that strangers often unintentionally caused offence via behaviours such as staring 
or comments that were not deliberate (Magin, 2013).  It has been found that there is an 
association of mental health morbidity with bullying and teasing. Depression is one of the 
diseases that is most often associated with those found in the dermatologist’s office (Tapia et 
al., 2015) (Magin, 2013). 
 
Since vitiligo is usually asymptomatic its effect on quality of life is usually attributed to 
psychological problems such as low self-confidence and unsuccessful social 
relationships.  According to published literature many vitiligo sufferers experience shame and 
embarrassment as well as feelings of low self-confidence and social isolation (Hedayat et al., 
2016).  In some developing countries, the situation is made worse by being associated with 
negative social beliefs, such as that the disease is a punishment from God for past sins.  India 
is one such example of this where vitiligo is considered a form of white leprosy and is 
associated with significant stigma, even going as far as to being the grounds for divorce. 
 
A study was carried out (25 patients as the pilot and another 173 patients as the main study 
group) to assess how having vitiligo affects the quality of life of people suffering from the 
diseases (Hedayat, 2016).  In this paper a pilot study of 25 patients was first performed in order 
that essential modifications could be made to the questionnaire based on the opinions of the 
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research teams, so that the interviewers could adapt their technique accordingly.  An example 
of such a modification was the change in the structure of complicated sentences to make them 
more comprehensible or to use words that were more familiar and made better sense.  This 
study found that the best quality of life was in patients with disease duration of 5 years or less 
or 15-20 years.  It is my conclusion that the reason for this is probably that it reflects either 
higher hopes for successful treatment in the early course of the disease or in the long term the 
patient getting used to it.   
 
Moreover, apart from psychosocial impact, a lack of melanin pigmentation in lesions leaves 
this area vulnerable to UV damage from the sun resulting in an increased incidence of sunburn 
and cancer (Eves et al., 2005) (Olsson and Juhlin, 2002) (Matsumura and Ananthaswamy, 
2003) (Amaro-Ortiz, 2014) (Mujahid et al., 2017).  Such consequences of this disorder occur 
because if the person has white patches of skin it means that they have lost the solar protection 
that is usually offered to it by melanocytes (Olsson and Juhlin, 2002). 
 
Table 3 is a presentation of the results of a study (Bonotis et al., 2015) involving 216 adults 
who were diagnosed with vitiligo but no other skin disorder or major 
psychopathology.  Unfortunately, a limitation of this is that the results of this study are difficult 
to interpret since nowhere in the paper is it mentioned which questionnaire each of these results 
come from.  The table below uses several factors to compare how men and women affected by 
vitiligo react to it and it gives a p value to determine if there is any statistical significance to 
the differences between men and women. 
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Table 3: The effect of vitiligo on a study population in reference to quality of life indicators 
(Bonotis et al., 2015). 
Variables Men (n=101) Women (n=115) P value 
Mean (S.D) Mean (S.D.) 
Age  35.81  12.37 35.65 10.41 0.9171 
Self-esteem  21.95  4.10 20.69 4.51 0.031 
Neuroticism  11.85  4.19 14.58 4.24 <0.00011 
Extraversion  13.79  4.37 13.10 4.37 0.2501 
Psychoticism  3.55  2.96 2.94 2.33 0.091 
Duration (months) 
median (10-90%) 
48  5.2-225 72 7.8-228 0.072 
Extent of disease 
(percentage) median (10-
90%) 
5.02  1.5-18 7 2-15.4 0.062 
DLQI median (10-90%) 2  0-8 3 0-11 0.0092 
GHQ-28 median (10-
90%) 
2 0-10.8 4 0-12.4 0.0022 
  Abbr.: DLQI, Dermatological Quality of Life Index; GHQ-
28, General Health Questionnaire 28, 1t-test, 2Mann-
Whitney 
 
The p-value is an important aid to analysing the results because if there is a p value of less 
than/equal to 0.05 than the difference seen between men and women is statistically significant 
but if the p-value is higher than 0.05 then the difference is not statistically significant, thus 
indicating that evidence against the null hypothesis is weak.  From the table above we can see 
there is now a significant difference in the age of the participants, extent and duration of their 
disease meaning that these factors should not influence the results.  Self-esteem and 
neuroticism did exhibit significant p values meaning that men and women did differ in their 
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reaction with regard to these factors with women being significantly more affected in these 
areas. 
 
2.5 Types of vitiligo  
The two types of vitiligo are non-segmental vitiligo and segmental vitiligo.  The most common 
is non-segmental vitiligo and it is characterized by lesions which are symmetrical and bilateral 
white patches.  Symmetrical areas that these patches appear on are the: backs of hands, arms, 
skin around body openings (e.g. the eyes), knees, elbows and feet.  The two types of vitiligo 
have been found to present different behaviours and responses to therapy (Picardo, 
2011).  There are several subtypes which are classified as generalized, acrofacial and 
universalis, each presenting with a bilateral distribution (affecting both sides of the 
body).  Also, in occurrence are some unclassified and rare variants such as vitiligo punctate, 
vitiligo minor/hypochromic vitiligo and follicular vitiligo (Boniface et al., 2017) which will be 
discussed in more detail further on. 
The vitiligo society has also developed definitions for segmental and non-segmental 
vitiligo.  According to this society segmental vitiligo is identified as a unilateral and localized 
spread of vitiligo patches.  Van Geel (2013) states that the mechanisms behind vitiligo are an 
enigma.  To develop a deeper understanding of this condition the distribution was compared 
amongst different skin conditions possessing mosaic or neurogenic backgrounds.  The results 
of these observations found segmental vitiligo does not show a similar pattern of distribution 
to other skin conditions but there is more overlap between vitiligo and some mosaic skin 
disorders than others.  The conclusion of Dr. Van Geel is that the classification of segmental 
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should be separate from other forms of vitiligo and the descriptor ‘vitiligo’ should be used as 
an umbrella term for all non-segmental forms of vitiligo. 
 
It has been observed that non-segmental vitiligo can develop at any age but it is most common 
in young people between 10 and 30 years old.  Segmental vitiligo characteristically appears in 
a unilateral distribution but this is less common and only happens in 5-16% of vitiligo cases.  
Non-segmental vitiligo is not limited to a set age range whilst segmental vitiligo is most 
common in the young, with 87% of cases appearing before 30 years and 41.3% before 10 
years.  The most basic diagnosis of both types of vitiligo is the loss of pigmentation in a patchy 
form from the skin, any overlying hair and in some cases the mucosa (Ezzedine et al., 
2015).  The subset of vitiligo present in the patient must be defined so that treatments can be 
tailored accordingly.  Often the reaction of the patient to any treatment is dependent upon the 
type of vitiligo that they are affected by. 
 
2.5.1 Segmental vitiligo 
Focal 
This is where there are one or more colourless areas of skin but without a typical segmental 
distribution.  Focal vitiligo is a rare subset of vitiligo with only 3.3% of patients out of the 
entire population identifying as being affected with this condition (Lommerts et al., 2016). 
 
Segmented 
This is where there are one or more colourless patches of skin; this often follows dermatomal 
distribution and involves a unilateral body segment.  Segmentary vitiligo presents onset at an 
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early age (between 5 and 30 years of age) and has no linkage to autoimmune 
diseases.  Segmentary vitiligo has greater resistance to treatment than the non-segmentary type 
(Anbar et al., 2006) (Ezzedine et al., 2011). 
 
Mucosal 
In this type only the mucous membranes are affected (Nagarajan et al., 2014). 
 
2.5.2 Non-segmental vitiligo 
Research appears to suggest non-segmental vitiligo can be attributed to being an autoimmune 
condition where the effect of this is the destruction of melanocytes (pigment cells) (Whitton et 
al., 2015). 
 
Acrofacial 
Typical lesions presenting in the toes or fingers (Zamanian et al., 2014). 
 
Vulgar 
Colourless patches of skin showing a random distribution.  There is no specific age for this and 
it is often linked to having an autoimmune disease, especially those of the thyroid 
(Schwartzmann-Solon, 1998) (Karelson et al., 2011).  
 
Mixed 
A combination of different types such as acrofacial and vulgar or segmentary and acrofacial 
with/without vulgar (Kovacevic et al., 2016). 
 
Universal vitiligo 
A depigmentation of 50% or more of the skin area and/or mucous membranes (Al Ghamdi and 
Kumar, 2011) (Majid and Imran, 2017).  
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2.5.3 Clinical presentation 
Clinical characteristics of this disorder are development of white macules of varying size, 
anything from a few millimetres to covering the entire body, which are attributed to the 
disappearance of functional melanocytes in the hair and/or skin (Ezzedine et al., 2015) (Figure 
2).  Characteristics of segmental vitiligo are that lesions are unilateral and segmental/band 
shaped.  The lesions of non-segmental vitiligo show bilateral distribution in an acrofacial 
arrangement or they are most usually located over the entire body in a scattering of a 
symmetrical nature and show evolution over time (Ezzedine et al., 2015) (Galvez et al., 2018).  
It is possible for non-segmental vitiligo to initially present in a distribution that is acrofacial in 
nature and then progresses later to a generalised or universal form. 
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Figure 2: An illustration of how vitiligo lesions present themselves (Ezzedine et al., 2015). 
Please note the stark white patches in contrast to normally pigmented skin.  Histological 
examinations showed that in lesioned skin there is an absence of melanocytes, however in some 
cases an occasional melanocyte can be seen.  The white areas in the above diagrams are the 
melanocyte absent vitiliginous regions. 
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2.5.4 Unclassified and rare variants 
2.5.4.1 Vitiligo punctate 
In this condition lesions appear as depigmented punctiform macules that are 1 to 1.5mm in size 
and have a sharp demarcation that can involve any body area.  Guttate hypomelanosis is a 
common condition which must be distinguished histopathologically from vitiligo punctate and 
is where there is a lack in occurrence of melanocytes where they are found on chronically sun 
exposed sites, examples of which are the legs and forearms (Boniface et al., 2017). 
 
2.5.4.2 Vitiligo minor/ Hypochromic vitiligo 
It has been stated that the only individuals that tend to be affected by this disease are those of 
darker skin (Boniface et al., 2017).  The ‘Minor’ part of the name of this condition can be 
attributed to the pigmentation defect being of a partial nature.  This variety can be related to 
‘true’ vitiligo via pathology and coexistence with more typical vitiligo macules.  It is important 
to note that repeated biopsies are required to rule out cutaneous T cell lymphoma with 
molecular studies of clonality and long-term follow-up is needed before any diagnosis can be 
made (Sharma, 2015). 
 
2.5.4.3 Follicular Vitiligo 
This name is given in reference to a type that was described by (Boniface et al., 2017).  In this 
example a young black patient who had generalised vitiligo that mostly involved the reservoir 
of the follicular pigment had restricted skin involvement and contrasting marked generalized 
hair whitening.  This contrasts with common vitiligo where hair depigmentation is followed by 
cutaneous depigmentation.   This happens in skin with a clinically normal appearance as well 
as in vitiliginous areas (Gan et al., 2016). 
 
69 
 
2.5.5 Diagnosis of vitiligo 
The practice of diagnosis revolves around both normal and colourless skin patches existing in 
the same person.  A woods lamp of 351 nm will cause affected skin to fluoresce blue white as 
because of 6-biopterine and 7-biopterine accumulating in these areas.  This lamp is very useful 
for identifying lesions in which visualising by the naked eye is difficult (Allam and Riad, 2013) 
(Oiso et al., 2013) (Plensdorf et al., 2017). 
 
2.5.6 Causes 
The occurrence of vitiligo can be attributed to a dynamic interaction of environmental and 
genetic factors that initiate melanocytes in the skin being attacked by the autoimmune system 
(Rashighi and Harris, 2017).  A variety of different theories have been presented for explaining 
the cause of vitiligo pathology and mechanisms that lead to functional epidermal melanocytes 
being lost (Bishnoi and Parsad, 2018).  Important theories include the individual possessing a 
genetic disposition to vitiligo, the autoimmune destruction of melanocytes, melanocyte damage 
via free radicals or catecholamine’s/neurotransmitters or heightened sympathetic response.  It 
is the combination of all these theories that essentially explain the vitiligo pathogenesis (the 
combination theory) (Bishnoi and Parsad, 2018). The consequence of the autoimmune theory 
is that before any surgical transplantation treatment vitiligo lesions should exhibit stability (this 
will be described further later in this chapter). 
 
The reason for melanocyte loss is subject to several theories, characteristically observed in 
those suffering with vitiligo.  The theory of genetic causes is supported by the fact that in 
approximately 20% of cases the vitiligo patient has at least one close blood relative that is also 
affected by this condition. Genome wide association studies have managed to identify some 
loci that exhibit susceptibility for the development of generalised vitiligo, one locus is the gene 
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that encodes tyrosinase (TYR).  Tyrosinase is an enzyme in melanocytes which catalyses the 
rate-limiting step in melanin biosynthesis.  It may be stated that vitiligo should be classified as 
a polygenic disorder since its onset is known to involve at least three different allelic genes 
(Majumder et al., 1993). This highlights the importance of genetic factors in developing vitiligo 
pathology. 
 
A genetic predisposition for this disease means that certain environmental chemical substances 
can show selective toxicity to melanocytes.  One such substance is hydroquinone, where hyper 
pigmented lesions are given topical treatment but for genetically susceptible individuals this 
has been found to be poisonous (Steiner et al., 2004).  Genetic factors are important even in 
typical vitiligo cases (Spritz and Anderson, 2017).  In early clinical cases it was observed that 
probands relatives had a vitiligo frequency of 11% to 38%.  Early clues to the heritability of 
vitiligo were in the fact that it happens more frequently in the immediate relatives of those 
patients with it.  In fact, research mentions (Spritz and Anderson, 2017) that vitiligo heritability 
is 46% to 72%.  For instance, in the general population it has been found that about 1% of 
individuals are affected by vitiligo but in a patient’s sibling the risk of development is 6% 
whilst in a study of European-derived white monozygotic twins the concordance of vitiligo is 
23%.  
 
In a study of European derived monozygotic twins, it was found that in probands first-degree 
relatives the overall vitiligo frequency was 7% whilst the risk in probands parents and siblings 
was 7.8% and 6.1% respectively (Spitz and Anderson, 2017).  These findings were consistent 
with polygenic, multifactorial inheritance and age-dependency of vitiligo onset.  Another 
important outcome found by the study of vitiligo probands is that male and female subjects had 
an equal vitiligo frequency.  This eliminates any female sex bias that is to be found in the 
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majority of vitiligo clinical case series.  In studies (Spitz and Anderson, 2017), it is mentioned 
that in a study of families where multiple relatives were suffering from vitiligo there appeared 
to be an earlier age of onset as well as an increased skin surface involvement in comparison to 
singleton cases.  The culture of melanocytes that are sourced from patients that have an active 
vitiligo have been found to have a reduced expression of c-Kit and stem cell factor.  These 
receptors are important for melanocyte differentiation and any subsequent melanisation 
(Steiner et al., 2004). 
 
The cause of vitiligo is believed to be multifactorial as disease initiation and progression can 
be attributed to both genetic and environmental factors (Ezzedine et al., 2015).  In the case of 
between 10% and 76% of patients the onset of this disease is attributable to some sort of 
precipitating factor in those individuals that are genetically predisposed to the condition such 
as intensive stress, intense solar exposure or exposure to certain pesticides. 
 
A progressive loss of melanocytes is often observed in cases of vitiligo, especially in non-
segmental vitiligo.  The full mechanism behind the development of vitiligo remains unknown 
but there are several key theories as to why this disorder occurs.  Three popular theories behind 
the development of vitiligo are: the destruction of melanocytes (autoimmune, neural and 
impaired redox status), melanocytes inhibition or defective inhibition.  At present, several 
different therapeutic modalities are available but therapeutic demands remain unmet.  To 
bridge the gap over the last few years, new aetiology-based treatments have been developed 
(Lee et al., 2012; Hameed et al., 2005). 
 
The melanocyte destruction theory is probably the most favoured for explaining the cause of 
vitiligo however this has never been clearly demonstrated.  The destruction of melanocytes 
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occurs either by apoptosis or necrosis, and animal studies have suggested the most likely 
underlying pathway is apoptosis.  In contrast to these animal studies, the apoptosis of human 
skin melanocytes has never been demonstrated.  In addition, the intrinsic destruction of 
melanocytes via apoptosis is also reasonably higher than in healthy skin (Hameed et al., 2005) 
(Yee et al., 2000) (Qiao et al., 2016). 
 
The autoimmune theory is one of the leading hypotheses for the cause of vitiligo as it is based 
on the observation that there is often a co-morbidity between vitiligo and several other 
autoimmune disorders e.g. thyroiditis (Speeckaert et al., 2014).  Since one theory behind 
vitiligo is that it is an autoimmune disease, whose target is pigmentary cells, some treatments 
revolve around immune suppression.  To suppress the immune reaction against melanocytes 
treatment methods include immunosuppressant’s, such as topical steroids, cytotoxic drugs and 
PUVA.  The strongest evidence for vitiligo being caused at least partly by immune reasons is 
that many patients have autoantibodies to melanocytes in their circulation giving even more 
support to the notion that vitiligo lesions must be stable before melanocyte transplantation is 
performed. 
 
Studies (Spitz and Anderson, 2017) observed that there was a greater than normal frequency 
of autoimmune diseases in vitiligo subjects which suggests that in multiplex families of this 
type it is probably the case that genetic factors have a higher contribution to vitiligo risk than 
in singleton cases.  This highlights the case that genetic factors are important as well as non-
genetic contributors in the pathogenesis of vitiligo (Spritz and Anderson, 2017).  In addition to 
this, patients with vitiligo and their relatives show a greater likelihood as far as the development 
of autoimmune diseases such as Addison disease, type 1 diabetes and pernicious anaemia 
(Rashighi and Harris, 2017).   
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The earliest evidence suggesting that vitiligo is of autoimmune origin was the original 1855 
report of Addison disease (Spitz and Anderson, 2017).  This report included a patient that had 
idiopathic adrenal anaemia, generalised vitiligo and idiopathic adrenal insufficiency and 
etiological factors were suggested by the co-occurrence of autoimmune disease. Since this case 
example various other investigators have noted that vitiligo often co-occurs with autoimmune 
disease.  Therefore, for any surgical vitiligo treatment to be effective it is best if disease has 
been stable for at least 6 months signifying that the autoimmune component is at minimal 
activity.  It is also important to note that these same autoimmune diseases happen more often 
in the first-degree relatives of vitiligo probands who themselves do not have vitiligo.  This 
suggests that vitiligo shares at least some of its genetic foundations with autoimmune disease 
(Spitz and Anderson, 2017).   
 
It is for this reason that a vitiligo patient must have disease stability for at least 6 months with 
lesions presenting no new expansion before they receive any interventional surgical 
treatment.  The occurrence of stable disease patches minimizes the risk of the patient suffering 
from any active autoimmune component and maximizes the likelihood of successful treatment 
since it reduces the chances of the transplant failing due to being attacked by the person's 
immune system (Sahni and Parsad, 2013). 
 
A study of 1098 patients (Gill et al., 2016) found out that 217 (19.8%) of vitiligo patients were 
affected by at least one other comorbid autoimmune disease.  The study originally consisted of 
1873 patients who were seen between January 2002 and October 2002.  595 patients were 
excluded from the study for having less than 2 dermatology nodes and 180 for not having a 
diagnosis of vitiligo from a dermatologist which has led to the figure of 1098 patients as 
mentioned above.  It was not found to be statistically significant but individuals with non-
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segmental vitiligo were twice as likely as other vitiligo sufferers to have an associated 
autoimmune disease. An investigation (Saleh et al., 2013) found that 83% of the 29 patients 
with vitiligo were found to have an autoimmune disease versus autoimmune disease being 
present in 7% of the healthy controls.  Whilst this study might appear to be reasonably small 
(only 29 patients) it does give an indication that there is surely a link between suffering from 
autoimmune disease and vitiligo since vitiligo patients definitely have a greater incidence of 
autoimmune disease than normal healthy sufferers. 
 
The most common conditions with an association to vitiligo are thyroid disease and alopecia 
areata.  Both conditions present higher prevalence in these cases than in the general US 
population.  In the general US population prevalence of thyroid disease is between 0.4% and 
2.0% whilst Fricke and Mileva (2015) state that the prevalence of alopecia areata is 
2%.  Clinical thyroid disease showed a 15-fold increase in vitiligo patients compared to the 
general population and females had a 4-fold higher rate than males.  The limitations to this 
study (Fricke and Mileva, 2015) were that a control group was lacking and this study only took 
place in one institution, this infers that there is a possibility for selection bias so the findings 
might not be an accurate representation of the overall vitiligo population.  A control is needed 
so that the prevalence of autoimmune disease in the unaffected population can be gauged to 
get an understanding of how this compares to the affected population to be studied. 
 
Relatives of vitiligo patients report an increased frequency of autoimmune disease suggesting 
that this disorder has a genetic component and is related to other auto-immune diseases.   The 
findings of an epidemiological survey of the UK and North America were that in 19% of 
vitiligo sufferers over 20 years old there was a clinical history of autoimmune thyroid disease 
which was reported in comparison to 2 % in age matched controls from the general white 
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population.  As of yet the association between vitiligo and autoimmune disease remains 
unexplained but valuable insights into this link have been provided by genetic data (Ezzedine 
et al., 2015). 
 
With regards to the theory of melanocyte destruction via an autoimmune method (Speeckaert 
et al., 2014) (Bhardwaj et al., 2017), autoimmune effector mechanisms direct cytotoxic T cells 
or autoantibodies to melanocyte surface antigens.  The human immune system usually would 
not recognise its own antigens and this is known as self-tolerance.  In autoimmune disorders, 
self-tolerance is lost and the immune systems recognise indigenous cells as a foreign body 
attacking melanocytes in the same way as a virus or bacterial cell.  It has been reported that 
melanosomal antigens cause a response whereby there is an influx of Th1 lymphocytes in the 
epidermis.  Th1 lymphocytes secrete factors that are lethal to melanocytes such as TNF-α and 
other cytokines.  The presence of cytotoxic T cells has been described in the peripheral blood 
of vitiligo patients. It is the inference of an autoimmune component to vitiligo that has become 
the justification for using immunosuppressive drugs to treat it (Hameed et al., 2005) (Li et al., 
2015). 
 
An alternate suggestion for the cause of vitiligo is the neural theory where melanocytes can be 
lost either directly or indirectly because of unsuitable reactions to neuropeptides, 
catecholamine’s or their metabolites or in some cases as a reaction to an overactive sympathetic 
nervous system.  Support for this theory is via evidence that states that a common preceptor of 
vitiligo is stress.  However vitiliginous skin does not have a high enough concentration of 
catecholamine’s to kill melanocytes suggesting that other mechanisms are involved.  It has 
been speculated that altered oxidative stress defences have a contribution to melanocyte loss 
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since generation of excess catecholamine’s results in oxidative products that are toxic for the 
melanocytes (Hameed et al., 2005) (Li et al., 2015). 
 
Melanocyte death in vitiligo may be the result of increased sensitivity to oxidative stress due 
to toxic intermediates made by melanin precursors or other sources.  A low activity of the 
enzyme catalase in skin leads to accumulation of hydrogen peroxide in the epidermis which 
inhibits melanogenesis.  Previous studies have suggested that catalase in non-segmental vitiligo 
patients can assist the establishment of melanocyte cultures and may have a role in re-
establishing melanocyte function after exposure to hydrogen peroxide.  Non-segmental vitiligo 
has been treated by oral or topical antioxidants (Hameed et al., 2005). 
 
Recent research (Rashighi and Harris, 2017) demonstrated that evidence for the theory of 
oxidative stress is increasing whereby melanocytes of vitiligo sufferers have a reduced capacity 
to manage cellular stress.  For instance, an individual’s epidermal cells which include their 
melanocytes have continual exposure to environmental stressors, for example various 
chemicals and ultraviolet radiation, causing an increase in the production of reactive oxygen 
species.  In healthy melanocytes these stressors do not cause a problem but in the melanocytes 
of vitiligo patients they seem to be more vulnerable.  Observations of the skin of vitiligo 
patients indicate that there is a high level of epidermal H2O2 and a reduced level of catalase, a 
vital enzyme for protecting cells from oxidative damage.  Therefore when melanocytes are 
transferred onto affected areas it is essential to ensure that they are healthy (achieved by 
microscopic evaluation before transplant) enough that they can withstand the daily stressors 
that they will be exposed to reducing the likelihood of the transplant failing.    
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Another group of theories regarding the aetiology of vitiligo centre around it being attributed 
to the inhibition of melanocytes or a defect in their adhesion.   Theory states that melanocyte 
death is not a must for depigmentation to occur in vitiligo but rather is due to an initial effect 
on melanogenesis inhibition or rather defective inhibition, which results in a disappearance of 
melanocytes.  This theory is supported by several observations, such as that residual 
melanocytes in follicular reservoir leads to a vitiliginous area being repigmented after 
phototherapy (Patel et al., 2017).  Also, persistent melanocytes which show an ectopic 
distribution of pre-melanosomes in the keratinocytes of the suprabasal layers have been found 
within the lesioned skin of those suffering from long standing vitiligo (Hameed et al., 2005). 
 
It is thought that the development of vitiligo is a two-step process with the first stage consisting 
of a decrease in tyrosinase activity and the second involving the inhibition of melanisation 
which results in the death of the melanocytes (Ghafourian et al., 2014).  It is also thought that 
melanocyte loss in non-segmental vitiligo can be attributed to defective adhesion.  In support 
of this theory is the finding that Tenacin-C, an extracellular matrix molecule, has been found 
in increased levels in the basal membrane and papillary dermis which suggests it inhibits 
melanocyte adhesion to fibronectin and therefore may add to melanocyte loss in vitiligo.  This 
is also seen in Koebner phenomenon, which is where there is a detachment and loss of 
melanocytes after a minor trauma (Hameed et al., 2005) (Sagi and Trau, 2011). 
 
Presently there are few studies to support the concept of melanocytorrhagy (Kumar and Parsad, 
2012) (Gauthier et al., 2003) with more research into it being needed, but the theory is that 
alteration of melanocytes response to friction and stress causes their weak attachment and 
therefore transepidermal loss.  The dendrites of melanocytes are not only required for the 
transfer of melanosomes to the surrounding keratinocytes but they also have a function in 
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helping melanocytes adhere to the basal membrane.  It has been observed that when vitiligo 
melanocytes are cultured their melanocytes appear to be ‘stubby.’  In addition to this when 
hydrogen peroxide is added to an established melanocyte culture a loss of dendricity is induced 
which in some cases leads to melanocyte detachment.  The different phenotype of vitiligo 
melanocytes to normal cells means that they can be identified by confocal microscopy (Xiang 
et al., 2015).  
 
The increase in the levels of catecholamines might be a factor that aggravates non-segmental 
vitiligo.  It has been suggested that in the case of adhesion deficient non-segmental vitiligo 
dendrites are lost as a response to oxygen species or due to an increase in the release of 
catecholamines, which exaggerates transepidermal loss (Hameed et al., 2005) (Hirobe, 
2014).  Reactive oxygen species are chemically reactive and contain oxygen.  The production 
of these is a natural by-product of normal oxygen metabolism but at times of stress their levels 
can have a dramatic increase resulting in significant damage to cell structures. Several 
abnormalities, in addition to defective adhesion and dendritic loss might cause the reduction of 
melanocytes frictional resistance in non-segmental vitiligo, which ultimately results in their 
detachment by chemical or mechanical injury.  
 
The treatment of vitiligo should have either or both of two aims.  The first involves halting the 
progression of active disease to reduce the expansion of the area that is involved in 
depigmentation whilst the second strategy involves the repigmentation of the depigmented 
area.  In any treatment for vitiligo it should be tailored to suit the individual and it should be 
designed in such a manner that it prevents any relapse and it maintains the disease in a stable 
phase (Bishnoi and Parsad, 2018).  This should be achieved by either of three distinct 
approaches which are to: reduce melanocyte stress, regulate the autoimmune response and 
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stimulate melanocyte regeneration.  Treatments currently in existence partly address such 
requirements but in future any new therapies might do this in a more targeted way or they might 
utilize a combination of therapies to produce an overall better response (Rashighi and Harris, 
2017). 
 
In summary, the main theories regarding how vitiligo develops are that it might be attributed 
to melanocyte inhibition, a decrease in tyrosinase activity, inhibition of melanisation or the 
Koebner phenomenon.  However, regardless of the theory as to how vitiligo develops the 
consequences of this disorder are the same. 
 
2.6 Anatomy and cells of the skin 
2.6.1 Structure of the skin 
Figure 3: Structure of the skin (McLafferty E et al., 2012).  
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This diagram illustrates the various layers of the skin as well as the location of several key 
features such as the sweat glands, nerve endings and blood vessels. Outermost epidermal layers 
comprise keratinocyte networks with interconnected melanocytes and a scattering of 
inflammatory cells. In the dermal layer there are fibroblasts and nerve endings, hair follicles, 
sweat glands, and blood vessels as well as other structures (Wang et al., 2016). 
 
Normal skin is the largest organ in the human body and is responsible for about 16% of total 
body weight.  One of the roles of the skin is prevention of water loss from components of the 
body into the environment as well as to protect the human body from a range of environmental 
abrasions.  The skin also has an important immune and sensory function as it has a role in the 
regulation of body temperature as well as the synthesis of vitamin D (Jablonski and Chaplin, 
2018).  The skin is composed of three main layers, as illustrated in Figure 3, which provide it 
with a strength and flexibility as well as it being involved in multiple functions. The skin also 
serves to protect the body from external stimuli, such as microbes (Kwiecien et al., 2019). 
 
The skin's top most layer is the epidermis and the function of this is to be a barrier to water loss 
from the body as well as microbial infection and the absorption of chemicals from the 
environment.  The epidermis is composed of histologically stratified squamous epithelium, 
which needs to be constantly renewed throughout life from birth to death (Hirobe, 2014). The 
epidermis’s barrier function occurs mostly in the upper stratum called the stratum 
corneum.  The epidermis is made up of several layers starting with the basal layer that is found 
just above the dermis.  This then proceeds upwards to the top layer through the prickle and 
granular layers.  
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In the epidermis, the most common cell type is the keratinocyte, which makes keratin and 
several other proteins.  The antimicrobial peptides produced by the skin control microbial 
growth on its surface.  The antimicrobial peptides have various roles in mediating inflammation 
and influence epithelial and inflammatory cells as well as influencing the proliferation of cells, 
wound healing cytokine/chemokine production and chemotaxis (Herman and Herman, 2019). 
 
In the epidermis, there are two other important cell types (Table 4) which are melanocytes and 
Langerhans cells (Otsuka et al., 2018).  Melanocyte function is pigment production and these 
cells are found in the basal layer of the epidermis where they make pigment granules which 
contain melanin, these are called melanosomes. The source of melanosomes is the melanocytes 
from which they are transferred to epidermal keratinocytes.  It is here that melanosomes 
provide the nucleus of the cell with some protection from ultraviolet light as well as giving skin 
its distinctive colour.  The process of melanin synthesis is continuous, but it can be increased 
by skin exposure to UV light, seen physically as creation of the sun tan.  There are two main 
melanin types called eumelanin and pheomelanin which will be described in much greater 
detail later in this literature review. 
 
The Langerhans cell is important for creating an immune barrier for the epidermis (Jaitley and 
Saraswathi, 2012).  Langerhans cells make up the skin and mucosa and are dendritic cells. 
These cells were first discovered in 1868 by Paul Langerhans and due to their dendritic nature 
were mistaken as being nerve cells of the epidermis.   It is thought that these cells are important 
for combatting infection of the skin, since they pick up and process microbial antigens which 
lead to them being antigen presenting cells that are fully functional.  Langerhans cells are 
important for induction of T-cell responses.  Since Langerhans cells have an involvement in 
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the immune response against diseases they are potential targets for immunotherapy (Stoitzner, 
2010).  However, for the purposes of my study I will be focusing on only the melanocytes and 
keratinocytes because concentrating on the interactions of any more than two cell types will 
make my study too complex at this stage. 
 
Table 4: Cells of the epidermis and their function (Yousef et al., 2019). 
Cell type Function 
Keratinocytes Formation of epidermal water barrier by making and secreting lipids 
Melanocytes Melanin production 
Langerhans’ Cells First line in skin defence and antigen presentation 
Merkel cells Sensory function as mechanoreceptors for light touch 
 
 
The dermis and hypodermis are the two layers below the epidermis.  Directly underneath the 
epidermis is the dermis which comprises tough connective tissue, hair follicles and sweat 
glands.  The hypodermis is underneath and this is deeper subcutaneous tissue that is made from 
fat and connective tissue (Cheong and McGrath, 2013). 
 
Another important constituent of the skin are the blood vessels which have the role of dilating 
or constricting respectively in response to heat or cold to maintain constant body 
temperatures.  Sebum is secreted by the sebaceous glands, located at the base of hair follicles, 
preventing skin becoming excessively dry.  Body temperature is also regulated by sweat glands 
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which produce sweat, in reaction to the body becoming excessively hot or stressed, or to cool 
it down.  Sweat glands can be found all over the body but are of greatest abundance in palms, 
soles, forehead and underarms (Best et al., 2019).   
 
The base of hair follicles is in deeper dermal tissue from which they extend beyond the skins 
border.  Arrector pili muscles and sebaceous glands anchor the hair follicle to the skin.  These 
follicles possess many sensory fibres which provide sensory feedback by wrapping around their 
base and extending up the hair shaft. The base of the hair follicle is also innervated by 
autonomic hair fibres (Robertson et al., 2011).  
 
The most abundant protein in the dermis is collagen which makes up to 30% of the total human 
protein content and constitutes 70% of dry mass skin content.  It is a vital part of the skin since 
collagen fibres make up the infrastructure for the protein Elastin.  Elastin is found alongside 
collagen which is also responsible for giving the skin and organs structure, maintaining skin 
elasticity and for enabling hyaluronic acid to trap moisture.  Over time the body’s ability to 
produce collagen diminishes which is responsible for the appearance of wrinkles and fine 
lines.   As well as collagen a reduction in the levels of these accessory proteins (e.g. elastin) 
will cause the skin to wrinkle and sag (Chong et al., 2019).   
 
Other skin components are keratinocytes and melanocytes, which will be discussed 
below.  Different cells can be identified and distinguished by the presence of cell surface 
markers.  Cell surface markers are proteins and carbohydrates that are attached to the cell 
membrane and are like a fingerprint for the cell.  Each cell has its own unique set of cell markers 
(combinations of different proteins on the cell membrane).  This will be discussed in more 
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detail in section 2.14 of this chapter but both melanocyte and keratinocyte cells have their own 
markers which can be used to confirm the presence or absence of these cells. 
 
2.6.2 Keratinocytes 
Keratinocytes have the important function of providing the body with protection from hostile 
forces as they are involved in expressing several surface antigens.  These antigens are 
immunologically significant antigenic fragments and they are internalised, digested and 
expressed on the cell surface, for example the major histocompatibility complex class II (MHC 
class II) molecules making it easy for individual keratinocytes to recognise self from non-self 
(Weber, 2006). 
 
Another function of keratinocytes is to secrete cytokines as well as being able to produce 
antimicrobial peptides.  It is these natural antibiotics that enable a signal to be sent to the host 
immune system that an infectious agent has mounted a challenge (Weber, 2006).  Therefore, 
the present study attempted to co-culture both cell types together as the addition of 
keratinocytes to the culture improves the functionality of melanocytes that are to be used in the 
treatment of vitiligo (Kumar et al., 2012). 
 
2.6.3 Melanocytes 
There are several stages to the melanocyte life cycle (Figure 4)  (Cichorek et al., 2013).  This 
view is confirmed by several other sources (Hirobe, 2014) such as the US national library of 
medicine and the national institutes of health websites (U.S. national library of medicine 
https://www.nlm.nih.gov/. accessed 3rd September, 2017).   
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Figure 4: Stages of the melanocyte life cycle 
 
The specification of lineage from neural crest cells (melanoblasts) 
 
The proliferation and migration of melanoblasts into melanocytes 
 
The differentiation of melanocytes from melanoblasts. 
        
The maturation of melanocytes (this involves the production of melanin 
in special organelles) 
                                                   
The transport of mature melanocytes to keratinocytes, which leads 
eventually to melanocyte cell death 
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Figure 5: Illustration of the relationship between keratinocytes and melanocytes (D’Mello et 
al., 2016). 
The basal layer of skin contains dendritic melanocytes which produce melanin. Melanosomes 
transfer melanin pigments to keratinocytes. 
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Figure 6: Production of melanin and its transfer to melanocytes (Hirobe, 2014). 
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Figure 7: Melanosome transfer pathway (Ando et al., 2011). 
Globules of pigment that contain many melanosomes are released by the dendrites of 
melanocytes into extracellular space.  Keratinocytes phagocytose these globules and the 
individual melanosomes are spread mostly around the keratinocyte’s perinuclear region. 
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Fitzpatrik and Breathnach proposed in 1963 and cited in Thinges et al (2012) that the melanin 
unit comprises one melanocyte linking to about 36 keratinocytes (normally this is in the range 
of 30-40) (Figure 5).  It has been proposed (Thinges et al., 2012) that keratinocytes are the 
major factor for determining the epidermal melanin unit’s size.  The epidermal melanin unit 
size is independent of race but does vary in different body areas. Difference in races occurs 
because of differences in the intensity of melanogenesis and the arrangement of melanocytic 
dendrites.  Contact between keratinocytes and the dendrites of melanocytes (Figure 6 & 7) is 
required for melanin to be transferred into keratinocytes and for determination of skin colour 
(Cichorek et al., 2013). 
 
Melanocytes can be recognised molecularly by the identification of proteins that are specific 
to melanocytes which are tyrosinase (TYR), tyrosinase-related protein 1 and 2 (TYRP-1, 
TYRP-2/DCT), microphthalmia transcription factor (MITF) and melanosomal matrix proteins 
(Pmel17, MART-1) (Cichorek et al., 2013).  Various microscopical methods can be used to 
identify melanocytes.  When the method of transmission electron microscopy is used sebaceous 
melanocytes can be identified as being of large shape which is either triangular or polygonal 
and a plasma membrane that does not have tonofilaments and desmosomes.  Desmosomes are 
a cell structure that are specialised for cell cell adhesion.  These cadherin-mediated junctions 
act via protein complexes to mechanically couple the intermediate filament network of 
neighbouring cells (Price et al., 2018). Another structure specialised for cell cell adhesion is 
the hemidesmosome and although similar to desmosomes the difference is that these cells are 
found in keratinocytes where they attach adjacent cells to the extracellular matrix. 
 
The nuclei could be observed as having a profile that is slightly irregular with shallow 
indentations.  There is a difference between sebaceous melanocytes and those on the epidermal 
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basal surface with the former appearing to contain fewer granules containing melanin. 
Something to note is that melanosomes with an individual distribution in the suprabasal layer 
are much bigger than melanocytes of the epidermis and these melanin granules did not show 
migration to the surrounding sebocytes (Jang et al., 2014).  Microscopical methods are 
important to my project so that I can address my first research question which is to create a 
new method that is reliable and reproducible to measure the ratios of different cell types using 
image processing.  If a picture of the cells in culture can be taken via a microscope then a 
method needs to be created whereby the different cell types can be identified and counted.    
 
2.6.4 Melanocyte and keratinocyte interactions 
Melanocytes and keratinocytes communicate with each other via cell-to-cell contact and 
secreted factors.  Keratinocytes control melanocyte growth and activity via paracrine growth 
factors and cell adhesion molecules.  Melanocytes and keratinocytes produce different 
hormones which are responsible for regulating melanocyte proliferation, melanogenesis and 
formation of melanocytic dendrites (please see below for further details regarding hormonal 
control of melanocyte proliferation) (Cichorek et al., 2013). 
 
As mentioned above the factors released by keratinocytes that influence melanocytes are 
hormones, cytokines and growth factors.  Specifically, these are: 𝞪-melanocyte stimulating 
hormone, hepatocyte growth factor, basic fibroblast growth factor, leukaemia inhibitory factor, 
nerve growth factor, stem cell factor, endothelin’s and granulocyte macrophage colony 
stimulating factor (Hirobe, 2014). 
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2.7 Melanogenesis 
2.7.1 Description of melanogenesis 
Melanogenesis is the name given to the process of melanin production and distribution by 
epidermal units in the skin.  These epidermal units are an example of paracrine signalling 
consisting of a melanocyte that is surrounded by keratinocytes (Lei et al., 2002). It is a complex 
process that consists of several different stages.   Melanin is the primary determinant of the 
colour of the skin, hair and eyes.  Melanin does not just define an important phenotypic trait in 
humans but it’s vital for the body’s photoprotection due to its ability to absorb ultraviolet 
radiation (UVR) (Videira et al., 2013). 
 
Melanocytes are very responsive cells that continuously sample their environment and can 
modulate their levels of melanogenesis or proliferation according to extrinsic signals, for 
example UV light, and other factors that originate from other cell types in the skin (Lei et al., 
2002) .  The process of melanogenesis when disturbed can lead to a variety of pigmentation 
defects resulting in hypo or hyper pigmentation.  These defects might occur both with and 
without an alteration in the number of melanocytes that are present (Videira et al., 2013).  
Research into such defects is important because they have a detrimental impact upon quality 
of life and current treatments can be unsatisfactory.  At present cosmetic and pharmaceutical 
companies are continuously looking for new treatments and solutions, a point which supports 
the value of this current study. 
 
2.7.2 Melanosomes 
Melanosomes are organelles that are found in all animal cells and they are where melanin is 
synthesised, stored and transported. Starting with the enzyme tyrosinase and then in association 
with other melanogenic enzymes (please see section 2.7.4), melanin granules that are made in 
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melanosome organelles are transported from melanocytes to keratinocytes.  As the 
keratinocytes desquamate, so their melanin granule content is lost (Lei et al., 
2002).  Melanosomes can sometimes be seen to be arranged superficially to the keratinocyte 
nucleus, forming a physical barrier for keratinocyte DNA as well as having a scavenging role 
for free radicals induced through exposure of the skin to UV radiation. 
 
Melanosomes are synthesised in several places which include the melanocytes of mammalian 
skin, choroidal melanocytes and in the retinal epithelial cells of the eye.  The actual function 
and fate of melanosomes is dependent upon what type the cell is.  For example, melanocytes 
in the epidermis supply their keratinocyte neighbours with melanosomes and this is responsible 
for pigmentation in the skin and hair, whilst in retinal epithelial cells of the eye pigment, 
granules are kept intracellularly (Wasmeier et al., 2006). 
 
Melanosomes are organelles of relatively large size (they have a diameter of 500 nm) which in 
combination with their dark pigment makes them easy to visualise with bright field 
microscopy.  Because of this, melanosomes are very useful as a model organelle, in particular 
in the case of studies that are on the motility and biogenesis of organelles.  Studies such as 
these have identified melanosomes as being lysosome related organelles. Study of melanosome 
biology has therefore provided crucial understanding of the biogenesis and transport of 
lysosome related organelles as well as how intercellular interactions happen in tissues that are 
complex (D’Alba and Shawkey, 2018). 
 
2.7.3 Stages of melanogenesis 
Melanosomes undergo four stages of development within the melanocyte, (Figure 8) which 
are: 
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Stage 1: Premelanosomes – These are small round vesicles that have an amorphous matrix. 
Stage 2: Melanosomes – These have a structured fibrillar matrix that is organised.  There is 
tyrosine present but the synthesis of pigment has not yet occurred. 
Stage 3: Beginning of melanin production 
Stage 4: Pigment fills the entire melanosome (Hirobe, 2011). 
 
 
 
Figure 8: An illustration of the stages of melanogenesis (Cichorek et al., 2013). 
 
 
 
2.7.4 Enzymes of Melanogenesis 
2.7.4.1 Tyrosinase 
Tyrosinase is a glycoprotein that is found within the membrane of the melanosome. It has an 
internal, transmembrane and cytoplasmic domain. Its catalytic region (accounting for 
approximately 90% of the protein) is contained within an internal melanosomal domain and is 
where copper ions bind for reaction with histidine residues, these copper ions are needed for 
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its activity.  This is since a copper dependent enzyme is responsible for the catalysis of the 
conversion of L-tyrosine into L-DOPA, which is the rate limiting step in melanin production 
(Gillbro and Olsson, 2011).  Superoxide anions can be used as a substrate for melanogenesis, 
suggesting that tyrosinase may have a role in protecting melanocytes from reactive oxygen 
species (Videira et al., 2013).  
 
The transmembrane domain is short whilst the cytoplasmic domain is made up of around 30 
amino acids.   This enzyme’s cytoplasmic domain aids in the enzymes transportation to 
melanosomes from the nucleus (Gillbro and Olsson, 2011).  Once Dopaquinone production is 
complete the melanin synthesis pathway divides into producing red-yellow Pheomelanin or 
black-brown Eumelanin and there is an instantaneous conversion to Dopachrome and 
Leucodopachrome (Gillbro and Olsson, 2011) (Figure 9). 
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Figure 9:  Illustration of how eumelanin and pheomelanin are produced from the same 
precursor because of the split of the pathway following the production of DOPAquinone (Zang 
et al., 2018). 
This pathway is conserved amongst species.  Formation of eumelanin or pheomelanin depends 
upon the presence/ absence of cysteine (D’Mello, 2016).   
 
 
The types of melanin formed and the amounts produced are determined genetically but they 
can be influenced by both extrinsic and intrinsic factors such as hormonal changes, age, 
inflammation and exposure to UV.  All these stimuli exert their influence by affecting different 
melanogenic pathways (D’Mello, 2016). 
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The properties of these two variants differ since eumelanin can scavenge and extinguish both 
oxygen and carbon derived free radicals whilst eumelanin is lacking in these properties and can 
serve to be a source of free radicals when irradiated with UV (Gillbro and Olsson, 2011).  It is 
the polymerisation of indoles and quinones that lead to the formation of eumelanin.  The 
pheomelanin and eumelanin pathways diverge at the L-dopaquinone stage with the 
pheomelanin pathway being dependent upon cysteine being present, which is moved across the 
melanosomal membrane via active transport.   
 
A characteristic of the eumelanin synthesis pathway is that dopachrome either undergoes 
spontaneous conversion to 5, 6-dihydroxyindole or enzymatic conversion to 5, 6-
dihydroxyindole-2-carboxylic acid via tyrosine-related protein-2 (TRP-2).  For pheomelanin 
synthesis cysteine needs to be present since it has a reaction with L-dopa producing cysteinyl-
dopa.  This then undergoes conversion into quinoneimine, alanine-hydroxyl, 
dihydrobenzothiazine and finally polymerisation into pheomelanin (Gillbro and Olsson, 2011). 
 
A balance is made and maintained between the production of eumelanin and pheomelanin via 
redox conditions that are in the melanosomes.  Levels of glutathione (GSH) directly determine 
which of these two substances are produced with them being at high levels for eumelanin and 
low levels for pheomelanin.  The action of functional enzymes such as this (e.g. catalase, 
thioredoxin reductase, glutathione reductase and glutathione peroxidase) modify the 
melanogenic pathway (Gillbro and Olsson, 2011). 
 
It has been shown that tyrosinase hydroxylase isoenzyme 1 (TH1) can indirectly activate 
tyrosinase.  Its presence has been found in melanosomes and it can act as a catalyst for L-dopa 
synthesis with L-dopa then acting as a cofactor for tyrosinase (Gillbro and Olsson, 
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2011).  Tyrosine hydroxylase isoform acts to catalyse L-tyrosine being converted into L-DOPA 
thus functioning as a promoter of tyrosinase activation.  This enzyme is found in the 
melanosomal membrane adjacent to tyrosinase (Videira et al., 2013). 
 
Phenylalanine hydroxylase is found in the cytosol and it acts to catalyse L-phenylalanine being 
converted into L-tyrosine.  This is the substrate for tyrosine, so it also acts as a promoter of its 
activation (Videira et al., 2013). The three previously mentioned enzymes (tyrosinase, tyrosine 
hydroxylase and phenylalanine hydroxylase) are needed for the beginning of melanogenesis 
(Schallreuter et al., 2008). 
 
The melanosome membrane is also home to two proteins that exhibit similarity to tyrosinase 
(40% amino acid homology, suggesting a common ancestry).  These proteins are a tyrosinase-
related protein-1 (TRP-1) and tyrosinase-related protein-2 (TRP-2).  The similarity of these 
proteins to tyrosinase is that they are found spanning the membrane of melanosomes.  These 
proteins exact functions are still unknown but the suggestion is that TRP-1 is involved in: 
stabilising tyrosinase, the synthesis of melanosomes, increasing eumelanin to pheomelanin 
ratios and acting against oxidative stress, which can be attributed to its peroxidase effect 
(Videira et al., 2013) (Gillbro and Olsson, 2011). 
 
2.7.5 Regulation of melanogenesis in skin melanocytes 
Skin pigmentation is regulated intrinsically by melanocytes, which produce several factors 
involved in inflammatory and immune responses that act via a paracrine or autocrine way on 
keratinocytes.  Examples of this include leukotrienes, prostaglandins, nitric oxide, cytokines 
and POMC peptides (Videira et al., 2013).  UV irradiation is the primary extrinsic stimulus for 
the synthesis of melanin, this is particularly so in the case of black eumelanin.  This stimulus 
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results in the generation of DNA photoproducts as well as release of paracrine and autocrine 
factors, most notably the secretion of α-melanocyte stimulating hormone (α-MSH) by 
keratinocytes. α-MSH activates the melanocortin 1 receptor in skin melanocytes plasma 
membrane.  The effect of this is cAMP-dependent signalling and microphthalmia-associated 
transcription factor expression (MITF) being stimulated.  A description for MITF is that it is a 
‘master regulator’ for melanocyte function and the process of melanogenesis.  MITF activity 
is important for causing expression of a multitude of genes needed for survival of melanocytes 
as well as their motility, differentiation, apoptosis and melanosome production (Wasmeier et 
al., 2006).  
 
2.7.6 Method of transfer of melanosomes to keratinocytes 
Protease-activated receptor-2 (PAR-2) is a seven-transmembrane G-protein-coupled receptor 
expressed by keratinocytes that can regulate the transfer of melanosomes via the phagocytosis 
of keratinocyte (Ando et al., 2012).  It is known that the transfer of melanosomes is skin-colour 
dependent with the pattern of distribution of melanosomes that are transferred into 
keratinocytes being determined by the keratinocytes racial and ethnic origin. However, we still 
do not understand exactly how melanosomes are transferred from melanocytes to 
keratinocytes. 
 
2.8 Main types of melanins  
Different skin pigmentation phenotypes can generally be classified by the Fitzpatrik 
system.  There are six phototypes (I-VI) which are classified by a person’s reaction to exposure 
to UVR by grading erythema and acquired pigmentation (Ferreira et al., 2012).  A person’s 
constitutive pigmentation reflects their level of melanin which is genetically 
determined.  However, pigmentation can be altered by several regulatory factors, extrinsic or 
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intrinsic.  Extrinsic factors include UVR or drugs whilst intrinsic factors may be released by 
fibroblasts, keratinocytes, endocrine, neuronal and inflammatory cells (Videira et al., 2013). 
 
2.8.1 Difference in melanins of dark and light skinned individuals 
Human skin colour is very variable across the globe with the variation in skin tones being a 
result of human migration and adaptation to tropical and non-tropical environments therefore, 
people don’t have pure black, white, red or yellow skin.  Melanin is the cause for skin colour 
and it is important because it protects individuals from environmental assaults and any potential 
subsequent cellular injury.  It prevents DNA damage by absorbing any UV light that penetrates 
the skin and by acting as a scavenger of free radicals (Kumar et al., 2012) (Lei et al., 2002).  A 
severe inverse correlation was found between the level of skin pigmentation and the occurrence 
of skin malignancies and UV photo damage (Lei et al., 2002). 
 
Differences in pigmentation phenotype are not attributable to there being any variance in the 
number of melanocytes since these numbers remain constant amongst the different ethnic 
groups but rather they are due to other causes such as how large the melanosomes are and how 
many are produced, the types and amounts of melanin that are produced and how melanin is 
distributed and transferred to the keratinocytes (Videira et al., 2013).  This is demonstrated by 
the fact that in dark skin the melanosomes are bigger, in greater quantities, and elongated 
meaning that their degradation in keratinocytes is delayed and there is an increase in 
pigmentation that is seen.  These factors are determined at birth rather than by extrinsic factors 
(Videira et al., 2013). 
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2.8.2 Division of the pigmentation pathway into eumelanin and pheomelanin 
Figure 10: Molecular structure of pheomelanin (A) and eumelanin (B) (Ito & Wakamatsu, 
2008).  
 
The differences in skin pigmentation that are seen among different ethnic groups is dependent 
upon eumelanin content and the eumelanin to total melanin ratio is the determinant of the skin 
colour.  It has been observed that eumelanins are better at protecting from the sun than their 
reddish-yellow pheomelanin counterparts which is why there is a 30-40 fold increased risk of 
skin cancer in lighter skin than in those with darker skin (Figure 10).  Skin pigmentation is not 
correlated to the amount of pheomelanin as it is present in similar quantities in dark and light 
skin (Land and Riley, 2000). 
 
Eumelanogenesis is the name of the process for creating eumelanin whilst that of phaeomelanin 
is called phaeomelanogenesis with both processes diverging at a fairly early stage in the 
101 
 
formation of pigment. This divergence occurs when dopaquinone, which is the first product of 
the oxidation of tyrosine, follows either one of two available paths for reaction, which are a 
reductive endo cyclisation where a Michael addition of the side-chain amino group occurs, or 
the production of cysteinyl dopa via the reductive addition of cysteine.  For the first process 
the product is cyclo dopa which undergoes a redox exchange reaction with dopaquinone to 
produce dopachrome which is the precursor of the eumelanogenic pathway.  In the case of the 
second mentioned reaction cysteinyl dopa leads to the formation of benzothiazoles which are 
known to be characteristic of pheomelanin.  Cysteinyldopaquinone is the precursor molecule 
of the pheomelanin pathway (Land and Riley, 2000). 
 
The biological benefits that are produced by pheomelanin are currently unknown so questions 
arise as to why its evolution has been promoted.  One such hypothesis is that production of this 
pigment is required to remove cysteine since the presence of cysteine residues in proteins can 
make them susceptible to oxidative stress and any associated damage.  It has been found in 
mammals that an excess of cysteine has associations with several conditions including 
rheumatoid arthritis, Parkinson’s disease, Alzheimer’s disease, systemic lupus erythematosus, 
an increase in the risk of cardiovascular disease and negative pregnancy outcomes (Galvan et 
al., 2012). 
 
Although not a recent study (Marmol et al., 1996) explains that the mechanisms that govern 
the balance of pheomelanin to eumelanin are dependent on the three main factors of L-cysteine, 
glutathione and tyrosinase related protein-1 expression but it is the case that none of these 
factors alone is dominant in the direction of the production of one type of melanin over 
another.  More recent descriptions are available (Wakamatsu et al., 2017). 
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2.8.3 Eumelanogenesis 
It is thought that the diversity that exists in the pigmentation of the skin, hair and eyes in 
humans can be down to the variation that exists in the pH of the melanosomes with acidic pH 
being responsible for the suppression of melanin production (Wakamatsu et al., 2017).  The 
enzyme tyrosinase shows optimum activity at a pH of 7.4 with this being greatly suppressed at 
lower pH levels (Ito et al., 2013).  In one study it was demonstrated that the action of depleting 
(Marmol et al., 1996) extracellular l-cysteine significantly increased tyrosine hydroxylase 
activity and promoted eumelanogenesis.  It must be acknowledged that this study is not 
relatively recent but a thorough literature search has not found any reason for these findings to 
be disputed. 
 
2.8.4 Phaeomelanogenesis 
The production of pheomelanin from either dopa or tyrosine by tyrosinase requires cysteine to 
be present and was maximised at the pH values of 5.8 to 6.3 whilst the production of eumelanin 
was suppressed at pH 5.8 (Wakamatsu et al., 2017).  This finding leads us to believe that at 
weakly acidic pH’s mixed melanogenesis is chemically shifted to a more pheomelanic state. 
 
2.8.5 Method of melanosome formation 
The development and maturation of melanosomes can be categorised into four morphologically 
distinct stages by classical electron microscopy studies, which are stage I and II that includes 
unmelanized immature pre-melanosomes whilst stages III and IV contain melanised 
melanosomes (Hirobe, 2014). 
 
Stage I pre-melanosomes are characterised as being non-pigmented vacuoles that originate 
from the endosomal system.  In stage II these obtain characteristic internal striations whilst in 
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stage III the melanin pigment is placed upon these striations.  The outcome of this is the 
creation of stage IV melanosomes that are mature and fully melanised.  In addition to this, it 
appears that other cell types that are pigmented (such as retinal pigment epithelial cells) show 
similar progression in development (Wasmeier et al., 2006). 
 
2.8.6 Differences in melanosomes forming eumelanin and pheomelanin 
The melanosomes that form eumelanin and pheomelanin are different and can be distinguished 
by the fact that those containing eumelanin (eumelanosomes) have an elliptical morphology 
with pigments being deposited longitudinally in intraluminal fibrils.  This differs from 
melanosomes containing pheomelanin (pheomelanosomes) which are spherical and have 
pigments deposited granularly within multivesicular bodies (Hirobe, 2014). 
 
The typical eumelansome is elongated (0.8-1 µm [800-1000 nm] long, and 200-400 nm wide) 
and has round ends (Raposa and Mark, 2007).  Phaeomelanosomes on the other hand show 
much more variance in terms of size and are usually between 500nm and 700nm long 
(sometimes even up to 900nm) and have a width of 300nm to 600nm (Raposa and Mark, 2007). 
 
2.9 Histological/clinical features of vitiligo 
2.9.1 Structure of the skin 
There are three main layers to the skin.  The outermost layer of the skin is the epidermis which 
provides a waterproof layer.  Below this is the dermis which comprises tough connective tissue, 
hair follicles and sweat glands.  Under this is the hypodermis, this is a layer of subcutaneous 
tissue made from fat and connective tissue (Watkins, 2013).  The epidermis can then be divided 
into five layers which are the stratum corneum, stratum lucidium, stratum granulosum, stratum 
spinosum and stratum germinativum (Figure 11).  Stratum germinativum (also known as 
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stratum basale) is the layer at the base of the epidermis.  It is a crucial layer since it has the 
only epidermal cells that have the capability for cell division.  Cells essentially germinate here 
which has led to the word germinativum.  It is in this layer that keratinocytes arise as a product 
of mitosis (Watkins, 2013). 
 
Keratinocyte movement is from the stratum basale to the stratum spinosum.  The stratum 
spinosum can lend such a characteristic name to the fact that its cells are of a spiny shape.    The 
strength and flexibility of the skin can be in part attributed to this layer and keratinocytes move 
from here to the next layer which is the stratum granulosum, named as such because it contains 
many granules.  It is in the granulosum that keratinocytes produce a large amount of keratin 
via keratinisation and the keratinocytes change to becoming flatter, more brittle and lose their 
nuclei (McGovern et al., 2012). Once keratinocytes move out of the stratum granulosum they 
die and make the stratum lucidum.  These cells die here because they are far from the rich blood 
supply which is below the stratum basale.  Since these cells are lacking nutrients and oxygen 
the keratinocytes are pushed towards the skin's surface (McGovern et al., 2012).   
 
The stratum lucidum is named as such because its appearance is lucid (clear/transparent).  This 
is found in the thickest areas of the skin such as the palms and soles of the feet.  This is the 
only layer that is seen with the eyes and it is to where the keratinocytes move next from the 
stratum lucidum.  It is here that the keratinocytes are called corneocytes and are absent of 
almost all water and a nucleus.  These cells are basically dead and have a greater protein mass 
than an average cell because they are filled with the protein keratin.  Corneocytes create a hard 
layer which protects against environmental trauma and they are eventually shed into the 
environment (Usui et al., 2013).  The entire keratinocyte life cycle from being produced in the 
stratum basale to being flaked off takes between 24 and 45 days (McGovern et al., 2012). 
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Figure 11: Histological appearance of normal epidermis (Agarwal & Krishnamurthy, 2019). 
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2.9.2 Appearance of melanocytes and pigmented keratinocytes  
Images from confocal scanning laser microscopy (CSLM) have enabled melanocytes and 
keratinocytes to be distinguished from each other.  In these images keratinocytes are polygonal 
cohesive cells that have a variably bright granular cytoplasm.  Melanocytes can be identified 
as bright cells that are round, dendritic, fusiform or oval (Busam et al., 2001). 
 
2.10 Description of rare forms of vitiligo  
Fitzpatrick first coined the term trichrome vitiligo in 1964.  It describes a condition where 
vitiligo lesions have an intermediate area of hypochromia, which is found between the principal 
unaffected skin and the achromic center.  This is seen visibly as three shades of a colour 
(brown, tan and white) occurring in the same individual.  After some time this trichome lesion 
will develop into a vitiligo macule that is normal. Trichrome vitiligo is only a transitory 
pigmentary state; however, it may exist for months or years without any change (Hann et al., 
1999) (Lee et al., 2011). 
 
The description of ‘chemical vitiligo’ is given to the cases where vitiliginous processes are 
initially switched on by chemical exposure but then continue even after halting the use of these 
chemicals (Alam and Ghosh, 2015).  Unfortunately, research on chemical vitiligo is very 
sparse, meaning that it is very difficult to gather any more information on this topic than what 
is presented here. 
 
2.11 Treatment of vitiligo 
A wide range of therapies have been developed to achieve repigmentation which range from 
the use of UV (e.g. narrowband UVB and PUVA), immunomodulatory therapies and laser to 
surgical procedures which include cultured epithelial autografts, cultured melanocyte 
suspensions, punch mini-grafting and suction epidermal grafting (Korobko, 2012).  I will be 
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describing these treatments to give a background as to what therapies are currently available 
however; these treatments are not very effective, which is why my research is needed to 
improve upon them (Plensdorf et al., 2017). 
 
It is important to assess a person’s psychological profile before treatment because as of yet no 
complete cure exists and the results of treatment vary depending on the individual, often 
proving to be unsatisfactory (Ezzedine et al., 2015). The face shows the best response to vitiligo 
treatment whilst acral lesions show poor response.  It must also be noted that treatment shows 
better results in lesions that have developed recently rather than older ones (Ezzedine et al., 
2015).  The term ‘Leucoderma’ is used to give a name to disorders where the skin becomes 
white in a place which in some cases is the result of melanin not being present in epidermis 
(Olsson and Juhlin, 2002) (Navneet et al., 2012).   
 
2.11.1 Phototherapies 
One of the first line treatments for stimulating melanocyte regeneration in vitiligo is 
phototherapy; this is of special importance in patients with widespread disease (Anbar et al., 
2019).  The exact mechanism of how this occurs is unknown but is probably because it induces 
both/either melanocyte stem cell differentiation and proliferation (Rashighi and Harris, 2017).  
One such key hormone that does this is alpha-melanocyte stimulating hormone.  One drug that 
also serves this purpose is Afamelanotide which is a synthetic analogue of alpha-MSH.  It is 
thought that Afamelanotide might mitigate photosensitivity and as such it might improve the 
outcomes of phototherapy in treating vitiligo (Fabrikant et al., 2013).  Clinical trials have found 
that combination therapy of NB-UVB and Afamelanotide led to better results in comparison to 
NB-UVB monotherapy and showed heightened response in darker skin types (Fitzpatrick skin 
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type IV to VI) however we are still unaware if Afamelanotide monotherapy (Rashighi and 
Harris, 2017) would produce favourable outcomes for vitiligo treatment.  
 
2.11.2 Medical therapies and other treatment options 
The options for medical treatment of vitiligo involve using immune-modulating drugs on 
patients such as vitamin supplements (especially vitamin B12 and folic acid), azathioprine, 
cyclophosphate, levamisole and systemic corticosteroids (Paul, 2011).  The British Association 
of Dermatologists guidelines make recommendations for the management of vitiligo using 
narrow band ultraviolet B, tacrolimus and topical steroids (Kim et al., 2012).  The treatment 
options for vitiligo were reviewed with each of their advantages and disadvantages being 
clearly outlined (Steiner et al., 2004) (Yazdani et al., 2014).  Below I will list each of the 
proposed therapies for adults and describe their advantages and disadvantages as set out in the 
British Association of Dermatology guidelines. 
 
Topical potent or highly potent corticosteroids: 
These can be used up to 2 months but it must be considered that a common side effect is skin 
atrophy  
Depigmentation with p-(benzyloxy)phenol: 
This is only suggested to be used where depigmentation is extensive and covers more than 50% 
of the body. 
Systemic treatment: 
Oral dexamethasone can arrest vitiligo progression but is not recommended as it is associated 
with a very high risk of causing side effects. 
Phototherapy: 
Due to side effects this should only be used when other traditional treatments fail.  
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Surgical treatments: 
This should only be used in cosmetically sensitive sites when no lesions have appeared for at 
least 12 months. 
 
In the treatment of vitiligo medical therapies should always be tried first and if this fails then 
the surgical option should be considered.  In cases where vitiligo affects more than 20% of the 
body surface, UV light is thought to be the ‘gold standard’ for treating this.  However, the 
limitations of this treatment are that the repigmenting process is slow and regular sessions of 
phototherapy are needed.  This treatment usually displays good tolerance in children and 
adults however exposure to UV does carry with it an increased risk of developing cancer 
(Tippisetty et al., 2013). 
 
Medical treatments are much more acceptable to the patient than surgical therapies as they are 
much less invasive and they tend to be cheaper however when medical treatments fail there is 
not normally any other option.  In my PhD project I have taken a commonly used surgical 
treatment, more specifically the autologous cell suspension transplantation technique, and 
attempted to modify it to improve its clinical outcomes.  The use of autologous cells is 
preferable, as the body tends not to reject its own cells and I will be improving the technique 
by modifying the melanocyte/ keratinocyte ratio before replanting the cells back on the body 
rather than just extracting and transplanting the suspension without any modifications.  The 
reason for modifying the melanocyte/keratinocyte ratio is that it has been found that 
melanocytes function much better in the presence of keratinocytes.  This can be further 
improved if an optimal melanocyte/keratinocyte ratio can be found, which is the basis of my 
project. 
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A review that used narrow-band ultraviolet B (NB-UVB) in combination with other therapies 
(excluding surgical grafts and transplants) was published Yazdani et al. (2014).  Several 
databases were searched with review and non-English articles being excluded.  Included in the 
paper were the results of original investigations.  In total 39 studies were identified for 
investigation in this paper.  It is thought that there are two stages to repigmentation via NB-
UVB.  The first step is where inactive melanocyte stem cells found in hair follicles (specifically 
the outer root sheath) and perilesional skin have their proliferation and migration activated by 
light.  It is important to note however that it is difficult to treat lesions on the distal extremities 
and bony prominences with this technique because hair follicles in these areas are sparse.  The 
second step is where the release from keratinocytes of melanocyte growth factors, such as basic 
fibroblast growth factor and endothelin-1, induces the proliferation of melanocyte growth 
factors.  This observation is supported by the fact that vitiliginous lesions have lower bFGF 
levels.  Phosphorylated focal adhesion kinase and matrix metalloproteinase expression 
stimulate melanocyte migration.      
 
Additionally, to this NB-UVB also serves to modulate the immune response in vitiligo since it 
works by inducing the production of interleukin-10 in the epidermis which then promotes 
differentiation of T regulatory cells and in turn suppresses the auto-reactive T cells.   Direct T-
lymphocyte apoptosis can be induced by NB-UVB.  It is stated that the first-line treatments for 
vitiligo tend to involve topical treatments such as corticosteroids and calcineurin 
inhibitors.  The areas that show the best response to this treatment are the face and extremities 
(Wong and Lin, 2013). 
 
It is the case that there have been multiple investigations of the combination of tacrolimus 0.1% 
ointment and pimecrolimus 1% cream with NB- UVB (Yazdani et al., 2014) (Wong and Lin, 
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2013).  These studies were carried out for a duration of 3 to 12 months with the smallest study 
consisting of 3 participants and the largest 110.  The results of one investigation (Yazdani et 
al., 2014) show that there is clearly a better result seen when NB-UVB is combined with 
tacrolimus/pimecrolimus than when compared to a placebo.  As much as 40% more subjects 
showed more than 50% repigmentation when NB-UVB pimecrolimus was used than with the 
control.  Tacrolimus is an immunosuppressive drug that is usually used after allogeneic organ 
transplant to lower the risk of organ rejection.  The fact that the use of tacrolimus has such an 
effect in improving the outcome of vitiligo treatment by NB-UVB suggests that the 
development of vitiligo is associated with an autoimmune reaction.   
 
Limitations in conducting studies into the treatment of vitiligo include trying to establish an 
effective control arm.  The two ways to do this are to utilise either an intra-individual or a 
parallel group comparison group design but both have challenges of their own.  The limitations 
of intra-individual studies are that participants may find it difficult to meet the requirements 
such as administering topical therapies on only half of the body during the long months of 
treatment time.  The improvement in quality of life is also difficult to assess and accurately 
identifying how much is due to combination therapy is challenging when only half of the body 
receives the treatment.  On the contrary, parallel group comparisons may be difficult to 
accurately analyse because different patients do not share the same degree of melanocyte loss 
or they do not have the same prognostic factors for a treatment result.  This worry can be dealt 
with by using large sample sizes and appropriate randomisation (Yazdani et al., 2014). 
 
One conclusion that has been reached (Yazdani et al., 2014) is that combining NB-UVB with 
other treatments potentially shortens the length of time that is needed by patients for 
phototherapy and reduces their total radiation exposure. Much more investigation is needed to 
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find which combination regimes are best, to find out if clinical outcomes last and if there are 
any additional effects uncovered by long-term follow ups (Wong and Lin, 2013). 
 
Topical corticosteroids have been found to be effective for use as monotherapy in vitiligo, 
especially in the areas of the head and neck but they do cause problems when used in these 
areas since the skin of these areas is amongst the thinnest of the body.  Topical corticosteroids 
are commonly used for treating a variety of skin disorders, such as eczema and psoriasis, as 
they have anti-inflammatory properties.  Fruitful use of corticosteroids as a monotherapy for 
vitiligo treatment once again adds more evidence to the theory that it is an autoimmune 
condition.  Steroids cause skin atrophy so the use of calcineurin inhibitors is recommended as 
an alternative to this treatment as they do not cause this side effect.  The efficacy of calcineurin 
inhibitors as a treatment for vitiligo was assessed and described (Wong and Lin, 2013) and in 
this, 23 studies concerning this treatment were reviewed.  The number of studies assessed in 
this paper was substantial and had a participant number involvement ranging from eight to 110 
people as well as a study duration of 8 weeks to 52 weeks. This review is also reliable since a 
double blind study was carried out where the use of the therapy was compared to a placebo and 
found to be superior (Leeuw et al., 2010) (Wong and Lin, 2013).   
 
Skin colour is also a factor in treatment success with vitiligo on the face of darker skin 
individuals showing superior treatment outcomes to their lighter skinned counterparts.  The 
type of vitiligo being treated by steroids is also a consideration with better responses associated 
with patients with vulgar disease forms than those that have a localised or generalised illness. 
The final factor that must be considered is the duration of the disease with more recent lesions 
showing a better response. 
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The second line treatments involve phototherapy combined with steroid treatment (Haines et 
al., 2017).  Light based treatments generally involve psoralen photochemotherapy (PUVAsol 
and PUVA) and NB-UVB, which are normally delivered to the whole body and a targeted 
phototherapy system which includes excimer laser and lamp (Paul, 2011) (Shenoi and Prabhu, 
2014).  There are three ways that Psoralens can be administered which are oral, topical or a 
combination of both.  The best effects are witnessed with oral administration, with this also 
having the least side effects.  In one study the therapeutic effect of combining mini-oral pulse 
steroids with Nb-UVB was compared to using the mini-oral pulse steroids on their own and 
Nb-UVB on their own as vitiligo treatments (El Mofty et al., 2016).  The study consisted of 45 
patients who were randomly assigned into one of three groups.  
 
The three groups were: 
Group A: These subjects were treated with Nb-UVB in combination with mini-oral pulse 
(MOP) steroids 
Group B: These subjects were treated with MOP steroids only 
Group C: These patients were treated with only Nb-UVB 
 
Allocating the patients randomly to each group is an attempt to remove any bias that might 
occur in the results (ElMofty et al., 2016).  Randomisation was done using the sealed envelope 
method.  The patients had to satisfy the inclusion and exclusion criteria, these were: 
 
1. Inclusion criteria: 
● Age: over 15 years. 
● Type of vitiligo: vulgaris. 
● Stable disease with no new lesions for the past year. 
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● No systemic or topical treatment for vitiligo received for the past month. 
● Extent: disease covers at least 10% of total body surface area. 
2. Exclusion criteria: 
● Contraindications to steroids. 
● Pregnancy and lactation 
3. Workup: 
● Full personal and family history were taken 
 
The study was conducted at the same dermatology and outpatient clinic and phototherapy unit 
at Kasr El-Aini hospital, Cairo University between September 2009 and February 2012.  When 
the patients were divided into three groups, differences in age, sex, duration of disease, family 
history or relationship with stress showed no significance. 
 
Table 5: A table showing a comparison of clinical data of patients during both the treatment 
and the follow-up periods in 3 different groups.  This table illustrates that the results of group 
A and B are of a significant difference (El Mofty et al., 2016).  
 
  Group A (Nb-
U.V.B and 
Steroids) n=15 
Group B 
(Steroids only) 
n=15 
Group C (Nb-
U.V.B alone) 
n=15 
p-value 
VASI Before 
therapy: 
Mean +SD 
20.8+/-10.6 14 +/- 7.5 18.2 +/- 10.7 0.186 
 After 
therapy: 
Mean +/- 
SD 
8.2 +/- 6.5 13.6 +/- 7.6 15.3 +/- 8.9 0.041 
Patients showing 
improvement 
Number 15 5 15 <0.001 
% 100% 33.3% 100%  
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Depigmentation of 
lesions 
Number of 
patients 
1 1 1 0.1 
Appearance of new 
lesions 
Number of 
patients 
2 6 1 0.041 
 
 
Patients were evaluated using VASI before and after three months of therapy.  The VASI scores 
in the above table illustrates that those treated with Nb-UVB with steroids and Nb-UVB alone 
showed significant clinical improvement than those treated with steroids alone (El Mofty et al., 
2016) (Table 5). 
 
There is no absolute definition of what the optimum duration of phototherapy should be with 
practice varying widely (Ezzedine et al., 2015).  Narrowband UVB phototherapy should only 
be suggested when patients couldn’t be successfully managed with treatments that are more 
conservative or when the patient has widespread or localised vitiligo that impacts quality of 
life significantly (Leeuw et al., 2010).  When repigmentation does not happen within the first 
three treatment months irradiation is usually stopped however this is not to say that cases of 
repigmentation have not been recorded later on.   An oral minipulse of betamethasone or 
dexamethasone in moderate dose can be used for 3-6 months to stop the disease progression 
when the vitiligo is of type that is fast spreading (Ezzedine et al., 2015).  
 
In patients who suffer with segmental vitiligo the lack of success of treatment with UV light 
and corticosteroids compared to those with generalised vitiligo (Steiner et al., 2004) (Van Geel 
et al., 2012) can be explained by the fact that in this condition the hair follicles do not have any 
pigment cells and there is no involvement of an autoimmune component (Olsson and Juhlin, 
2002) (Van Geel et al., 2012).  The success of this therapy is dependent on where on the body 
the lesion can be found with those on the face showing the best response and the distal areas 
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of the extremities and genitalia showing little response.  An explanation for these areas not 
having successful treatment outcomes is that they do not have any hair follicles (Steiner et al., 
2004).  For estimating the success of treatment factors that must be taken into consideration 
are the age and skin colour of the individual with better responses being in the young and those 
with dark skin.   
 
Combination therapies tend to show better outcomes compared to monotherapy which is 
supported by a study search by Ezzedine. 29 studies that were similar in nature to Ezzedine 
where identified and all supported the same conclusion. These supporting studies did have their 
own limitations since the statistical power used was not adequate; only patients that have non-
segmental or generalised vitiligo were included.  These vitiligo types account for 85% of all 
vitiligo cases and they affect both body sides in adults (Ezzedine et al., 2016).   
 
Only 42% (40 out of 96) of studies that were referenced (Ezzedine et al, 2016) made use of an 
active control where the intervention was applied simultaneously on both sides of a specific 
body area in the same patient.   It was therefore very difficult to identify which of the therapies 
used caused the adverse effect when combined therapies were used in the study.  Another 
limitation is that none of the studies carried out an assessment of long-term repigmentation 
(e.g. follow up at two years) as a secondary outcome. 
 
Current practice guidelines from the European Dermatology Forum (Taieb et al., 2013) and 
the Vitiligo Japanese Task Force (Oiso et al., 2013) support other findings (Ezzedine et al., 
2016).  The recommendation of all these studies is that a combination of therapies is used with 
the primary treatment being light.  The European Dermatology Forum recommends the use of 
narrowband UV-B excimer light in combination with topical steroids or with topical 
immunomodulators.  The advice of the Japanese task force differs in that its recommendation 
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is for  UV-B photochemotherapy in combination with UV-A and topical steroids or topical 
vitamin analogues.  It can therefore be concluded that the recommendations of both 
organisations are in fact consistent with the findings of (Ezzedine et al., 2016).  The use of 
combined therapies with narrowband light is a primary treatment and if this fails then the option 
of surgical treatment will be considered.  My PhD study is an extension of this investigation.  I 
will be studying a surgical intervention however; UV light will be used to modulate the 
melanocyte/ keratinocyte ratio in culture.  
 
2.11.3 Heliotherapy 
Heliotherapy can be described as being the use of natural sunlight to treat skin conditions such 
as vitiligo (Grzybowski et al., 2016).  The advantages of this treatment are that it is cheap and 
easily available.  However, the disadvantages of this therapy are that there is a risk of sunburn, 
premature skin aging and skin cancer.  Currently a thorough literature search has not identified 
any studies into the effects of heliotherapy when used as a treatment for vitiligo (Jarrett and 
Scragg, 2017). 
 
2.11.4 Khellin 
Khellin, a furano chrome, is extracted from the Mediterranean plant Khella.  This extract has 
several properties such as that it is vasodilative, spasmolytic, can cause melanocyte 
proliferation and can inhibit the activity of fibroblasts.  Most importantly in the context of my 
doctoral work Khellin has the ability to be a photosensitizer since its chemical structure is 
similar to that of the psoralen family.  Khellin has the same photobiological and 
phototherapeutic effects as the psoralens but it doesn't have the same side effects of being 
phototoxic or carcinogenic (Beyazit et al., 2019).  Such unwanted side effects are witnessed 
during treatment when ultraviolet A radiation (PUVA) is combined with psoralen. 
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Although as mentioned above Khellin is a good treatment for vitiligo its use should be done 
with caution.  Research into the exact benefits of Khellin is still inconclusive and at times 
contradictions have been found (Leeuw et al., 2011).  Khellins mechanism of action is to 
directly enhance the proliferation and melanogenesis in isolated melanocytes.  The first 
reported uses of Khellin in dermatology as a treatment for vitiligo were in 1982 when its use 
was combined with natural sunlight.  Attempts to avoid systemic side effects meant that it was 
primarily used as an oral and then as a topical treatment (Fenniche et al., 2018). 
 
To improve Khellins action and diffusion different vehicles of delivery have been used such 
as: oil/water emulsions, microemulsions, cyclodextrin-containing gels, water/2-
propanol/propylene glycol, and liposomes.  Establishing the correct form to use is important 
because it can cause a substantial difference in the clinical results that are seen for vitiligo 
treatment (Fenniche et al., 2018). 
 
2.11.5 Topical, systemic and intralesional steroids 
Steroids are an effective treatment with vitiligo but they have a major drawback in that they 
are associated with serious side effects which has resulted in a search for alternative therapies 
(Kumar et al., 2004) (El Mofty et al., 2016).  Topical calcipotriol is one of several aetiology 
based treatments for vitiligo.  It is a vitamin D derivative and acts in a similar manner to other 
derivatives of the same type in that it increases the intracellular calcium concentration via the 
hydrolysis of phosphatidyl inositol phosphate which results in the production of diacylglycerol 
and inositol triphosphate. The release of intracellular calcium stores that follows is essential 
because proliferation and differentiation of melanocytes, along with other cellular functions, 
are regulated by intracellular concentrations of calcium.  The basis for the use of this treatment 
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is that a disturbed calcium homeostasis has been observed in vitiliginous skin.  However, there 
are limitations to this treatment since studies have shown that for the treatment to be at optimal 
efficiency it must be used in conjunction with PUVA or narrow band UVB but if we are to 
assess its real efficiency then more research is needed.  This treatment is not perfect since side 
effects have been observed in 10-34% of all cases but these are usually not very severe 
(Hameed et al., 2005). 
 
Ex vivo studies have identified that catalase enables the establishment of melanocyte cultures 
from non-segmental vitiligo cultures or to re-establish their function after exposure to hydrogen 
peroxide.  This observation has served as the basis of the idea for using topical catalase in the 
treatment of vitiligo.  A clinical study (Hameed et al., 2005) made use of catalase over a period 
of 36 months with a sample of 33 patients.  No explanation is given in the paper why 33 patients 
were chosen to be included in the study, we do not know if this is because only 33 patients 
were available or it was because a power calculation was conducted and this was the figure that 
was reached.  Patients affected by both focal, segmental and vulgaris were included in the study 
and the results varied accordingly.  In focal vitiligo all the cases studies exhibited a 
repigmentation in the range of 90-100%.  Segmental vitiligo on the other hand did show a 
partial response but this happened slowly.  
 
In vitiligo vulgaris the response was good to moderate but nothing was observed on the feet 
and toes.   In Hameed et al. (2005) the participants applied a mixture of pseudocatalase and 
calcium chloride twice a day.  Following this the entire body was exposed to erythemogenic 
UVB twice a week.  Within 2-4 months it was found that excellent repigmentation occurred 
especially on the hands and feet.  This study did identify that the success of the therapy was 
dependent upon the type of vitiligo since, for example, focal vitiligo showed 90-100% 
120 
 
repigmentation in all cases but the response in cases of segmental vitiligo was partial and 
extremely slow.  The cases of vitiligo vulgaris showed moderate response but no 
repigmentation on the fingers and feet.  Therefore, when we are considering what treatment to 
use it is important to consider the type of disease that is present in the observed patient.   
 
A limitation to the study quoted (Hameed et al., 2005) is that after 4 months the results of the 
treatment were no longer available.  It must be emphasized that although the quoted (Hameed 
et al.) study is 12 years old and although this study is not recent at all it does identify the points 
that I am trying to make about how aetiology based treatments are useful.  
 
2.11.6 Depigmentation 
Camouflage treatments for vitiligo include temporary make up, such as creams and lotions 
whilst depigmentation therapy involves the removal of pigmented skin.  Where the 
depigmentation covers more than 60% to 80% of the total body area (AlGhamdi and Kumar, 
2011) it might in fact be more straightforward to remove pigment from all remaining skin rather 
than attempt to re-pigment the affected areas.  Depigmentation occurs in the opposite way to 
pigmentation therapies by removing any remaining pigment in the skin rather than regaining 
it. The article states that there is a difference in opinion among practitioners as to what 
percentage of body coverage qualifies for depigmentation therapies.  However (Steiner et al., 
2004) before any adult is treated via the depigmentation process, it is important that they are 
aware that the treatment involving chemical depigmenting products will be a long-term 
process.  They must also be aware that this treatment will significantly change their 
physiognomy as well as creating requirements for extra precaution to solar exposure for the 
remainder of their lives.  The choices that are available for depigmenting agents are listed in 
Table 6. 
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Table 6: A list of established and potential depigmenting agents (AlGhamdi and Kumar, 2011). 
Established agents Potential agents 
Monobenzyl ether of hydroquinone Imatinib 
Monomethyl ether of hydroquinone Imiquimod 
88% phenol solution Diphencyprone 
Laser Catechol 
Cryotherapy Hydroquinone bis (2-hydroxyethyl) ether 
 4-Ethoxyphenol 
 
 
The option of using depigmenting treatment should only be considered when more than 50% 
of that person’s body is affected by vitiligo or when it is extremely disfiguring to the affected 
person. Bleaching of the skin can be achieved by several methods including: cryotherapy, laser 
treatment, monobenzone ethyl ester or 4-methoxyphenol (Ezzedine et al., 2015).  When 
medical treatments are not successful it is often the case that surgical therapies will be 
attempted as described below. 
 
2.11.7 Surgical therapies 
It has been seen from the literature that clinical therapies for vitiligo do not always work well 
which might occur for several reasons, for example this is not the right method for creating 
repigmentation or because there were not enough melanocytes in the lesion.  This has led to 
the development of treatments that involve either a graft or melanocyte transplant (Razmi et 
al., 2018).  However, this form of treatment is only successful when the disease is stable.  One 
judge of stability is whether the lesion has increased in size at all in the last two years.  It is 
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preferred that patients recruited for therapy are emotionally stable adults who are in full 
knowledge of the risks of any surgical treatment such as scars or incomplete repigmentation 
(Steiner et al., 2004). 
 
There are only a few patients that would be considered to be suitable for surgical therapies as 
surgery is only considered an option for those with segmental vitiligo or with stable disease for 
at least one year after there has been a documented non-response by that patient to medical 
therapies (Ezzedine et al., 2015).  As mentioned previously, it is recommended that the disease 
has been inactive for a period of 6 months to 2 years (DeLeeuw et al., 2011).  When the vitiligo 
is stable (e.g. Segmental unilateral vitiligo) it is usually the case that the outcome of 
transplantation is very good and for some circumstances is the only treatment available that 
provides effective results.  It is even possible for the same individual to have at the same time 
one area of skin with active vitiligo and another area that is inactive or regressive.  As such, it 
is difficult to predict/assess the stability of the diseases in an individual (DeLeeuw et al., 
2011).  Another difficulty in treatment of vitiligo is that (DeLeeuw et al., 2011) no trustworthy 
tests are available to reliably assess and predict melanocyte transplantation outcomes in vitiligo 
patients.    
 
The different treatments available for the treatment of vitiligo were evaluated (Olsson and 
Juhlin, 2002).  This paper took several surgical treatments that will be critiqued later and 
followed up patients that had been treated by them after 1-7 years by questionnaires and clinical 
examinations.  It found that the success of the treatment was dependent on the stability of the 
vitiligo beforehand.  The limitation of this paper is that the follow up was performed on patients 
from Scandinavia between 1993 and 1999 meaning that differences between races and 
ethnicities are not accounted for and cannot be investigated further.  The treatment was 
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determined to be a success depending upon the amount of re-pigmentation that occurred.  For 
example, treatment was deemed successful when pigmentation levels of 65-100% were 
achieved whilst levels below 65% (0-64%) were judged to be a treatment failure.  The study 
described in the aforementioned paper found that the age of onset of the disease was not 
important but the age of the patient when the treatment took place was important in determining 
the procedure's success. 
 
The first stage of treatment of this disease usually involves the stimulation of pigment 
production in affected skin areas but after stimulation by ultraviolet light or dermabrasion they 
became active (Bagherani, 2016).  The various treatment options proposed can be described as 
depigmentation, therapy, camouflage, surgical treatments, light-based treatment or medical 
treatment (Adotama et al., 2015). However not all these treatments are effective for every 
person and success often depends on the area treated therefore this must be taken into 
consideration before the appropriate treatment is chosen. 
 
2.11.8 Blister technique 
The epidermal blister roof transplantation technique was created to repigment stable but 
refractory areas of vitiligo.  In two studies (Iwanowski et al., 2018) (DeLeeuw et al., 2011) it 
was examined how combining the blister roof transplantation technique with UV light and 
khellin in liposomes improved outcomes for treating recalcitrant vitiligo by this method.  After 
this it was important to gauge how satisfied patients were with the treatment (DeLeeuw et al., 
2011).   
 
For the epidermal blister roof transplantation technique, the donor sites for melanocytes are the 
blister roofs themselves.  There are three stages to the transplantation of blisters which are: 
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creation of the blisters, preparation of the recipient site and transplantation.  Blisters were 
created by a suction device connected to a rectangular plastic block (Iwanowski et al., 
2018).  The way the plastic block acts is to divide negative pressure across 28 holes, each of 
these have a diameter of 5 mm.  This is then applied to a skin area where the pigmentation is 
normal (ideally the patient’s upper arm).  To obtain manageable blisters upon application of 
300 mm mercury takes approximately one to one and a half hours but the procedure itself is 
painless and topical anaesthesia is not required (DeLeeuw et al., 2011).   
 
In the second stage which involves the preparation of the recipient area superficial erosions 
that have a diameter of 5-6 mm are made by ablation with an Erbium-YAG laser.  The laser 
ablation is continued until pin-point haemorrhages appear as the appearance of these indicates 
that the ablation has reached the papillary dermis as required.  The stage two procedures require 
topical anaesthesia with lidocaine 1-2% (in the absence of adrenalin) (DeLeeuw et al., 2011). 
 
The third stage involves the removal of the blister roofs with scissors and smooth forceps and 
the delivery of them to damaged sites in the recipient area (Dellatorre et al., 2017).  To protect 
transplants in the recipient area silicone sheeting was applied and this was covered with 
standard gauze which was fixed via an adhesive bandage to prevent it moving.  Stitches were 
not used in this procedure because the blister roof grafts are too delicate for this to be 
possible.  After a week the bandages were removed using water to enable the silicone sheets to 
be detached from the grafts as removal is far easier when the silicone sheets are wet.  After this 
the grafts were protected for another week by a new bandage with paraffin gauze and standard 
gauze after which bandages were no longer used (DeLeeuw et al., 2011). 
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The referenced (DeLeeuw et al., 2011) study consisted of 19 patients.  The study included 12 
women and 7 men with ages ranging from 25-68 years.  When analysing the results it should 
be remembered that that sex and age as well as area being treated (some areas of the body 
respond better to treatment than others) could have an impact on treatment outcomes however 
as described later in this section the inclusion/exclusion criteria do try to consider these 
conditions.  It is also important to make sure that the recipient does not have any other co-
morbid conditions, such as autoimmune disease, which could seriously hinder the success of 
the treatment.  At the end of the procedure, the participants were interviewed and 75% of 
patients (12 out of 16) responded that they were satisfied with the results of the procedure and 
that its advantages outweigh its disadvantages whilst all the participants said that they would 
recommend it to other vitiligo patients.  The reason that the participants’ satisfaction was 
measured out of 16 patients rather than 19 was because 3 patients did not fill out the 
questionnaire at the end of the study.  Since the study is so small the fact that three patients did 
not respond could be potentially significant.  The loss of 3 patients from a total sample size of 
19 is significant since this equates to a drop out of 16%.  It might be that the inclusion and 
exclusion criteria for the (DeLeeuw et al., 2011) study are so specific that only 19 patients were 
available in the time period that was studied. 
 
For this study (DeLeeuw et al., 2011) the inclusion criteria were that the vitiligo lesions should 
be stable and refractory despite having been treated with KLUV for a minimum of 1 year.  The 
lesions that were studied were situated on: the hands (11 patients), the arms (four patients), the 
neck (three patients), the shoulders (one patient), the chest (one patient), the wrist (one patient), 
and the face (one patient).  Only one patient with segmental vitiligo (on the neck) was included. 
 
The exclusion criteria (DeLeeuw et al., 2011) were pregnancy, lactation, history of allergy to 
sunlight, photo-induced diseases, and medication with drugs known to have potency for light 
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toxicity or light sensitization, phenylketonuria, impaired hepatic and renal functions, malignant 
skin diseases, a history of exposure to arsenates and ionizing radiation.  This paper does not 
justify the reason for the study size that was used and there was no evidence of a power 
calculation or any statistical test being used.   
 
2.11.9 Epidermal/dermal grafts 
Cellular and tissue grafts are a type of surgical treatment for vitiligo but the advantages and 
disadvantages of these should be seriously considered before choosing this option. Tissue graft 
techniques include suction blister epidermal grafting (SBEG), punch grafting (PSG) and split 
thickness grafting (STG).  STG has benefits including that large areas can be treated in a fairly 
short window of time but the limitations are colour mismatching, donor site scarring, milia and 
an unwanted appearance at the recipient area (Majid, 2013). 
 
2.11.10 Non-cultured and cultured autologous cells 
A novel technique for vitiligo treatment is the replenishment of melanocytes by autologous 
melanocytes.  The advancement of culturing melanocytes means that there is now a possibility 
for large recipient areas to be treated with a relatively much smaller sample of skin.  Various 
techniques are described in more detail below. 
 
Autologous cultured melanocytes 
Pigmented buttock skin is used as the source for a superficial shave biopsy (Verma et al., 
2014).  Melanocytes are separated from the epidermis, cultured in M2 medium (PromoCell, 
Heidelberg, Germany) and transplanted.  Czajkowski et al. (2008) state that a combination of 
autologous melanocyte transplantation with PUVA therapy resulted in repigmentation in 100% 
of recipient sites however it must be remembered that acral skin (skin of the extremities) is 
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extremely difficult to repigment.  The strength of the paper (Pandya et al., 2005) is that it gives 
a clear methodology for the preparation of autologous culture from melanocytes.  The 
methodology is outlined systematically and gives an account of the reagents, equipment and 
processes required.  This paper then goes on to describe the various factors that contribute to 
the success and failure of this technique such as body area being treated and the type of skin 
sample that cells are extracted from (e.g. punch biopsy versus superficial split thickness thin 
skin grafts). 
 
For a satisfactory cosmetic result to be achieved correct patient selection is an important 
contributing factor (Majid, 2013).  Other factors that must be considered are: patient age, 
vitiligo site, tendency for keloids along with crucially vitiligo stability. The term stable vitiligo 
refers to the disease process being inactive in the patient. When the vitiligo is stable it can be 
seen clinically as occurrence of no new lesions becoming present, with no spread of existing 
vitiligo lesions, and no Koebner’s phenomenon. For stable vitiligo the transfer of autologous 
melanocytes is a simple and effective technique for quick production of homogeneous 
pigmentation.  Cultured melanocytes are at a disadvantage over non-cultured melanocyte 
techniques since they are time consuming and labour intensive to create but the benefits of 
them are that they can be used to cover an area that is over 100 times the donor area making 
them suitable to cover large areas of body surfaces.  An advantage of this technique is that it 
only requires very little donor skin (Verma et al., 2014).  Verma et al. (2014) is a study where 
melanocytes were harvested from a donor split thickness graft as an autologous melanocyte 
rich suspension.  Cultured or non-cultured melanocytes were transplanted onto a recipient site 
that had been superficially debraded.  100 patches of vitiligo in patients were then allocated 
into any of these two groups to receive either of these interventions. 
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For dermatologists with the expertise and facilities to create autologous cultured melanocytes 
this offers a treatment for even the most difficult cases of vitiligo.  However, the limitation of 
this technique is that most clinicians do not have the ability to maintain it (Czajkowski et al., 
2008).  A critical analysis of this technique includes highlighting its limitations which are not 
only due to the lack of clinician skills but also its high cost and requirement of 3 weeks to 
obtain the cultured melanocytes (Fioramonti et al., 2012). The limitations of using autologous 
cultured melanocytes mean that non-cultured melanocyte transfer should always be tried first 
when the vitiligo is not so widespread. 
 
The effectiveness of using cultured versus non-cultured melanocytes in the treatment of 
vitiliginous areas was compared (Verma et al., 2014).  The paper found that using autologous 
melanocytes when compared to cultured melanocytes produced a much better result with the 
non-cultured technique showing an excellent response in 62.17% of cases and the culture 
technique showing an excellent response in 52% of cases. A limitation of this paper is that it 
does not give a definition of what an excellent response is or what it means.   In total 100 
patches of vitiligo were studied over a period of one year.  This is a relatively large sample size 
and enough time was given for the results of the intervention to present themselves.  To remove 
any anomalous results only patients who have had stable vitiligo for at least one year were 
included in the trial.  This study's results are only three years old, meaning that they are current 
with the latest available techniques.  To remove any bias the selection of whether patients 
should be recruited to the group for cultured or non-cultured melanocyte treatment was 
completely random.   No blinding was done in this study however this should not have any 
impact on the results that are obtained. To remove any sex bias that might occur almost equal 
numbers of men and women were studied in each group. 
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The benefits of using autologous melanocytes over existing dermato-surgical procedures, such 
as punch grafting and split thickness skin grafting, are that the other techniques have various 
deficiencies such as cobblestoning, pigment mismatch and patient discomfort (Verma et al., 
2014).  The (Verma et al., 2014) paper is of relevance to my study because it discusses 
implanting both melanocytes and keratinocytes which then get entrapped within the healing 
site, multiply and repigment the depigmented site.  However, what is not performed in the 
(Verma et al., 2014) study is that the melanocyte/keratinocyte ratio is not manipulated prior to 
implantation; it is likely that doing so would improve the results seen although it might make 
the procedure more complicated.  Keratinocytes secrete factors that improve melanocyte 
growth and function so implanting both cells types together rather than just melanocytes alone 
should improve the results that are seen. 
 
2.11.11 Additional surgical therapies 
Ultrathin epidermal sheets 
A Zimmer – air dermatome (manufactured by Zimmer, Dover, OH, USA) was used to harvest 
ultrathin donor skin from normal gluteal skin that had been subject to local anaesthesia. This 
was then transplanted to the site where it is required (Olsson and Juhlin, 2002). 
 
Basal layer cell suspension 
Pigmented buttock skin was used as the source for a superficial shave biopsy (approximate 
size: 2 x 5cm2).  EMLA cream (a local anaesthetic cream) (Manufactured by Astra, Sodertalje, 
Sweden) and lignocaine (lidocaine) injection were used as local anaesthetic for the recipient 
area.  The cell pellet underwent washing and centrifugation before its re-suspension in a small 
volume of s-minimal essential medium (S-MEM Life Technologies Ltd., Gaithersburg, MD, 
U.S.A).  This was directly transferred to dermabraded skin from a test tube via a pipette before 
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Mepitel (silicon netting, moistened compresses) and Tegaderm semi-occlusive film were used 
to cover it. 
 
In (Olsson and Juhlin, 2002), patients were given a questionnaire to complete as follow up as 
well as being offered a complimentary follow up consultation.  In this study (Olsson and Juhlin, 
2002) leucoderma patients that had been treated with autologous cultured melanocyte 
transplants, ultrathin epidermal sheets and basal cell layer suspension underwent long term 
follow up.  Statistical methods were used to analyse this data which included Kruskal-Wallis 
test for group comparison and Spearman’s rank correlation test.  Re-pigmentation was assessed 
numerically with 65-100% pigmentation being judged successful and 0-64% as failure.   This 
paper also gives a clear description of the methodology used to assess the effectiveness of the 
various techniques at follow up.  The Olsson and Juhlin study was published in 2002 which 
means that it is at least 15 years old.  It is possible that this paper is no longer entirely relevant 
as it is likely that since its publication new techniques or modifications to existing ones would 
have been developed.  However, a literature search has confirmed that these techniques are still 
relevant in today’s world (Pandya et al., 2005). 
 
Micropigmentation 
Micropigmentation is a type of tattooing, a useful method for concealing vitiligo lesions, where 
small inert granules of pigment (approximately 6mm in size) are introduced into the superficial 
dermis (Hossain et al., 2016).  These granules are made up of inert, nontoxic, insoluble 
chemicals which become permanently embedded into the dermis via mononuclear cells and 
collagen fibres when inserted into it. The pigment that is used for medical micropigmentation 
is mostly composed of iron oxide.  When injected this has a light to dark brown colour in the 
skin and it is normally delivered via an electrical tattooing machine.  This machine’s active 
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component is an array of several 25-G needles with a penetration depth of about 1 to 2 mm and 
they can attain a speed of up to 9,500 strokes per minute.  The correct colour dye is achieved 
by creating a paste or colloidal suspension mixing it before injection with various dyes, water, 
saline, or alcohol (Patel et al., 2012). 
 
The operator’s skill can be a crucial determinant of the cosmetic outcome since a criterion for 
achieving a permanent uniform pigmentation is how deep the pigment granules are injected 
into the skin.  Ideally insertion depth should be about 1.5mm and it should be done between 
the upper and mid-papillary dermis.  When granules aren’t injected to a sufficient depth, they 
tend to be expelled quickly after the procedure is performed but conversely if the injection is 
too deep then the pigment will be removed by macrophages (Patel et al., 2012).  
 
Other factors contributing to cosmetic appearance include: how thick the pigment paste is, how 
many needles are used in the tattooing machine, and how thick and elastic the recipient’s skin 
is. Micropigmentation is normally adequately received by the body; the side effects are 
minimal. Side effects that can occur in the few days following micropigmentation procedure 
include: localized infection, oedema, bleeding, and crusting.  Rare side effects that have been 
experienced are: granuloma formation, allergic reactions, keloid formation, and reactivation of 
herpes simplex virus (Patel et al., 2012).  Another technique that can be used is permanent 
dermal micropigmentation.  This works in a similar way to eyelid tattooing.  This technique 
shows few complications but there is a risk of infection by the herpes simplex virus in those 
individuals that are predisposed to it (Steiner et al., 2004). 
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2.12 The use of therapies based on autologous co-cultured cells 
Due to social and political pressure, the use of animals for research and clinical trials is now 
decreasing.  Therefore, there is a necessity for versatile and translatable skin models to be 
developed so that the biology of pigmentation and the pathophysiology of the skin disease 
vitiligo can be studied.  It is the case that many models have been developed however in vitro 
and in vivo models are often a poor representative of the clinical scenario.  The use of in vitro 
models is at an advantage since they allow the analysis of environmental changes, substrate 
and dose response interactions in a standard fashion (Kumar et al., 2012). 
 
Artificial models of skin pigmentation are needed so that research can be performed on various 
pigment skin diseases and so that the regulation of pigmentation can be understood.  If an 
artificial skin could be created this could be used to test chemicals and skin care products for 
any adverse effects.  However, skin samples for chemical/cosmetic testing will not reveal all 
side effects as it’s an artificially isolated part of a complex organism and as such may not mirror 
the biology as closely as is needed (Kumar et al., 2012). 
 
At present, the demand for artificial skin is not satisfied with experiments involving artificial 
skin being very expensive due to its limited availability.  There have been many 
melanocyte/skin equivalent models used to assess the potential efficacy of melanogenic 
compounds in the regulation of pigmentation.  Variation in such results can either be attributed 
to the use of different cell lines or due to monoculture of melanocytes/keratinocytes since in 
vivo melanocytes are usually present with keratinocytes (Kumar et al., 2012). 
 
The use of co-culture models is very important since they provide a better representative of the 
in vivo situation than a mono-culture or animal model does (Goers et al., 2014) (Lei et al., 
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2002) (Miki et al., 2011). Experimenting with compounds on only melanocytes does not 
represent the conditions that are found in skin.  Keratinocytes secrete many factors which act 
on melanocytes (Kumar et al., 2012). Studies using models of in vivo systems have confirmed 
that human keratinocytes produce factors such as α-MSH, nerve growth factor and 
ACTH/ACTH fragments.  The role of these factors is regulation of melanogenesis and/or 
dendritogenesis of human melanocytes in primary and/or serial cultures (Hirobe, 2014). 
 
The use of co-culture techniques has an array of applications for achieving an understanding 
of the natural or synthetic interactions that happen between different populations of cells and 
they are vital in the quest to understanding any type of cell-cell interaction studies.  In its most 
elementary form, there is some degree of contact between two or more different cell types when 
they are grown together (Goers et al., 2014).    
 
To develop an understanding of the mechanism by which keratinocytes regulate the growth of 
melanocytes using a co-culture model of these two cells proves to be invaluable.  Processes 
where epidermal keratinocytes influence melanocyte growth include: proliferation, 
melanogenesis, differentiation and dendritogenesis of epidermal melanocytes. Using serum 
free media is preferred so that any unidentifiable factors can be eliminated as being a cause for 
influencing any of the processes being studied (Hirobe, 2014). 
 
Many low complexity co-culture systems are in existence but higher complexity systems are 
much rarer and beyond certain levels of complexity they are non-existent.  The problem with 
a high complexity system is that it inherently vastly complicates the experimental 
procedure.  Therefore, most co-culture systems involve two populations with co-cultures of 
more than three distinct cell populations being very rare.  However, (Goers et al., 2014) it has 
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been suggested that co-culture studies with many populations might not actually be 
advantageous as it becomes more difficult to analyse the data/results.  This outcome supports 
the main aim of synthetic biology which is to design a system that is as complex as necessary 
to reach the desired goal. 
 
In any co-culture model the cell populations might exhibit similarities, e.g. the same strain with 
a minor difference in gene expression, or very different from each other e.g. different 
species.  Common sense dictates that similarity of co-culture population’s results in a more 
straightforward establishment of a stable system but many successful examples exist of co-
cultures amongst contrasting species (Goers et al., 2014). 
 
In this study using a melanocyte/keratinocyte co-culture model is extremely relevant since it 
has been observed that both cell types influence each other in several ways.  Melanocytes are 
extremely responsive cell types that modulate their levels of melanogenesis or proliferation in 
accordance to extrinsic signals and factors that are produced by keratinocytes (Kumar et al., 
2012).  For example (Hirobe et al., 2014) found that in human skins that have been irradiated 
with UVB or UVA, the keratinocyte derived factors Endothelin-1 and GMCSF regulate human 
melanocytes proliferation and melanogenesis/dendritogenesis. It was also found that human 
keratinocytes produced and released the factors IL-6 and IL-8 which have the action of 
stimulating dendritogenesis in cultured human melanocytes of the epidermis (Hirobe et al., 
2014).   
 
The proliferation of melanocytes in humans has also been found to be regulated by bFGF as 
well as by stem cell factor being expressed by keratinocytes.  When proteinase-activated 
receptor 2 is stimulated, prostaglandin E2 (PGE2) and prostaglandin F2α (PGF2α) are released from 
135 
 
human keratinocytes.  The effect of all these is the stimulation of dendritogenesis in cultured 
human epidermal melanocytes via prostaglandin EP1/EP3/FP receptors in a cAMP 
independent way (Hirobe, 2014). 
 
In a co-culture the amount of contact that occurs between different cell types is dependent on 
the experimental design for example the different cell populations can either be thoroughly 
mixed or partially separated.  The way in which the co-cultures are separated must be chosen 
and tailored to how the co-culture will ultimately be used. An example of this is that for some 
purposes different types of cells should be in direct contact; this is sometimes referred to as a 
‘mixed culture.’ Direct contact such as this is occasionally required in mammalian tissues and 
some types of eukaryotic cell cultures so that physiological behaviours can be preserved e.g., 
the melanocyte/keratinocyte co-culture model.  For mixed cell cultures different cell 
populations must be under symmetrical conditions.  This is achievable when there are similar 
requirements amongst the two different cell types (Goers et al., 2014). 
 
When the populations are different but a mixed culture is desired it is necessary to optimise the 
growth medium so that the best medium for sustenance of the cell populations can be 
established.  Before they are placed in co-culture both the melanocyte and keratinocyte cell 
populations are grown and established separately (Goers et al., 2014).  An additional aim of 
this study is the development of a co-culture medium that supports the growth of both 
melanocytes and keratinocytes in a mixed culture. 
 
An important consideration that one must make when designing a co-culture model is that 
different cell types proliferate at different rates with one type being dominant over 
another.  Therefore, in co-cultures it is often necessary that the population ratio is optimised so 
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that the culture is stable and one cell type does not eliminate another. In mammalian cultures, 
it is common for the population ratio to be set to a value that is in resemblance to the natural 
situation (Goers et al., 2014). 
 
2.12.1 Current methods available to manipulate and measure cell proportions in co-
culture 
Since keratinocytes produce a lot of growth factors for the proliferation and migration of 
melanocytes it is advisable that simultaneous transplantation of melanocytes and keratinocytes 
be attempted to improve the technique of cultured melanocyte transplantation (Lim et al.,2014). 
 
Several preliminary experiments were performed where cells were seeded in various 
keratinocyte to melanocyte ratios of 1:1, 2:1, 5:1 or 10:1 in various medium formulations with 
differing levels of calcium (Lei et al., 2002).  A co-culture can be prepared with the ideal 
melanocyte to keratinocyte ratio being 1:5 (Kumar et al., 2012). Investigations (Lei et al., 2002) 
go further to explain that optimum responses were obtained when low calcium was added to 
the co-culture.  In (Kumar et al., 2012) the co-culture could be maintained for up to 6 days.  In 
the first step the keratinocytes were seeded in the culture plate and two days later melanocytes 
were added.   
 
After one day the co-cultures underwent treatment with melanogenic compounds which were 
then replenished every two days.  Lei et al. (2002) found that after day 6 the keratinocytes in 
the co-culture model were grown almost to confluence with melanocytes seeming to grow over 
them; phase contrast counting showed that by the end of the experiment the melanocyte to 
keratinocyte ratio had decreased from 5:1 to 2.5:1.   My study is an extension to the other (Lei 
et al., 2002) (Kumar et al.,2012) studies.  In my study like in these studies a co-culture medium 
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was developed as part of research objective 1 and my cells were exposed to known amounts of 
melanogenic stimulators to find an optimal dose. 
 
The effect of two melanogenic stimulator compounds, stem cell factor and latanoprost, on the 
co-culture system was examined (Kumar et al., 2012).  It was found that after treatment with 
melanogenic stimulators cellular melanin content increased considerably as well as cellular 
proliferation and tyrosinase activity.  Skin pigmentation is attributed to tyrosinase-regulated 
melanin synthesis.  The compounds MSH, DOPA and 8MOP were identified as being 
melanogenesis stimulators (Lei et al., 2002). MSH treatment in a dose dependent manner could 
stimulate tyrosinase activity and melanin content with a two to three times increase in 
comparison with untreated controls.  The effects of a melanogenesis stimulator (Lei et al., 
2002) were much stronger in the case where melanocytes are co-cultured with 
keratinocytes.  Findings such as this are an indication of the fact an important synergistic 
function is attributed to keratinocytes in the regulation of melanogenesis by MSH.   
 
Since MSH is known to have an effect on melanocyte action and that is quite widely available 
it was decided that using controlled concentrations of this hormone could be used in the 2nd 
objective of my study to see how it can be used to manipulate melanocyte keratinocyte ratios 
in culture.  Another environmental factor that is known to affect co-culture ratios is UV 
light.  UV light is known to stimulate melanocyte action and this is also widely available.  For 
example, dentists and dermatologists regularly use UV light sources in their practice so this 
equipment was easily available in KSHEMA.  For this reason, to fulfil the second objective of 
my study, I also decided to investigate the effect of using UV light to manipulate 
melanocyte/keratinocyte ratios. 
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In recent studies (Lim et al., 2014) the melanocyte keratinocyte co-culture model concept is 
taken one step further by the recommendation to use a co culture composed from melanocytes 
and adipose derived stem cells rather than melanocytes and keratinocytes.   This suggestion is 
made since adipose cells are much easier to obtain than keratinocytes.  It was found that 
although using adipose cells resulted in less proliferation than keratinocytes it was still 
significantly greater than melanocyte monocultures.  Using co cultures of adipose stem cells 
and melanocytes could be an extension to and my PhD work in the future. 
 
However, the Lim et al. (2014) study could be progressed further if the melanocyte adipose 
cell culture was performed on humans rather than mice as is currently the case.  Mice are a 
useful model since they are mammals and the reaction can be indicative of a human result 
however if we want a more accurate assessment of the use of melanocyte/adipose co culture 
then the application of this to humans should be studied as well.  Positive and negative controls 
were used and 4 weeks’ time was given for any significant results to appear. 
 
2.12.2 Methods of manipulating cell ratios in vitro co-culture 
Melanocyte stimulating hormone (MSH) 
Alpha melanocyte stimulating hormone, or α-MSH, is a peptide hormone that is made in the 
body. The differentiation of melanocytes is stimulated by melanocyte stimulating hormone 
(Hirobe, 2011).  The origins of this hormone are in a precursor peptide called 
proopiomelanocortin (POMC) and as such the family of peptides that it belongs to are called 
melanocortins.  α-MSH’s amino acid sequence comprises 13 amino acids and it has a primary 
structure of: Ac-Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val.  Hirobe (2011) 
gives details of the genetic factors involved in melanocyte differentiation.  The limitations of 
this paper are that it uses mouse and not human models to assess how regulating different genes 
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affects melanocyte synthesis.  As mentioned previously in section 2.12.1 mouse models are 
useful to give us an indication of how MSH will affect the co-culture but we will not know the 
definite effects of this in humans until the experiment has been performed in a human 
model.  For the sake of safety, a mammalian model to test an experimental model is ideal but 
until this has really been translated into a human we cannot be sure of how it will really act in 
the human body. 
 
Production of α-MSH occurs in epidermal cells of the skins, predominantly in the keratinocytes 
but this has also been observed occurring in melanocytes and Langerhans cells.  α-MSH 
production happens as a defensive response against damage by UV radiation.  It binds with the 
melanocytes MC1R receptor to stimulate melanin production.  Following this granules of 
melanin are transferred to organelles called melanosomes via which they are transported to the 
dendrites which are found projecting from the ends of melanocytes.  Melanin granules are 
released into neighbouring keratinocytes when the ends of melanocyte dendrites are engulfed 
by them. Once the melanin granules are in the keratinocyte, they form an arrangement as being 
a protective barrier over the nucleus of the keratinocytes.  The effect of melanin in the cell 
nucleus is that it protects it from being damaged by UV light by absorbing, reflecting and 
refracting light (Bohm et al., 2005). 
 
Basic fibroblast growth factor 
Basic fibroblast growth factor (FGF2) is a product of keratinocytes and the function of it is to 
prompt human melanocyte proliferation.   FGF2 is potent because it can bind to all 4 FGF 
receptors and their subclasses.  FGF2 is the most potent proliferation factor of all the 21 or so 
FGF molecules (Lee et al., 2017).  The presence of this cannot completely account for increase 
of melanocyte growth rate in vivo or in vitro, when it is thought that melanocyte proliferation 
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is potentially stimulated by co-culture keratinocytes.  It is thought that the other factors that are 
responsible for the stimulation of the normal human melanocyte growth in monoculture or 
keratinocyte co-culture remains largely unknown (Luca et al., 1993). 
 
Alpha melanocyte stimulating hormone is thought to be one of the most obvious candidates for 
adenylate cyclase-dependent melanocyte growth stimulation.  This has been shown to increase 
the intracellular levels of cAMP in target cells.  Cholera toxin has also been found to increase 
cellular levels of cAMP.  𝝰-MSH (Luca et al., 1993) does stimulate melanocyte proliferation 
in a dose dependent nature but for its mitogenic effect to occur it requires basic fibroblast 
growth factor (FGF2) and/or the activation of protein kinase C (Lee et al., 2017). 
 
A literature search revealed that the optimal cholera toxin and FGF2 concentrations for the 
induction of melanocyte growth were 10M and 1ng/ml respectively (Luca et al., 
1993).  Maximum growth stimulation occurred upon the addition of FGF2 and alpha-MSH or 
Cholera toxin.  The capability of cholera toxin to stimulate melanocyte growth has been 
confirmed (Kormos et al., 2011).  It was found that alpha-MSH was ineffective in its action 
when FGF2 was absent even at concentrations of up to 100ng/ml.  1ng/ml of bFGF was enough 
for the growth stimulatory effect of alpha-MSH at concentrations that were as low as 1ng/ml 
whilst maximal values were reached at 10ng/ml (Luca et al., 1993).  
 
Interferon – Gamma 
Interferon-gamma, a type of cytokine, is expressed in the serum of those with vitiligo indicating 
that it could have a part to play in disease onset.  In normal human melanocytes interferon-
gamma causes cell cycle arrest and apoptosis.  The effect of this can be seen physically since 
normal human melanocytes are pale and dendritic with small cell bodies whilst those 
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persistently exposed to interferon gamma treatment are larger and flatter with shorter and fewer 
dendrites. 
 
UltraViolet light 
Sunlight is made up of two main types of rays which are long wave ultraviolet (UVA) and short 
wave ultraviolet (UVB).  These affect the skin differently with UVA penetrating deep into the 
thickest layer of the skin (the dermis) and UVB just burning the skin's uppermost layers. 
 
It was shown that the normal melanocytes respond differently to UVA and UVB irradiation 
depending upon culture conditions and whether melanocytes were grown as a mono- culture 
or as a co-culture with keratinocytes.  In the co-culture model the exposure to UVB irradiation 
at doses as low as 5mJ/cm2 led to the synthesis of melanin increasing whereas in monocultures 
of melanocytes it was found that UVB doses of up to 50mJ/cm2 had no melanogenic 
effect.  UVA exposure differs from UVB in that it causes the same melanogenic effect in both 
mono and co cultures.  When keratinocyte growth factors were removed from the culture 
medium the melanogenic response was abolished to UVB but not UVA exposure (Duval et al., 
2001) (this is a slightly older paper but its conclusions are still relevant).  Tyrosinase is a vital 
enzyme of melanogenesis and it is activated by exposure of skin to UV radiation (Gillbro and 
Olsson, 2011). 
 
Physical removal of cells 
The dish containing the cells will be viewed under a microscope.  Cells for removal will be 
identified and essentially ‘scratched out’ using the tip of a needle. 
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Melanogenic inhibitors 
The effect of two melanogenic inhibitor compounds that are used in the treatment of hyper 
pigmentary disorders on the melanocyte/keratinocyte co-culture was examined (Kumar et al., 
2012).  It was found that after treatment with Kojic acid and Hydroquinone there was a 
significant decrease in tyrosinase activity, melanin content and proliferation.  Other 
melanogenic inhibitors include arbutin and niacinamide (Lei et al., 2002). 
 
The rate limiting step of melanin synthesis is subject to the enzyme tyrosinase meaning the best 
way to control the formation of pigment is by inhibiting or stimulating the activity of 
tyrosinase.  Four compounds are used by dermatologists to alter the appearance of disorders 
involving hyperpigmentation which are: hydroquinone, kojic acid, arbutin and niacinamide.  
Studies have found that when melanocytes and keratinocytes are co-cultured these components 
have an inhibitory effect that is more noticeable.  This was seen by its effect on tyrosinase 
activity, melanin content and cellular proliferation.  The assumption that can be reached from 
this observation is that keratinocytes have a fundamental role in modulating the function of 
melanocytes in situ (Lei et al., 2002). 
 
2.13 Vitiligo studies using animal models 
It has been proposed that animal models be used to study the pathogenesis of vitiligo and to 
develop new treatments since before going directly to humans (Essien and Harris, 2014) a proof 
of concept is needed in a relevant animal model (Taieb, 2011).  The limitations of using animal 
models for studying this disease are that its underlying pathogenesis is so complex that it is 
unlikely that just one animal model will be enough to give an accurate reflection of all the 
factors that have a role in disease initiation, progression and maintenance (Essien and Harris, 
2014). It has been suggested that the best way to deal with the aforementioned problem is to 
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use multiple animal types since each has their own different strengths and 
weaknesses.  However, when considering the use of animals, it must not be forgotten that doing 
this can be both costly and very time consuming.    An example scenario of how an animal 
model differs from a human is that of melanocyte distribution in the skin. In mice these are 
found in hair follicle and are not present in the epidermis of hair bearing skin significantly 
different from humans where they are present in the follicles and epidermis of such skin (Singh 
et al., 2016). 
 
2.13.1 Mice 
Mice have for a long time been viewed as a good model organism for studying the genetics of 
skin and hair pigmentation.  Most mouse vitiligo models are carriers of transgenes leading to 
immune activation which means they can replicate autoimmune melanocyte destruction but not 
the other features of melanocyte loss (Singh et al., 2016).  Another setback to using murine 
models for vitiligo is that they do not have any interfollicular melanocytes (Manga and Orlow, 
2012).  A new mouse vitiligo model was made when melanocytes were kept by overexpressing 
a mutant form of the ligand kit (other names for this are stem cell factor, SCF or 
KITL).  Transplanting melanocyte – targeting CD8+ T cells (CTLs) triggers melanocyte loss 
by immune factors (Harris et al., 2012).  The theory for destruction of melanocytes by 
immunological factors is that CTLs being targeted again certain proteins that are specific to 
melanocytes is a major part of this happening (Manga and Orlow, 2012).  
 
The fact that mice are mammals means that their use is still preferable as animal models over 
other species and that within the mammal group they are relatively easy to maintain, for 
example, in contrast to chimpanzees and monkeys, but it is important to remember as 
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highlighted above that this is not a perfect system and that there are some disadvantages to it 
(Harris et al., 2012). 
 
2.13.2 Smyth line chicken 
Smyth line chickens are a useful model organism for studying vitiligo because affected animals 
display a pathogenesis that has much in common with the human form.  This means that there 
is a possibility that such an animal model can help us to understand how stress, defects in 
melanocytes, genetics and cellular immune responses interact with each other to cause this/the 
onset of disease.  Sequencing of the chicken genome and the relative ease of obtaining parental 
control lines further adds to the advantages of using this model (Shi et al., 2012). 
 
Vitiligo in this chicken model presents itself as a depigmentation in its feathers. With regards 
to studying autoimmune mechanisms, 70-95% of hatchlings that are vaccinated against 
lymphoma develop depigmentation but when there is no vaccination these figures are much 
lower.  It is hypothesised that viral infections can be a trigger for autoimmunity in vitiligo but 
this is yet to be definitively proven.  The Smyth line chicken has a much greater incidence of 
vitiligo than their human counterparts (Essien and Harris, 2014). 
 
Smyth line chickens exhibit a susceptibility to uveitis and autoimmune disorders that have an 
association with human vitiligo.  Hypothyroidism and feather loss is viewed to have similarities 
with alopecia areata.  The feathers of Smyth line chickens have increased levels of reactive 
oxygen species and their melanocytes can be seen to have a marked morphological 
abnormality. Similar to humans these defects alone are not enough for causing disease but 
rather also require the presence of immune responses.  Similar to human vitiligo, CD8+ T cells 
infiltrate the feathers of SL chickens with active disease and also IFN-γ and IFN-γ induced 
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genes are seen to be expressed in affected feathers.  We can prove that melanocyte destruction 
might be caused by antibodies by observing the fact that performing Bursectomy procedure 
reduces disease incidence as well as this auto-antibodies have been isolated from vitiligo 
affected Smyth line chickens (Essien and Harris, 2014). 
 
2.13.3 Dog breeds 
There are breeds of dogs that have a genetic predisposition for developing vitiligo and these 
include: German Shorthaired Pointers, Dachshunds, Doberman Pinschers, Old English 
Sheepdogs, German Shepherds and Rottweilers.  It has been observed that in animals with 
vitiligo their serum has autoantibodies for melanocyte antigens which are not present in the 
serum of healthy individuals.  The use of dog breeds for genome wide association studies is 
especially powerful since they are genetically homogeneous meaning that fewer individuals 
are required for statistical power than in humans (Essien and Harris, 2014).  
 
2.13.4 Sinclair swine 
Swine are increasingly being used as a serious alternative to dogs and non-human primates in 
translational research.  This can be attributed to the fact that swine have much in common with 
humans in terms of anatomy and physiology making them a much more suitable models for 
certain studies and procedures than other available species (Swindle et al., 2012).  Sinclair 
swine are particularly useful for modelling vitiligo since their disease state shows similar 
features to that of humans (Frisoli et al., 2018). 
 
Previously rats, mice and rabbits were used as models for experimental and toxicology studies 
of the skin but in recent times pigs are becoming the preferred choice for skin studies because 
there is a great deal of similarity in the skin of pigs and humans.   In terms of structure pig and 
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human skin resemble each other because they have similar epidermal thickness as well as 
dermal-epidermal thickness ratio.  The skin of these two species also has in common the fact 
that in both the skin is fairly hairless with a secure subcutaneous layer and hair follicles in the 
dermis.  Pigs are a physically advantageous model because they respond to several growth 
factors, physically and molecularly, in a similar way to humans.  Pigs also have a dermis with 
a similar content of dermal collagen and elasticity (Swindel et al., 2012). Pig and human skin 
differ in the fact that pig skin is seen to be thicker on the neck dorsum as well as not being as 
vascular in all parts.  Although like humans’ pigs possess apocrine sweat glands and sebaceous 
glands all over their skin these have a negligible part to play in thermoregulation. 
 
2.13.5 Horses 
Horse breeds with the Gray coat hair allele (Andalusians, Arabians and Lipizzaners) have been 
observed to spontaneously develop vitiligo.  This tends to present on body areas such as 
perigenital, perioral, perianal areas and the face.  The mechanisms of vitiligo in horses are fairly 
unknown but horse sera of infected individuals have been found to have antibodies acting 
against surface melanocyte antigens.  This has led to scientists theorizing that such horses are 
useful for studying the formation of vitiligo antibodies because quantities wise they can provide 
a large amount of serum for antibody purification (Essien and Harris, 2014). 
 
2.14 Differentiation markers 
Differentiation markers are most widely used to determine a cell's lineage and sub lineage. 
They are also known as cell surface antigens and function as monograms to enable the 
identification and classification of cells.  In the majority of cases a cell marker is a molecule or 
antigen within a cell’s plasma membrane with different cell types possessing specific 
combinations of markers or antigens.  For example, T cells can be identified by the expression 
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of the CD3 marker.  A mature T cell on the other hand might belong to the T4 subset in which 
case it will express the marker CD4.  In such a manner there are markers for other cell 
populations and subpopulations (Zola, 2000). 
 
Within a cell's lineage it is often helpful to be able to distinguish cells that are at different stages 
of differentiation and activation.  It is particularly useful to use differentiation status in the 
diagnostic analysis of the lymphoid and myeloid malignancies as well as in research on the 
hematopoietic system.  Examples of this include markers for the naïve or antigen experienced 
cells (especially for CD45 isoforms) and molecules such as CD9 which are to be found upon 
B-lineage precursors, including B lineage acute lymphoblastic leukaemia.  The activation 
status is especially interesting in the studies of cell function.  Markers of activation include 
CD25 (a growth factor receptor) and CD69 and CD98 (the cellular function of this is not yet 
fully understood).  
 
It is markers such as these that have revolutionized aspects of pathology and research, and such 
is the case that the ease with which some cell populations can be identified has led to some 
unrealized, and perhaps unrealistic, expectations. It can be expected that the identification of T 
helper type 1 (TH1) and T helper type 2 (TH2) cells on the basis of a simple surface marker 
was frustrated by the lack of a single marker for all dendritic cells or for all NK cells, confused 
by the un-coordinated expression of different activation markers, or have an over-interpreted 
phenotype in some situations.  Solutions to these problems can be examined by why the 
successful lineage markers work so well or by a reconsideration of our expectations (Zola, 
2000).  Several markers that are useful in the identification of melanocytes and keratinocytes 
have been identified and will be explained further below. 
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1α(OH)ase shows significant expression in keratinocytes.  1α(OH)ase-null mice do not display 
any particular phenotype but they do have a lowered expression of keratinocyte differentiation 
markers involucrin, profilaggrin and loricrin.  In 1α(OH)ase-null mice one observation is they 
have a lowered capacity for recovering a normal functioning of the skin barrier once it has been 
disrupted (Hendy et al., 2011).    
 
It has been concluded that the local production of 1,25(OH)2D is needed for epidermal cells to 
undergo normal differentiation.  When the alleles for 1α(OH)ase were inactivated in a ras-
transformed keratinocyte cell from nude mice, that make a squamous cell carcinoma, these 
tumours did not react to the inhibition of growth by 25(OH)D,that was administered locally, 
but they did react to 1,25(OH)2D antiproliferative and differentiating effects.  This makes us 
infer that the activity of keratinocyte 1α(OH)ase has a vital role in the autocrine regulation 
of  keratinocyte differentiation and growth (Hendy et al., 2011). 
 
2.14.1 Filaggrin 
Filaggrin (filament aggregating protein) is a matrix protein which exerts its function by binding 
to keratin fibres of the epithelial cells.  Filaggrin is the product of a large profilaggrin precursor 
protein undergoing post translational hydrolysis to make ten to twelve filaggrin units when 
epithelial cells are terminally differentiating.  Fillagrin is also important when the stratum 
corneum is forming because it becomes part of the physical barrier of the skin which has the 
responsibility of controlling the movement of molecules into and out of the skin.  Further 
processing of Filaggrin happens in the upper stratum corneum where free amino acids are 
released which aids in water retention (Norreslet et al., 2018). 
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A decrease in filaggrin expression or loss of function mutation are thought to present as causing 
an epidermal barrier defect that results in a heightened exposure to environmental allergens 
and greater susceptibility to bacterial and viral infections.  This barrier defect also appears to 
result in an increased susceptibility to and exacerbation of asthma with a deficiency in Filaggrin 
being one of the top genome wide genetic determiners of asthma (Archer et al., 2019).  Another 
clinical presentation of filaggrin abnormality (truncation mutation in the gene) is that such 
individuals show a strong predisposition to severe dry skin.  Almost 50% of all severe eczema 
cases present with this gene mutation (Brown and McLean, 2012). 
 
When epidermal cells are terminally differentiating a huge (>400Da) profilaggrin precursor 
protein is post translationally hydrolysed into ten to twelve filaggrin units.  The gene that codes 
for human profilaggrin is called FLG and it is a member of the fused type protein family S100.  
Filaggrin structures are found in several areas such as keratohyalin granules of the epidermis 
and they are a major constituent in cells of the stratum granulosum skin layer (Brown and 
McLean, 2012).  Amidst the interface of the skin layers, the stratum granulosum and stratum 
corneum profilaggrin is reduced into filaggrin monomers by proteolytic processing which is 
assisted by enzymes that are calcium dependent. A characteristic of filaggrin is its high pH 
which can be attributed to the high presence of histidine in the primary structure and its 
relatively low constitution of methionine and cysteine (sulphur containing amino acids) 
(Brown and McLean, 2012) (Norreslet et al., 2018). 
 
2.14.2 Involucrin 
In terms of terminal keratinocyte differentiation, Involucrin is a useful marker for this.  It is 
coded for by the gene IVL and it is a soluble protein part of human skin.   Involucrin is not 
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only present in humans but its size does differ in different species with it in dogs being of 285 
residues whilst in orangutans it is of 835 residues in size.  When it binds with the protein 
Loricrin it aids in the formation of the cross-linked envelope to which it is a precursor.  The 
function of this envelope is to protect the skin's corneocytes.  Involucrin is made once 
keratinocytes have departed from the basal layer and started to get bigger. However, this is 
some time before the envelope starts to cross-link and this only happens in the cells outermost 
layers (Watt, 1983). 
 
Involucrins structure consists of a rod shaped ɑ-helix and one of its functions is to be a substrate 
of the formation of covalent ε-(γ-glutamyl)lysine isopeptide bonds.  This protein's N-terminal 
region is made up of approximately 75 amino acid residues which come before two segments 
containing glutamine-rich tandem repeats that are very variable in length.  The function of 
tandem repeats is for the glutamine residues to act as a substrate for transglutaminase via a 
cross-linking reaction (Abadie et al., 2019). 
 
Involucrin is a soluble cytosolic protein when it is first made but when it terminally 
differentiates at the epithelial cell surface it is covalently cross linked via areas on the plasma 
membrane inner surface.  It is in this region that Involucrin helps to stabilise the cells structure 
by it taking on the role of being a scaffold protein (Adhikary et al., 2005).  Since Involucrin is 
a type 1 transglutaminase it can be a catalyst for interprotein ε-(γ-glutamyl)lysine bond 
formation.  This then serves to be a catalyst for interprotein covalent cross links being made by 
involucrin with other proteins (Adhikary et al., 2005). 
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2.14.3 Loricrin 
Loricrin is a structural protein, a characteristic of which is that it is terminally differentiating.  It 
encompasses more than 70% of the cornified envelope and it aids in the function of the stratum 
corneum being a protective barrier.  This protein is expressed in the stratified epithelia of all 
mammals in vivo.  Its expression levels are particularly high in ‘humid tissues’ examples of 
which are: the new born epidermis, the epithelia of the oral cavity, anus, oesophagus, foreskin, 
vagina and epidermal parts of the sweat ducts.  It is not expressed in the non-keratinizing 
epithelium and in actual fact its expression at these sites represents a defensive or protective 
mechanism of the body (Abadie et al., 2019).   
 
2.14.4 Keratin 10 
This is a type I keratin that in combination with type II keratin 1 forms heteropolymeric 
structural proteins to produce the keratinocytes intermediate filament cytoskeleton in the skins 
spinous and granular layers.  The function of the intermediate filaments in conjunction with 
microfilaments and microtubules is to build a network providing strength and stability to the 
epithelial cell’s cytoskeleton (Frommherz et al., 2019). 
 
2.14.5 Keratin 5 
Human Keratin 5 protein is coded for by the gene KRT5.  Keratin 5 associates with the keratin 
14 proteins in the human body to create an interaction that produces molecules which make up 
the cytoskeleton of basal epithelial cells; these are called the intermediate filaments.  Failure 
of this protein has been attributed to being the cause of several diseases including epidermolysis 
bullosa simplex but also even breast and lung cancer (Abadie et al., 2019).   
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Keratin 5 along with the case of other members of the keratin 5 acts as an intermediate filament 
protein.  These polypeptides have characteristics such as a 310 residue central rod domain made 
from the four alpha helix segments (helix 1A, 1B, 2A and 2B) which are linked via the three 
short segments (L1, L1-2, and L2).  It is observed that there is remarkable conservation 
amongst the extremities of the central rod domain (the helix initiation motif and the helix 
termination motif).  These parts are needed to make the helix stable and to produce the 
heterodimer and filament.  Variable, non-helical head and tail regions can be seen extending 
out from the intermediate filament surface and these make the differing IF polypeptides specific 
(Inaba et al., 2018).    
 
In the intermediate filament the central rods are made up of heptad repeats.  These repeats are 
repeating patterns of seven residues which allow via hydrophobic interactions the two different 
IF proteins to intertwine with each other to form a coiled coil.  These heterodimers are made 
by the specific pairing of type I (acidic) and type II keratin (basic). K5 is a type II keratin which 
can form a pair with type I keratin K14.  In these coiled coil dimers, a stepwise assembly can 
happen when they connect in an antiparallel arrangement and cause interactions that are end to 
end with other coiled coils and then result in the formation of large 10nm intermediate filaments 
(Inaba et al., 2018). 
 
The majority of Keratin 5 (and K14) expression happens in the basal keratinocytes but they are 
also found in the epidermis (particularly the stratified epithelium that makes up the lining of 
the skin).  The cytoskeletal scaffold that is found inside the epithelial cells is made by keratin 
intermediate filaments.  The function of this scaffold is to support the architecture of the cells 
and to provide cells with the capability to endure both mechanical and non-mechanical 
stress.  There is an extensive bundling of the K5/K14 keratin pairs as the non-helical tail of 
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K15 functions as a cross-linker at the surface of the intermediate filament.  Via this bundling 
the intermediate filaments have an improved mechanical resilience and elasticity (Abadie et 
al., 2019).  The anchoring of basal cells intermediate filament desmosomes connects K5/K14 
cells to neighbouring cells by way of desmoplakin and plakophilin-1.  Association of plectin 
and BPAG1 with the transmembrane protein 𝝰6𐌁4 integrin happens at the hemidesmosome.  
This adhesion molecule is how K5/K14 filaments found within basal cells are connected to the 
basal lamina (Inaba et al., 2018).  
 
2.14.6 Type IV collagen 
The type IV collagens in mammals are all made from six α-chain polypeptides that are 
genetically distinct (α1–α6).  The structures of the domains of the α-chains of these type 
IV collagens do have a similarity and at the amino acid level they demonstrate a homology of 
50-70%.   The α-chains mentioned here can be divided into three domains, these are: amino-
terminal 7S domain, a middle triple-helical domain, and a carboxy-terminal, globular, non-
collagenous (NC)-1 domain (Abreu-Velez and Howard, 2012). 
 
The longest domain is the triple-helical domain which has a length of about 1,400 amino acids 
and approximately 22 interruptions in the collagen Gly-X-Y sequence motif.  Every α-chain if 
the NCI domain has a length of 230 aa.  Like other collagen types the importance of the NC1 
domain is in aiding construction of the type IV collagen trimeric structure.  A molecular 
interaction amongst the three α-chains is stimulated when a trimer beginning with the three 
NC1 domains is put together. The protomer trimerization continues from the carboxy-terminal 
end forming a protomer that has a flexibility enabling it to bend. 
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The next stage in the creation of this collagen is the forming of type IV collagen dimers.  To 
do this two-type IV collagen protomers collaborate by way of their carboxy-terminal NC1 
trimers to make a NC1 hexamer.  Following this four protomers make tetramers via interactions 
at the glycosylated amino-terminal 7S region.    The outcome of these interactions is creation 
of a nucleus for type IV collagen scaffold.  Lateral associations and those of an end to end type 
amongst the type IV collagen protomers transform the scaffold into a type IV collagen 
superstructure (Wu and Ge, 2019).   
 
At a genetic level COL4A3 codes for the alpha3(IV) chain of type IV collagen, this protein is 
flexible.  In combination with two other types of alpha (IV) chains (the alpha4 and alpha5 
chains) this makes a molecule of type IV collagen (Abreu-Velez and Howard, 2012).  Type IV 
collagen molecules make complex protein networks by making bonds with each other.  These 
protein networks are a large component of basement membrane zones (thin structures that are 
sheet-like) which act to separate and support the cells of various tissues. alpha3-4-5 networks 
of type IV collagen are important to the functioning of basement membrane zones in the eye, 
inner ear and the kidney (Wu and Ge, 2019). 
 
Type IV collagen is composed of networks of Alphal(IV) and alpha2(IV) and in particular 
tissues it is the basement membranes principle skeletal macromolecule.  Via carboxy-terminal 
NC1 domains these chains make heterotrimers which have a role in the collagenous domains 
folding into triple helices.  By a few intermolecular interactions these helices have the ability 
to form networks.  Associations between type IV collagen molecules make a non-fibrillar 
polygonal assembly which has the function of being a scaffold for other matrix glycoproteins 
being deposited in addition to cell attachment (Abreu-Velez and Howard, 2012). 
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2.14.7 Laminin V 
Laminins are a collection of glycoproteins which have a contribution to basement membranes 
being formed and organized in nearly every tissue, their molecular weights are between 400 
and 900kDA.  The binding of these to cell surface receptors activates cell signalling cascades 
and interacts with ECM resulting in the production of scaffolds of migrating cells, ultimately 
this process/Laminins are active in causing cell adhesion (Hartwig et al., 2006). 
 
The structure of Laminins can be described as being a heterotrimeric molecule that has an 
alpha, beta and gamma chain all three of which are coded for by different genes.  There have 
been identified five alpha, three beta and three gamma subunits that can arrange into at least 
15 different types of laminins.  There is the possibility to produce many more variations of 
these via processes such as proteolytic processing and alternative splicing (Armony et al., 
2016).  Each of the chains has sections of approximately 600 amino acid residues at the C 
terminus which make coiled coils which possess other non-identical laminin subunits and 
stability is provided here via disulphide bonds.  When the chains are assembled, they make a 
cross shaped trimer where the cross’s short arms are made by the individual subunits N terminal 
parts (Armony et al., 2016). 
 
Laminin V is of particular interest, and it has also been known under any of the three names: 
Kalinin, Epiligrin and Nicein.  This Laminin has also been named as Laminin 332 because its 
composition is one alpha 3, one beta 3 and one gamma 2 chain.  This Laminin's biological role 
is to act as the major adhesive part of the epithelial basement membrane where it enables the 
stable attachment of keratinocytes which bind to α6β4 integrin via hemidesmosomes.  For cells 
to be able to migrate in monolayers that are wounded interactions between laminin-5 and α3β1 
are crucial.  When laminin-5 is disrupted in the keratinocytes of mouse models the effect of 
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this is to cause a block and inhibition of keratinocyte migration caused by a response to 
EGF.  Other functions of Laminin 5 include promoting gap junctional communication and cell 
cell interactions in keratinocyte cell culture (Hartwig et al., 2006). 
 
Recent studies have identified laminin-5 is required for the keratinocytes polarized state and 
persistent linear migration.  When the epidermis is subject to injury it can cause the activation 
of laminin-5 gene transcription resulting in keratinocytes and laminin-5 secretion into the 
basement membrane.  Laminin 5 deposition over any exposed collagen has a fundamental part 
to play in re-establishing the integrity of the dermal epidermal junction.  Laminin-5 has a 
pivotal part to play in the polarisation of cells that are at the leading edge.  This can lead us to 
conclude that Laminin-5 is a crucial ligand for keratinocyte migration.  Keratinocyte migrations 
are an essential requirement for wound healing to happen in the epidermis (Hartwig et al., 
2006).  When laminin V is missing it can present as the disorder epidermolysis bullosa which 
is a blistering disorder that is quite rare and recessively inherited (Matsui et al., 1998). 
 
2.14.8 Alpha 6 Beta 4-integrin 
𝞪6β4 is a protein whose function is to moderate basal keratinocytes interacting with laminin-
332 these are found to be positioned between the dermal and epidermal skin layers. The 
importance of 𝞪6β4 is due to the fact that it is believed to have a function associated with skin 
maintenance, a theory which has been validated via knock-out mouse models and human 
studies.  The effect of losing 𝞪6β4 in mouse models is seen physically as the epidermal skin 
layers separating from the dermal ones at the basement membrane zone whilst skin blistering 
and pot-natal lethality are other demonstrated effects.  Mutations of the 𝞪6 or β4 integrin genes 
in humans presents clinically as a manifestation of the disorder junctional epidermolysis 
bullosa (JEB), symptoms of this are skin blistering and pyloric atresia (Klygis et al., 2012). 
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𝞪6β4integrins functions outside of being involved in stable adhesion are that they are up-
regulated when wound healing and tumorigenesis are taking place where they have a key role 
in the determination of motile behaviour in skin cells.  Various other integrin’s that are 
improved epidermal basal cells include 𝞪3β1 integrin (receptor for laminin-332) and 𝞪2β1 
integrin (receptor for collagen I), both are involved in regulating the healing of wounds in the 
skin and the migration of cells during tumorigenesis. 𝞪3β1 can improve proteolysis of the 
matrix during tumorigenesis including wound healing.  Prevention of   𝞪3β1 action in vitro can 
prevent skin cell migration (Klygis et al., 2012) (Stewart and O’Connor, 2015). 
 
2.15 Benefits of the use of co-culture over mono-culture models 
A co-culture at its most basic level is when two or more different cell populations are grown 
together with there being contact of some type between them.  Figure 12 demonstrates that 
there are three main reasons for using a co-culture setup (Goers et al., 2014).  One clear 
advantage of co-cultures over their monoculture counterparts is that they give a more accurate 
representation of the human in-vivo scenario.  For instance, the body itself does not feature one 
cell type in isolation but rather many different cells interacting with each other (Kook et al., 
2017). 
 
As is the case with my doctoral work sometimes a co-culture scenario is required because the 
growth of some cell types is improved by their interaction with a completely different 
population.  Therefore, the presence of one population of cells might improve the success of 
culture or behaviour of another.  A co-culture system can also enable us to understand how 
cells interact in nature (Miki et al., 2012).  Co-cultures have many favourable characteristics 
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over their monoculture counterparts such as that they are more robust, predictable, scalable and 
stable. 
 
Figure 12: An illustration of the main reasons and benefits for conducting experiments with 
co-culture models 
 
 
 
Synthetic biology is a branch of science that aims to benefit society via medical, environmental 
and industrial applications.  Many synthetic systems can be benefitted by co-culture models as 
this is a method by which synthetic interactions can be modelled.  For instance, before any 
synthetic systems are used in a medical, environmental or industrial context a co-culture model 
means that they can be tested for function and safety (Goers et al., 2014).  One of the most 
important reasons for using the co-culture technique is that cell-cell interactions of any type 
(natural or synthetic) can be studied or even so that new interactions can be designed (Kook et 
al., 2017).   
 
In designing a co-culture system, it must be remembered that the extracellular environment has 
a big influence on how cells interact and as such it might be important that the environment in 
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which the co-culture may finally be used must be replicated for any experiment.  Ultimately a 
cell's phenotype is dependent upon the complex interactions of environment and genotype.  
There are many modifications of the basic co-culture model such as the number of separate 
populations being used, how much similarity there is between the populations, how the 
populations are separated and the extent to which this occurs, the amount of time over which 
the co-culture takes place and the differences in the local environments of the populations 
(Kook et al., 2017). 
 
Co-culture models do have limitations such as that many of the systems already in creation 
tend to be of low complexity with there being very few high complexity systems in comparison. 
A reason for the preferred simplicity is that studying any more than three populations 
interacting with each other at any one time can become very difficult to manage in terms of 
understanding molecular interactions and this often causes an element of instability and 
unpredictability (Goers et al., 2014).  
 
Therefore, as well as for how difficult it is to create a stable system when many more 
populations are involved, until recently most co-culture experiments have been limited to 
studying just two populations at any one time.   These systems for a long time have been 
employed to study cell-cell interactions and as such their use is fundamental to doing this.  
Studies with more than three separate cell populations are relatively rare due to the increase in 
complexity that they require.  However, this might not always be such a problem because 
sometimes in synthetic biology a system only needs to be as complex as to reach a desired goal 
(Bogdanowicz and Lu, 2013).   
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It is often concluded that the greater the similarity between populations, the easier it is for a 
stable system to be established but this does not mean that there are not successful co-cultures 
of populations from different species.  Co-culture is probably the last step before creating 
artificial tissues and organs.  By co-culturing different strains, we can simulate the natural 
environments and test evolutionary theories, it is also possible to study complex behaviours 
(Goers et al., 2014).    
 
2.16 Next steps 
Now that I have provided a scientific background to my study and placed it in context the next 
chapter of my thesis will describe the methods used in my practical work in such a manner that 
any of these steps will be easy for the reader to follow and replicate.  It clearly explains the 
workflow from extracting cells from the skin sample to manipulating cell ratios in co-culture.  
To support this chapter I have also included as appendices the plastic wares and list of 
equipment used.  A further appendix lists the media, reagents and chemicals used along with 
the companies they were purchased from and catalogue number for ordering. The aim of these 
appendices is that they will further clarify the methods if there is any need for the reader to 
repeat them in the future. 
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CHAPTER THREE: MATERIALS, METHODOLOGY AND METHODS 
 
3.1 Chapter introduction 
This study was an in vitro investigative quantitative laboratory experiment which will form the 
basis of potential future quantitative studies targeted at informing the delivery of therapeutic 
clinical techniques in the treatment of vitiligo.  Tissue was cultured, modulated and analysed 
entirely in the laboratory and the findings are qualitatively described.  An in vitro approach 
was taken because it allows scientists to isolate the effects of compounds on two cell types 
without the distraction of looking at the whole organism.  A co-culture of only two cell types 
was observed because studying a larger number of interacting populations of cells than this 
vastly complicates the experimental procedure.  When there are more than three cell 
populations interacting with each other this can result in a level of complexity that is 
unmanageable in regard to the molecular interactions the consequence of this being 
unpredictability and instability.   
 
The name quantitative research is given to a style that is used to quantify a problem by 
generating numerical data or data that can be changed into usable statistics.  This style is used 
to quantify opinions, behaviours, attitudes and other defined variables.  It can also be used to 
generalize results from a much larger sample population. Quantitative research works by using 
measurable data to formulate facts and identify patterns in research.  Quantitative methods 
differ from the qualitative style in that they are much more structured.  They include various 
types of survey such as systematic observations, online polls and face to face interviews 
(Bloomfield and Fisher, 2019). 
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A quantitative approach was used in this study since I had to determine the success of the 
various co-culture medium formulations by counting how many of each cell type grew in the 
medium over a period of time.  I compared the number of cells that grew in several co-culture 
medium formulations to see which produced the best result.  After this I determined the effect 
of the melanogenic stimulators alpha melanocyte stimulating hormone (α-MSH) and UV light 
by counting how this changed the number of each cell type, therefore taking another 
quantitative approach to measure outcomes. 
 
3.2 Study settings 
3.2.1 The two settings 
The first setting was: 
No.1a. This was the outpatient Plastic Surgery clinic at a private hospital in Kent where 
discarded skin from patients undergoing plastic surgery procedures was obtained with the 
patient’s consent. 
 
No. 1b. This was the Stem Cell Research and Advanced Bio-Engineering Laboratory 
(SCRABEL) at the Medway Campus of Canterbury Christ Church University (CCCU).  Skin 
cells were cultured here. 
 
The next setting was: 
No. 2a. The Department of Plastic Surgery at Justice K. S. Hegde Charitable Hospital, Nitte 
University, Mangalore, Karnataka, India.  This was the source of skin tissue samples for 
research. 
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No. 2b. The laboratory work was carried out in the Nitte University Centre for Stem Cell 
Research and Regenerative Medicine (NUCSReM), K. S. Hegde Medical Academy, Nitte 
University, Mangalore, Karnataka, India. 
 
3.3 Ethics approval 
3.3.1 Research ethics approval study setting one– England 
An online research ethics approval application was completed and submitted through the IRAS 
(integrated research application system) to the London – City and East Research Ethics 
Committee.  Approval was received in August 2016 (Appendix 1). 
 
3.3.2 Research ethics approval study setting two – India 
An application was submitted to the Central Ethics Committee of Nitte University in India in 
September 2017 and was subsequently accepted and approved (Appendix 2). 
 
3.3.3 Confidentiality 
Maintaining the anonymity and confidentiality of patients/participants is central to ethical 
practice in research.  All of the work completed in this study complied with the Declaration of 
Helsinki (2000) which is a set of ethical guidelines with regard to human experimentation that 
was developed for the medical community by the World Medical Association (WMA).  In 
order to maintain anonymity and confidentiality, each patient's consent form was given a 
number which was entered onto both the consent form and the tube holding the tissue.  This 
made the patient's tissue anonymous but still enabled identification of the patient by the 
researcher’s supervisor but not the researcher if the need had arisen for example, if a patient 
wanted to leave the study at any time.  As the collection of skin samples was ultimately done 
in India, consent forms were kept in KSHEMA according to local procedures and guidelines. 
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3.4 Population 
Study setting 1a) – Private hospital – Kent, UK 
Participants were patients who were undergoing routine plastic surgery who met the later 
described inclusion and exclusion criteria.  As mentioned previously after consideration no 
samples were eventually obtained from study setting 1. 
 
Study setting 2a) – Nitte University, Mangalore, India 
Collection of tissue samples: The Department of Plastic Surgery at Justice K. S. Hegde 
Charitable Hospital, Nitte University, Mangalore, Karnataka, India.  Participants were patients 
who are undergoing routine Plastic Surgery who met the later described inclusion and exclusion 
criteria. 
 
Laboratory experiments (In vitro): Nitte University Centre for Stem Cell Research and 
Regenerative Medicine (NUCSReM), K. S. Hegde Medical Academy (KSHEMA), Nitte 
University, Mangalore, Karnataka, India. 
 
3.5 Recruitment and Consent 
Two Consultant Plastic Surgeons who undertook surgical procedures at a private hospital in 
Kent agreed to take part in this study.  The Consultants were sent a letter (Appendix 3) that 
explained the study.  The researcher discussed the study with the Consultants as well as 
explaining the consent form (Appendix 4) and patient information leaflet (Appendix 5) to 
ensure that they fully understood the procedure and the ethical considerations.  Patients 
attending the Consultant Plastic Surgeon's out-patient clinics, who met the study inclusion 
criteria (as described below) were recruited into the study by the Consultant Plastic Surgeon.  
The Consultants were asked to identify patients who attended their out-patient clinic that met 
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the inclusion/exclusion criteria and gave these patients a pack which consisted of three consent 
forms (Appendix 6), a patient information leaflet and a pre-paid envelope.   Patient consent 
was obtained for the use and storage of their tissue that would otherwise normally be discarded 
after routine surgery.  The Consultant explained the study to the patient and invited them to 
take the information home with them.  The patient was asked to sign each of the consent forms 
if they agreed to take part in the study and send the two signed forms back to the Consultant’s 
secretary via a pre-paid envelope in the post. The patient retained the third signed consent form.  
The researcher ensured the consultant had information packs available to him for each of his 
clinics.    
 
The person from whom the tissue sample was being collected from was not identifiable to the 
researcher. Participation in this study did not pose any additional risk to the patient since there 
was no change made to their surgical treatment.  The sample/patient was allocated an 
identifying number and kept securely, with this number also being put in the patient’s clinical 
notes for traceability.  Consent forms were kept in patient’s notes and the university in secure 
holdings in accordance with CCCU policies and the 1998 Data Protection Act.  Transport of 
tissue followed (UN3373), storage of tissue (HTA guidelines/ www.hta.gov.uk) and disposal 
of tissue followed guidelines.  They were put into a yellow bag and were collected by a waste 
disposal company to be incinerated. 
 
The Spire Alexandra Hospital and Department of Plastic Surgery at Justice K. S. Hegde 
Charitable Hospital, Nitte University agreed to take part in the study subject to research study 
approval and were satisfied that protocols and procedures would be adhered to.  To ensure that 
the patient consent process was unprejudiced it was important that I did not have any contact 
with the patients at any stage of this study.  After transfer of the practical work to India, the 
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same procedure was followed for recruitment and consent and samples were still harvested 
from routine surgery by a Plastic Surgeon in India.  As the work was carried out in India, the 
consent forms were kept in KSHEMA according to local procedures and guidelines. 
 
3.5.1 Inclusion criteria 
All patients who fulfilled the following criteria were eligible to take part in the study.  These 
involved patients who: 
1. underwent surgery which resulted in discarded skin that would normally be destroyed 
at the end of routine practice of procedure. 
2. had agreed to take part and had capacity to consent. 
3. were between 18 and 60 years old. 
4. could provide a normal skin specimen that was not affected by vitiligo or any other 
disorder. 
5. who were not taking any contravening medication or treatment that would affect the 
results. 
 
3.5.2 Exclusion criteria 
All patients who met the following criteria were ineligible to take part in the study.  These were 
all patients who: 
1. were aged less than 18 years old and who were ages above 60. 
2. had not agreed to take part in the study. 
3. did not have the capacity to clearly understand the study requirements and give 
informed consent. 
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3.6 Sample size 
Previous similar studies such as Matsuzaki and Kumagai (2013) have included skin taken from 
27 patients in order to enable quantitative analysis; however, this paper did not state how their 
power analysis was undertaken.  The research statistician from a surgical research group at the 
Catholic University of South Korea (this group was initially providing scientific advice before 
my work was transferred to India), and the Canterbury Christ Church University statistician 
were consulted for advice.  It is important that sufficient numbers of patients are recruited in 
order that data can be analysed to produce results of confidence (Biau et al., 2008).   
 
The results of this study were used to create a reverse power analysis to determine the minimum 
number of dishes required to accurately compare the rates of cell growth in our three conditions 
(control, exposure to UV and Hormone stimulation). Only three conditions were chosen at this 
stage since anymore becomes difficult to analyse at any one time.  The conditions of UV light 
and hormone exposure were chosen for this study because they are both easily available and 
there is a vast amount of literature concerning these two factors.  Obviously for any scientific 
experiment a control is needed so in this case the control will be a dish of cells being grown in 
an environment without any UV light or MSH hormone exposure.  This study is only a pilot 
study to assess the number required by a complete analysis that would take more time than is 
available for the purposes of this study. There are four or five factors that are involved in a 
power analysis with the values for each being chosen before the analysis is done.  The factors 
that must be considered are called: the effect size, alpha and beta/power (Nayak, 2010). 
 
The effect size is the minimum deviation from the null hypothesis that is hoped to be detected.  
An example of this is if hens are treated with something that will change the sex ratio of their 
chicks.  If it was decided by the experimental designer that the minimum change in the 
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proportion of sexes is 10% then you would set the effect size at 10%.  The alpha value is the 
significance value of the test (the P value) and is the probability of rejecting the null hypothesis 
even if it is true (a false positive).  It is usually the case that the alpha value is set at 0.05.  The 
beta value is the probability of accepting the null hypothesis even though it is false (a false 
negative), when the real difference is equal to the minimum effect size.  There is no clear 
consensus as to which value to use but the most common is a power of 80% (this is equivalent 
to a beta of 20%).  The choice of power should be influenced by the cost of a false negative.  It 
is absolutely necessary that the effect size is detected then a higher value for power (a lower 
value for beta) which will lead to a bigger sample size (Nayak, 2010). 
 
The analysis was therefore performed for a one-way Analysis of variance (ANOVA) with a 
between subjects design and three levels for the one factor utilized. In this study the minimum 
power was set to beta=.80, the alpha level was set to .05, and because it was not possible to 
determine a suitable effect size from previous literature, given the innovative nature of this 
research, we performed three parallel analyses, one for each of three different effect sizes 
where f was set to large (g power suggesting a coefficient of .40), medium (with a suggested 
coefficient of .25) and small (with a suggested coefficient of .10). Analyses were performed 
using g-power version xxx. G-power is a very good free program that can be used by Mac and 
Windows, and it will do power analyses for a large variety of tests. The total sample sizes 
calculated were respectively 66; 159 and 969. This represents the total number of dishes 
necessary for each of the three different effect size coefficients. Considering that we are aiming 
to extract three tissue samples from each clinical participant, so that variability within each set 
of three conditions is reduced, we are aiming to obtain discarded tissues from 22, 53 and 323 
different individuals.   As mentioned previously, these numbers are so large it was not practical 
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to assess or obtain this many samples in my experimental work which should rather be 
referenced as a pilot rather than a full scale study (Mishra et al., 2019). 
 
There are two ways that a power analysis can be done which are either before (a priori) or after 
(post hoc) the data has been collected.  The a priori power analysis is usually undertaken before 
the research study commences and is mostly used to estimate a sufficient sample size so that 
adequate power is achieved.  A post hoc power analysis on the other hand is undertaken once 
the study has been completed.  In a post hoc analysis the sample and effect size that is obtained 
is used to calculate the power in the study assuming that the sample effect size is equal to that 
in the population.  However the use of retrospective techniques is controversial and as such in 
this study I used an a priori approach.  It is thought that using statistical analysis of collected 
data to make an estimate of power will lead to uninformative and misleading values.  In its 
simplest form the post hoc power has been shown to be a one to one function of the p value 
that is obtained.  It has been shown that post hoc power analyses are susceptible to what is 
called the “power approach paradox” which is where a study with a null result shows more 
evidence that the null hypothesis is in fact true when the p-value is smaller, this occurs since 
the apparent power to detect an actual effect would be higher. In actuality a smaller p-value is 
properly understood to make the null hypothesis less likely to be true (Mishra et al., 2019). 
 
3.7 Chemicals, media, reagents and plastic wares 
Chemicals were purchased from Sigma-Aldrich (St. Louis, MO, USA). All media and reagents 
were procured from Thermo Fisher Scientific (Gibco-Invitrogen, Life Technologies, Grand 
Island, NY, USA) (Appendix 7), unless otherwise specified. All cell culture plastic wares, 
dishes and items were purchased from Thermo Fisher Scientific (Roskilde, Denmark) 
(Appendix 8).  A list of the laboratory equipment used is attached for reference (Appendix 9). 
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3.8 Tissue handling procedure 
The next few paragraphs will outline how the tissue will be handled starting with its collection 
from the hospital to how it will be stored in the laboratory prior to use. 
 
3.8.1 Collection and transport of skin tissue from the hospital to the laboratory 
Protocol for collecting skin tissue from the hospital 
The laboratory technician collected the signed consent forms and samples from the hospital 
and filed these so that the researcher had no contact with the patient. 
 
Protocol for receiving skin tissue at the lab 
If the skin sample was to be processed straightaway, it was received in Dulbecco’s phosphate 
buffer saline (DPBS) solution with 1% penicillin-streptomycin. It was found that the cells were 
prone to infection and two skin samples had to be discarded for this reason.  It was therefore 
imperative that the transport medium that was used was freshly mixed with the antibiotic’s 
penicillin streptomycin and fungizone (Amphotericin B) before the skin sample was placed 
within it. 
 
If the sample was only to be processed after several hours then it was received in Dulbecco’s 
modified eagle’s medium (DMEM). The preference for DPBS is that it is a much cheaper 
alternative to DMEM.  The antibiotics penicillin, streptomycin and fungizone were added to 
the transport solution (regardless of if it is DMEM or DPBS) to make sure that the sample did 
not become affected by any contamination.  The advantage of DMEM over DPBS is that it 
contains additional growth factors such as vitamins and amino acids.  If the sample is only to 
be stored for a short time then these factors are not required as they are not depleted from the 
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sample however if a longer time of storage is needed then these factors need to replace those 
lost from the original sample (Osmanovic et al., 2018). 
 
Protocol for storage of skin sample in laboratory 
If the tissue was not to be processed immediately then it was stored in a 40C refrigerator until 
required.  Tissue cannot be stored in DPBS for more than a few hours however it can be stored 
in DMEM overnight.  This is because unlike DPBS, DMEM contains additional factors that 
support cell growth.  DMEM is a modification of Basal Medium Eagle (BME) that contains a 
four-fold higher concentration of amino acids and vitamins, as well as additional 
supplementary components. 
 
3.8.2 Extraction of cells from the skin sample (Ultimately all experimental work only 
occurred in KSHEMA, Mangalore, India, Study setting 2)  
When cells were to be extracted from the skin sample, they were sequentially put into the 
enzymes, 0.25% trypsin-EDTA,  for a time period of 2 to 4 hours at 37°C or overnight at 4°C, 
until the epidermis was seen to be peeling away easily from the dermis (shorter incubation 
tends to be at warmer temperatures than longer ones), and 0.1% collagenase (30 mins to 2 
hours).  There are several enzymes that might be used but a recently published study has found 
that digestion time appeared to affect the isolated cells more than the choice of enzyme (Skog 
et al., 2019).  It is preferable that an enzyme of non-mammalian origin is used in any human 
cell work to avoid any possibility of the occurrence of zoonotic diseases (Torgersona et al., 
2018).  In the laboratory, for initial optimization of cell isolation procedures from skin samples, 
the primary preference for enzyme use was given to those that are more economical and easily 
available.  
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Skin source used for cell isolation 
Since my work was carried out in a lab associated with a hospital that had a Plastic Surgery 
unit, it was decided to use cells from excess skin which was a surgical by-product as a matter 
of convenience.  Best isolation results were obtained when the skin sample was placed in 
enzyme at 37°C for approximately 4 hours rather than the cells being left overnight in enzyme 
in the fridge (4°C).  Different incubation times are required because the availability of the skin 
is dependent upon what time of day the surgeons operation is booked.  If the operation happens 
in the morning, then it is possible for an incubation of 4 hours but if the operation is very late 
in the day then leaving the sample overnight might be the only option to avoid wasting it. 
 
An important factor to take into consideration when comparing the experimental work in India 
and the UK was the differences in the skin used.  It is much easier to isolate the epidermis from 
the dermis in India rather than the UK because in India the dermis in most cases is pigmented 
and appears brown.  Therefore, it is easy to identify when the dermis has been removed from 
the dermis because the brown layer is removed leaving behind a whitish layer.  In England 
since the population is mostly of lighter skin it is much more difficult to determine where the 
dermis begins and the epidermis is removed.  When the skin sample was placed in enzymes to 
separate the epidermis from the dermis this was successful but initially the sample had to be 
closely monitored to ensure that the epidermis was not digested rather than just being separated 
from the dermis.  
 
3.8.3 Monoculture of melanocyte and keratinocyte cells in the laboratory (Ultimately all 
experimental work only occurred in KSHEMA, Mangalore, India, Study setting 2)  
1. All solutions and equipment coming into contact with living cells were sterile and 
aseptic techniques were used accordingly. 
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2. All (co) culture incubations were performed in a humidified 37°C, 5% CO2 
 
Protocol for mono-culture of melanocytes and keratinocytes 
The study requires the culturing of melanocytes and keratinocytes, which have different 
proliferation potentials.  In order to do this, established techniques for mono culture of these 
individual cell types were used, and these techniques were applied to co-culture.   
 
Coating of cell culture dish with attachment factor 
Attachment factors are used to coat the petri dish to be used for cell culture.  They are structural 
proteins or protein-like substances that have adherent capabilities and serve to increase the cell-
substrate interactions in a culture.  It is the case that several glycoproteins have been identified 
that influence/promote the in vitro cell attachment to the surface or substratum of the culture 
vessel.  Under normal circumstances the attachment and growth of a large number of cell types 
is dependent upon attachment factors and extracellular matrix components.  Some cells are able 
to synthesize these components whilst others need an exogenous source, especially when 
grown in serum free culture.  The glass or plastic culture flasks that are used as a substrate 
strongly influence the growth and differentiation of anchorage-dependent cells.  To aid the 
attachment, cell spreading, and growth of cells, biological industries offer a wide line of 
attachment and matrix factors (Products and full product descriptions are available from the 
company ‘Life technologies, India’). 
 
Method: 
Petri dishes were coated with attachment factor by using 100 µL to 200 µL for 35 mm or 60 
mm dishes or 500 µL for 100 mm dishes, and spread to form a thin layer. (Alternatively pipetted 
174 
 
1 mL of attachment factor into dishes to spread liquid and then pipetted back up). Then, the 
dishes were kept in sterile conditions to air dry with the lid of the dish at a loose angle. 
 
Attachment factor is received as a stock solution of 1x strength.  For use, it was diluted by 
adding 1 mL to 9 mL in DPBS to prepare a 0.1x solution.  
 
Seeding density 
The cell density that is used has a significant influence upon how cells grow in vitro.  Using 
the correct seeding density for cell culture is important since cells growing in media tend to 
secrete a range of beneficial factors into it and as such they are able to condition the medium 
in which they are growing. The cell density has a direct effect upon the stimulation of 
neighbouring cells via the interaction of cell surface receptors and growth factors/cytokines 
that are secreted. An increase in the cell-cell contact can directly stimulate a variety of 
membrane-bound receptors.  When considering what cell density to use it must be considered 
that as the cell density becomes greater there is an increase in the cell-cell interaction.  (Xia et 
al., 2011).  
 
The recommended cell seeding density was: 3000 - 5000 cells per cm2.  Therefore depending 
on the size of the dish that is used for culture, the optimal seeding density is as follows:  
35 mm dish = 0.05-0.1 million cells  
60 mm dish = 0.1-0.5 million cells  
100 mm dish = 0.5-1 million cells  
These figures were calculated after discussion with a Senior Scientist based in the lab in India.  
This scientist has a lot of experience in cell culture work and as such these were the figures 
recommended by them.  
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After consulting the literature it was suggested to start with a 1:5 or 1:10 ratio of melanocytes 
to keratinocytes.  Due to the highly specialised nature of this topic it was very difficult to find 
recent papers to consult when the experimental work commenced but one paper suggested that 
the initial seeding ratio of melanocytes to keratinocytes should be  1:5 (Kumar et al., 2012) 
whilst another suggested a ratio of 1:10 (Liu et al., 2008).  After consultation with the Senior 
Scientist in India it was decided from their experience that a seeding density of 1:3 should also 
be investigated. 
 
The titer experiments were performed to decide ratio for the experiments.  
 
Passaging of cells  
Cell passage (splitting) is necessary to maintain cells that are undergoing exponential growth 
(Liao et al., 2014).  Once cells have reached confluence in one dish they are removed from the 
dish using enzyme and split into several dishes to ensure that their growth continues.  If the 
cells are not split into several dishes their growth will start to decrease because as the dish gets 
fuller and fuller they will start competing with each other for the same limited resources such 
as space and growth nutrients, once these nutrients are used up the cells will start to die. 
 
Most cell types show the same patterns of behaviour which is that the ability to spread and 
migrate is best at early passages but that this does reduce after later passages, the exact number 
of passages before cell differentiation capacity reduces is dependent on cell type and culture 
conditions (Liao et al., 2014). 
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3.8.4 Development of a co-culture medium that supports the growth of both melanocyte 
and keratinocyte cells at the same time (Ultimately all experimental work only occurred 
in KSHEMA, Mangalore, India, Study setting 2)   
Protocol for co-culture of melanocytes and keratinocytes 
There are several co-culture protocols available for melanocytes however at the time of writing 
this study was unique as there are no co-culture protocols for melanocytes and keratinocytes.  
Rather a literature search found that protocols are available for melanocytes and adipocytes 
and melanocytes with fibroblast cells (Bonifacino et al., 2014; Shariati et al., 2008). 
 
To fulfill research question two, once a reliable protocol for the isolation of cells from skin had 
been created, a co-culture media and method for co-culture was developed.  The co-cultured 
cells were exposed to specific intensities of UV light and concentrations of alpha-melanocyte 
stimulating hormone (α-MSH) following which the effects of these were observed.   
 
A study that might be an extension of this project may be performed to observe the effects on 
cells of exposing them to both UV light and α-MSH at the same time. The rest of the protocols 
such as how to change media, passage cells, cryopreserve cells and revive cells are standard 
protocols that can be found within most molecular biology/cell biology textbooks. 
 
Melanocyte and keratinocyte cells in co-culture 
Initially the cells were isolated and grown individually in their specific medium.  The cells 
were then seeded and grown together.  The culture medium used for the co-culture was a 
mixture of both the melanocyte and keratinocytes mediums in the ratio to which the cells need 
to be seeded. For e.g. for 1:5 melanocytes to keratinocytes, the culture medium had a 1:5 mix 
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of melanocyte-keratinocyte medium.  The purpose of this study is to develop optimized 
medium and culture conditions which support the growth of both cell types.  
 
Developing a method of counting melanocyte and keratinocyte cells in culture 
At present cell counting is carried out by a hemocytometer. The numbers of each cell type in a 
grid are counted by eye.  It would be preferable if a computer program could be developed to 
do this automatically by identifying the different cell types and counting their number.  
 
The current analysis of cell viability and counting requires taking cells out of culture and 
counting them in suspension.  This interruption of the culture process may adversely affect the 
methods that are going to be used to modulate the cell culture.  A way of addressing this is to 
see if image processing can allow us to derive the same data during the culture itself without 
disturbing the cells.  Images captured may allow us to see the cell density, viability and 
phenotypic differentiation and allow us to better track the consequences of various methods of 
culture modification. 
 
3.8.5 Investigation of whether ratios of cell populations in in vitro co-culture could be 
altered using environmental, biochemical or physical methods 
Identifying factors to manipulate the cells 
A literature search identified that Ultraviolet (UV)-light and α-MSH are common melanogenic 
stimulators.  It is for this reason that the present study investigated the properties of these two 
factors on melanogenesis by adding factors to the culture medium or exposing the cells to them 
(Chung et al., 2019). 
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UV-radiation serves as an environmental stress for human skin, and results in melanogenesis, 
with the pigment melanin having protective effects against UV induced damage.  It is for this 
reason that I exposed the melanocyte/keratinocyte co-culture to UV light to observe the effects 
of exposure on cell proliferation (D’Mello et al., 2016). 
 
α-MSH is produced in the skin by epidermal skin cells (keratinocytes and less commonly 
melanocytes and Langerhans cells) as a protective response to any damage that is caused by 
ultraviolet radiation.  α-MSH molecules work by binding to the MC1R on melanocytes and 
activating the production of melanin (this is done via a series of chemical reactions that are 
known as a signaling pathway).  As such I exposed the cells in this experiment to α-MSH to 
explore the effect that this has on melanogenesis and cell proliferation (Chung et al., 2019). 
 
Identifying how the added factors manipulated cell ratios in co-culture 
The cells in culture were observed over a period of time and the cells of each type counted 
frequently. 
 
3.9 Protocols for experimental work 
In the next sections of this chapter, I will be detailing the protocols used as well as the 
requirements for these such as materials and equipment/reagents required. 
 
3.9.1 Isolation of epidermal cells 
Normal skin was removed with sterilization toothless tweezers and washed in 10 mL DPBS 
and then they were disinfected in the 10-30 mL 75% medical alcohol for 30 sec. The disinfected 
skin was washed in 30 mL DPBS three times, and then put it into a petri dish and cut it into 
small squares in the size of 0.2 × 0.2 cm2 with sterile scissors.  The disinfected skin tissues 
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were put into a 50 mL aseptic mixing bottle, and 0.25% trypsin-EDTA and 0.1% collagenase 
were added sequentially, and incubated in 5% CO2 at 37°C for 30 min to 2 hrs.  After the 
digestion, the sample was filtered with nylon mesh, and DPBS was added to wash.  Then the 
sample was centrifuged at 1500 g for 5 min.  Supernatant was discarded with a pipette and 
washed with 20 mL DPBS centrifugally twice, and then used to resuspend cells. 
 
3.9.2 Isolation and expansion of melanocytes 
The isolated cells were then placed in the attachment factor coated culture dishes (35 mm dish, 
BD Falcon, Franklin Lakes, NJ, USA) along with complete media containing Minimum 
Essential Medium (MEM-α) supplemented with 10% fetal bovine serum (FBS), 1% Human 
Melanocyte Growth Supplement (HMGS) and 2 ng/ml epidermal growth factor (EGF, 
Biolegend, San Diego, CA, USA).  Further, the plates were incubated in a 5% CO2 humidified 
atmosphere at 37°C (Eppendorf Galaxy 170S CO2 Incubator, Germany). The medium was 
firstly changed after 48 hrs and then twice a week with occasional wash with DPBS 
supplemented with antibiotics (Penicillin-Streptomycin) to ensure sterile cultures.  Once the 
cells reach confluence of 90%, they are labeled as primary (P0) generation and passaged up to 
two times for further analysis using MEM-α supplemented with 10% FBS, 1% HMGS and 2 
ng/mL EGF. 
 
For expansion, the cells were suspended in Medium 254 (Gibco-Invitrogen) supplemented with 
fetal bovine serum (FBS), bovine pituitary extract, bovine insulin, hydrocortisone, bFGF, 
bovine transferrin, heparin, and phorbol 12-myristate 13-acetate. Taking FBS into account, the 
concentration was 0.5%. When the cells reached 80% confluence, they were detached from the 
flask and seeded into other culture flasks in preparation for an experimental procedure or to 
maintain and propagate the cell culture. Melanocyte cell lines were designated as MEL. 
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For further analysis, isolated and expanded melanocytes at early passages were cryopreserved 
using 80% FBS, 10% MEM-α and 10 dimethyl sulphoxide (DMSO) as a cryomedia at -80°C 
ultralow freezer or at -196°C in liquid nitrogen. 
 
3.9.3 Isolation and expansion of keratinocytes 
The isolated cells were placed in the attachment factor coated culture dishes (35 mm dish, BD 
Falcon) along with complete media containing MEM-α supplemented with 10% fetal bovine 
serum (FBS), 1% Human Keratinocyte Growth Supplement (HKGS), 2 ng/ml keratinocyte 
growth factor (KGF) (Peprotech, NJ, USA) and 2 ng/ml epidermal growth factor (EGF).  
Further, the plates were incubated in a 5% CO2 humidified atmosphere at 37°C. The medium 
was firstly changed after 48 hrs and then twice a week with occasional wash with DPBS 
supplemented with antibiotics to ensure sterile cultures.  Once the cells reach confluence of 
90%, they were labeled as P0 generation and passaged up to two times for further analysis 
using MEM-α supplemented with 10% FBS, 1% HKGS, 2 ng/mL KGF and 2 ng/mL EGF. 
For expansion of keratinocytes, instead of supplemented Medium 254, the cells were 
suspended in EpiLife Medium supplemented with Human Keratinocyte Growth Supplement 
(HKGS), human EGF and KGF. When the cells reached confluence, they were detached from 
the flask and seeded into other culture flasks. Keratinocyte cell lines were designated as KRT. 
 
For further usage and analysis of keratinocytes, cells at early passages were cryopreserved 
using 80% FBS, 10% MEM-α and 10 dimethyl sulphoxide (DMSO) as a cryomedia at -80°C 
ultralow freezer or at -196°C in liquid nitrogen. 
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3.9.4 Co-culture of melanocytes and keratinocytes 
Cultured keratinocytes were harvested by treatment with 0.25% trypsin/EDTA and seeded at 
2.5×105 cells/well in six-well plates.  After two days, cultured melanocytes (5×104) were 
collected by trypsin/EDTA and added to each well containing the keratinocytes. Co-cultures 
of melanocytes and keratinocytes were maintained in culture media (melanocyte media + 
keratinocyte media), the initial seeding ratio of melanocytes to keratinocytes being 1:3, 1:5 and 
1:10. After one day of co-culture, fresh medium containing melanocyte inhibitors and 
stimulators were added. Again after two days fresh medium with fresh compounds at the 
appropriate concentrations were added; two days after that, cultures were photographed and 
then harvested with trypsin/EDTA. The cells were dislodged with trypsin/EDTA; media was 
added to inactivate the trypsin. The remaining cell suspension was centrifuged at 1500 g for 5 
min, washed with DPBS, and assays were then conducted. 
 
For co-culture experiments, the assays such as morphology, melanin content and tyrosinase 
activity by L-DOPA staining were performed. 
 
3.9.5 Assessment of morphology and cell viability 
Morphology of the cells was observed under phase contrast microscope (Olympus CKX41, 
Japan) and any change in cell structure was noted periodically at different passages. The 
viability of the cells at different passages was estimated by trypan blue exclusion method. Here, 
the cells are cultured for a period of 10-15 days or until confluence was reached. Then the cell 
suspension was obtained by detaching the cells with 0.25% trypsin-EDTA followed by 
treatment with 0.4% Trypan blue dye which traverses through membranes of dead cells only. 
20 µL of cell suspension was treated with 20 µL of the dye and the number of live cells against 
dead cells was counted in 10 µL of the treated cell suspension under phase contrast microscope 
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using a hemocytometer chamber. The cell count was carried out in triplicates to obtain an 
accurate value. 
 
3.9.6 Proliferation rate and population doubling time 
To determine the proliferation rate of melanocytes and keratinocytes, 5000 cells were seeded 
in each well of a 12-well plate (Thermo Scientific, Roskilde, Denmark) and cultured for 12 
days. Cells in every three wells were detached with 0.25% Trypsin-EDTA on days 3, 6, 9 and 
12, and counted using a hemocytometer. The culture medium was changed every 3 days. 
Population doubling time (PDT) was calculated as, PDT = t (log2) / (log Nt-log No), where t 
represents culture time, and No and Nt are the cell numbers before and after seeding, 
respectively. PDT was then expressed as the average number of hours taken for the population 
of cells, undergoing exponential growth, to double its number. 
 
3.9.7 Melanin content assay 
Melanin content assay was carried out in melanocytes alone and also, after the culture of 
melanocytes with keratinocytes at different ratios. Melanin content was determined by 
following previously published protocol (Promden et al., 2018). Cells were seeded in a 24-well 
plate at a density of 5×104 cells/well and cultured for 96 hours. Cells were lysed with 500 µL 
2N NaOH containing 20% DMSO. Then, the cells were incubated at room temperature for 1 
hour, and the extracted cells were centrifuged at 13000g for 5 minutes. A supernatant of 100 
μL from each well was collected. Relative melanin content was determined by absorbance at 
405 nm in a microplate reader. 
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3.9.8 Cytochemical staining of melanocytes by L-DOPA 
To observe melanocytes more clearly, the cells were stained by L-DOPA (L-3, 4- 
dihydroxyphenylalanine) by following a previously published protocol (Zhang et al., 2018) 
with minor modifications. Briefly, cultured melanocytes or melanocyte-keratinocyte co-
cultures were washed with DPBS followed by fixation with 4% paraformaldehyde for 10 min 
at room temperature. The cells were washed with DPBS again for three times. Then the cells 
were stained with 5 mM L-DOPA and incubated for 2 hours at 37°C. Then the stained cells 
were washed with DPBS for three times. Control dishes were kept without adding L-DOPA. 
Finally, the cells were observed under a microscope (Olympus, Tokyo, Japan). 
 
3.9.9 Tyrosinase assay 
Tyrosinase activity in melanocytes was analyzed as DOPA oxidase activity using a protocol 
previously published by Tu et al., (2012) with minor modifications. Cells were seeded in a 24-
well plate at a density of 5×104 cells/well and cultured for 96 hours. The cells were washed 
with ice-cold 1x DPBS. 150 µL lysis buffer (1% Triton X-100 in 0.1 M phosphate buffer) was 
added to each 24-well plate. Then the plates were allowed to stand for 30 min at -20°C and 
immediately transferred to 37°C for 30 minutes. Cells were then scraped and transferred to a 
1.5 ml Eppendorf tube, lysed through 3~5 times and centrifuged at 15000 rpm for 5 to 10 min 
at 4°C. The samples (300~500 μg /80 µL) were added to a new 96-well plate on the ice. 20 µL 
of 5 mM L-DOPA (L-3, 4- dihydroxyphenylalanine) was added to each well. The plates were 
then incubated at 37°C for 30 minutes, and measured absorbance at 475 nm (Tu et al., 2012). 
 
3.9.10 Flow cytometric analysis 
To assess the purity of the melanocytes and the proportion of cells expressing specific internal 
markers (S100, TRP1 and TYR), fluorescence activated cell sorting (FACS) was performed on 
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cells at Passage 2 to 4 (FACSCalibur, BD Biosciences, Becton Dickinson, NJ, USA). After 
being harvested, the cells were detached by 0.25% Trypsin-EDTA, centrifuged and 
resuspended. Cells were fixed in 3.7% paraformaldehyde (Sigma-Aldrich) for 30 min and 
permeabilized with 0.1% Triton X-100 (Sigma-Aldrich) for 20 min. The cells were then 
incubated sequentially with unconjugated primary antibodies (mouse mAB, 1:100 dilution, 
Novus Biologicals, Centennial, CO, USA) prepared in cell staining buffer (Thermo Fisher or 
Biolegend) overnight at 4ºC and FITC-conjugated secondary antibody (Anti-mouse IgG FITC, 
1:100 dilution, E-bioscience, Thermo Fisher, USA or Santa Cruz Biotechnology, San Diego, 
CA, USA) for 1 hour in the dark at room temperature. Further, the flow cytometric analysis of 
intracellular markers was performed by a BD FACSCalibur flow cytometer (BD FACSCalibur, 
Becton Dickinson, USA). 
 
For phenotypic determination of keratinocytes, the specific markers were analysed by 
FACSCalibur (BD Biosciences, Becton Dickinson, NJ, USA) or PARTEC-flow cytometer 
(PARTEC-CY FLOW SPACE, Gloritz, Germany). Keratinocytes at the passage 2 to 4 were 
treated with 0.25% trypsin-EDTA and cells were harvested. Cells were fixed with 3.7% 
paraformaldehyde for 30 min. Unconjugated primary antibodies, pancytokeratin (K1, Novus 
Biologicals, CO, USA, 1:100), keratin 10 (K10, Novus Biologicals, 1:100) and filaggrin 
(Novus Biologicals, 1:100) prepared in cell staining buffer (Thermofisher or Bilegend) were 
incubated with cells for 1 hr at 37°C water bath. Further, the cells were stained with fluorescein 
isothiocyanate (FITC)-conjugated anti-mouse IgG (E-bioscience, Thermo Fisher or Santa Cruz 
Biotechnology, San Diego, CA, USA, 1:100 dilution) as a secondary antibody and incubated 
at dark for 1 hr at room temperature. Isotype controls were kept in parallel and at least 10,000 
events were acquired and analysed. 
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3.9.11 Co-culture of melanocytes and keratinocytes and α-MSH supplementation 
The role of α-MSH in in vitro melanocytes-keratinocytes co-culture system was analyzed. The 
cells of passages 3 to 5 melanocytes and keratinocyte co-cultures at different ratios, such as 
1:3, 1:5 and 1:10 were employed for the experiments on the supplementation of α-MSH 
(Sigma-Aldrich). After 48 hours of culture, the cells were exposed to α-MSH at different 
concentrations (2.5 µg/mL, 5 µg/mL and 10 µg/mL) and the changes in morphology were 
observed on day 3 and day 7 of culture.  The exposed cell lines were further analyzed for 
morphological changes, melanin content assay and tyrosinase activity by L-DOPA assay. 
 
3.9.12 Co-culture of melanocytes and keratinocytes and UVB irradiation 
The cells of passages 3 to 5 were used for the following experiments. At 24 h after plating, the 
supernatant was replaced with a thin layer of DPBS with calcium and magnesium and exposed 
to UVB radiation after lids were removed. Immediately after irradiation, the PBS was removed 
and replaced with Medium 254 supplemented with HMGS and EpiLife supplemented with 
HKGS at the ratio of 1:3. Irradiation using various doses of UVB at 10 mJ/cm2, 20 mJ/cm2 and 
30 mJ/cm2 (Schmid et al., 2018) was performed using a UV irradiator thrice (24 hrs, 48 hrs 
and 72 hrs), and irradiated cells were cultivated for 2 weeks. Each cell line co-culture was 
irradiated three times with an interval of 24 hrs between treatments. Control cells were kept in 
the same culture conditions without UVB exposure.  The exposed cell lines were further 
analyzed for morphological changes, melanin content assay, tyrosinase activity by L-DOPA 
assay and markers expression by flow cytometry. 
 
In total 10 individual melanocyte (MEL1-MEL10) and keratinocyte (KRT1-KRT10) cell lines 
were established (10 patients) but for establishing co-culture and further analysis cell lines 
which showed the strongest growth were used (MK2, MK4, MK6). 
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Co-culture was established using cells from the same patient.  Therefore MK2 means that in 
this co-culture the melanocyte and keratinocytes were both established from patient 2 samples. 
 
Three melanocyte to keratinocyte cell culture medium ratios (1:3) (1:5) (1:10), three α-MSH 
concentrations (2.5 μg/ml) (5 μg/ml) (10 μg/ml) and three UVB intensities (10 mJ) (20 mJ) (30 
mJ) were used as variables for this study. 
 
3.9.13 Statistical analysis 
All measurement data expressed as mean ± SD were collected and sorted in Excel (Microsoft).  
Statistical analyses were performed by analysis of variance (ANOVA) using Bonferroni’s and 
Tukey’s multiple comparison test with GraphPad Prism software programme, version 8.2 
(GraphPad, San Diego, CA, USA). P value <0.05 was considered statistically significant for 
all tests.  All the experiments were performed in a minimal of triplicates. 
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CHAPTER FOUR: RESULTS 
The results of the study are presented under the four specific objectives as outlined below. 
1. Isolation, and characterization of melanocytes and keratinocytes in terms cellular and 
phenotypic markers expression. 
2. Establishment of a co-culture system of melanocytes and keratinocytes and their functional 
assessment. 
3. Influence of α-MSH on melanocyte-keratinocyte co-culture systems. 
4. Exposure of melanocyte-keratinocyte co-cultures to UVB radiation. 
 
Figure 13 is a workflow schematic which explains how cells were derived from extraction of  
skin, to growth of monocultures and derivation of co-cultured cells.  It is a summary of all the  
steps that were taken to enable completion of objectives 1 to 4. 
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Figure 13: Demonstration of the workflow schematic that was followed during my entire 
experimental procedure 
 
 
Day 0 = Day of initial cell seeding for each assay performed with melanocytes and 
keratinocytes. 
Total duration of lab work to complete all the assays from start to finish = Minimum 18 
months  
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Objective 1: To isolate and characterize melanocytes based on their cellular, biological 
and phenotypic properties and Objective 2: To isolate and characterize keratinocytes 
based on their cellular and phenotypic features. 
 
4.1 Observations of preliminary study 
4.1.1 Isolation and establishment of melanocytes and keratinocytes from skin sample 
The images of successful isolation and establishment of melanocytes and keratinocytes from 
skin samples during the preliminary study are presented in Figure 14.  The skin specimens 
were collected from patients as a part of treatment procedures and brought to the laboratory for 
further processing.  The samples were washed extensively in PBS and disinfected with medical 
grade alcohol as a part of the sterilization process.  Later, the subcutaneous tissue and dermis, 
if any, were removed and the remaining epidermal tissue was cut into smaller pieces of 3-5 
mm width and approximately 0.5 mm thickness.  The tissue remnants were then placed in 
trypsin-EDTA solution at 37°C 30 min to 2 hrs.  The digestion was terminated by the addition 
of serum and the cell suspension was obtained by filtering through strainers.  The cells were 
seeded into culture dishes with seeding density of 10000 – 20000 per cm2 and cultured at 37°C 
in a humidified atmosphere with 5% CO2.  On day 0, the round, single cells were observed 
after initial seeding.  The culture medium was changed after 48 hrs. After two days of cells 
seeding, the initial adherence and growing of primary culture of skin cells were noticed.  On 
day 5, the formation of small clusters by melanocytes and keratinocytes were clearly observed.  
Melanocytes were seen with dendritic features scattered among the epidermal cells and 
appeared round and small in culture.  Representative image of primary cultured melanocytes 
with elongated bipolar or tripolar morphology is presented.  However, the majority of the 
melanocytes had a spindle-shaped morphology. By day 7, primary cultures of keratinocytes 
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with round or polygonal shape were also present in culture dishes.  The primary cultured cells 
were passaged after being grown for 2 to 3 weeks.  Phase-contrast or inverted microscopy 
revealed that the primary culture had the combination of both melanocytes and keratinocytes 
in varied numbers or density.  Subsequently, it was decided to continue the expansion in 
specific media for obtaining the pure population of melanocytes and keratinocytes with basic, 
distinguishable phenotypic characteristics. 
 
When establishing and expanding melanocytes and keratinocytes from skin tissues, the 
presence of fibroblasts was observed and it was a common challenge to obtain the purity of 
desired cell population devoid of fibroblasts.  However, the number of fibroblasts during the 
later stages of culture expansion gradually reduced, as the cells were maintained in specific 
media that supported the growth of either melanocytes or keratinocytes. 
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Figure 14: Isolation and establishment of melanocytes and keratinocytes from skin sample  
 
 
A. The epidermal tissue was cut into smaller pieces of 4-5 mm width and placed in trypsin-
EDTA solution.  
B. Day 0. Suspension of single cells from epidermal tissue after initial seeding.  
C. Day 2. Initial attachment and growing primary culture of skin cells.  
D. Day 5. Formation of small clusters by melanocytes and keratinocytes.  
E. Day 7. Representative image of primary cultured keratinocytes with round or polygonal 
shape.  
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F. Day 7. Representative image of primary cultured melanocytes with elongated bipolar or 
tripolar morphology.  
Magnification (B-F)- 10x  
 
4.1.2 Culture and expansion of melanocytes and keratinocytes from skin sample 
Established primary cultures of melanocytes and keratinocytes were expanded in vitro.  The 
images of culture expansion of melanocytes and keratinocytes from skin samples are depicted 
in Figure 15.  At passage 1, initial attachment and proliferation of skin cells in DMEM were 
observed by day 2.  On day 6, a mixed population of cells representing melanocytes, 
keratinocytes and a smaller number of fibroblasts was noticed.  Sub-cultured keratinocytes 
displayed round or polygonal shape, as their characteristic features.  In addition, sub-cultured 
melanocytes in the M254 medium with human melanocyte growth supplement (HMGS) 
exhibited bipolar or multipolar morphology.  
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Figure 15: Culture and expansion of melanocytes and keratinocytes from skin sample 
Passage 1. 
 
 
A. Day 2. Initial attachment and growing culture of skin cells in DMEM.  
B. Day 6. Mixed population of cells representing melanocytes, keratinocytes and a smaller 
number of fibroblasts.  
194 
 
C. Day 6. Representative image of sub-cultured keratinocytes with clear round or polygonal 
shape.  
D. Day 6. Representative image of subcultured keratinocytes and melanocytes growing as a 
mixed population of cells.  
E & F. Representative images of subcultured melanocytes in M254 medium with human 
melanocyte growth supplement exhibiting bipolar or multipolar morphology.  
Magnification (A-F)- 10x. 
 
4.2 Processing of split skin sample 
The split skin samples were obtained from normal skin of patients undergoing graft surgery, 
and the details of patients characteristics are presented in Table 7.  
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Table 7: Details of patients used for collection of skin samples and the in vitro establishment 
of melanocytes and keratinocytes 
Sl. No. Sample and cell lines ID Age 
(years) 
Gender  Condition 
1 MEL1 & KRT1 57 Male Normal skin was collected 
from the patients undergoing 
graft surgery. 
2 MEL2 & KRT2 15 Male 
3 MEL3 & KRT3 20 Male 
4 MEL4 & KRT4 Not 
provided 
Male 
5 MEL5 & KRT5 Not 
provided 
Male 
6 MEL6 & KRT6 28 Male 
7 MEL7 & KRT7 30 Male 
8 MEL8 & KRT8 25 Male 
9 MEL9 & KRT9 58 Male 
10 MEL10 & KRT10 44 Male 
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The steps involved in the processing of skin samples are presented in Figure 16 and Figure 
17.  
 
Figure 16: Processing of split skin sample for the isolation of melanocytes 
 
 
A. Split skin samples in sterile DPBS with antibiotics and antimycotic solution, received from 
the Dept. of Plastic Surgery, K. S. Hegde Charitable Hospital, Nitte (Deemed to be University) 
after signing informed consent from the donor.   
B, C, D, and E. Skin sample was washed in DPBS with antibiotic and antimycotic solution 
twice then with 10 µg/ml gentamicin solution and dipped in iodine solution for 3 minutes and 
finally washed in 75% ethanol for 10 min. Each step was followed by DPBS wash. This 
sterilization procedure was followed strictly to avoid the sample-oriented contaminations.  
F. Skin sample was kept in 0.25% trypsin-EDTA solution for 3 hrs at 370 C and for 2 hrs in a 
shaking incubator for the separation of epidermis from dermis. 
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Figure 17: Processing of split skin sample for the isolation of melanocytes (Contd.) 
 
 
G. Collagenase activity was inhibited by washing the cells in DMEM medium with 10% foetal 
bovine serum (FBS). Later epidermis was separated from dermis using sterile surgical scalpel 
and blade.  
H. Separated epidermis from dermis.  
I. Dissociated cells after passing through 100 and 70 micron cell strainers.  
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4.3 Isolation, establishment and morphological characteristics of melanocytes from skin 
sample 
Human melanocytes were isolated from skin tissue samples, by following enzymatic treatment 
that separates the dermis and epidermis, and incubation in trypsin-EDTA to obtain a single-
cell suspension.  In the present study, a total of 10 melanocyte cells lines were successfully 
established and designated as MEL1 to MEL10. Cell lines such as, MEL1 and MEL5 were also 
established by following an explant culture system.  The processing of skin tissue, primary 
culture establishment, and morphological characteristics of melanocytes of MEL1 to MEL10 
cell lines are presented.  The melanocytes established by explant culture, such as MEL1, MEL5 
and MEL8 are presented in Figures 18, 19 and 20, respectively. The remaining cell lines 
established by suspension culture are presented in Figures 21 to 24.  
 
As explained in the methods section, isolated epidermal tissue remnants were pooled in a 
trypsin/EDTA solution and single-cell suspensions were prepared by filtering and pipetting.  
Separated cells were collected in serum to stop enzymatic action of trypsin.  The pooled 
epidermal cell suspensions were centrifuged and resuspended in growth medium.  Cell 
suspensions were placed in tissue culture dishes in growth medium containing HMGS.  After 
48 hrs of seeding cells, the medium was changed and unattached cells were removed.  From 
day 3 onwards till the cells reached confluence, the attachment patterns and morphological 
features of melanocytes were observed regularly and the images were recorded. 
 
Melanocytes in tissue culture were easily distinguished from keratinocytes and fibroblasts by 
their morphological characteristics.  Melanocytes appeared round, small, spindle-shaped 
during early stages of culture and later transformed into bipolar or polydendritic features.  
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Initially, the cultures had a fairly good number of fibroblasts showing the heterogeneity in cell 
population, but in later passages, their growth and number was reduced.  In the primary culture, 
melanocytes readily attached onto the plastic culture dish/plates and proliferated best in the 
presence of attachment factor and the supplementation of HMGS. 
 
During the initial culture period, a small number of melanocytes based on their characteristic 
smooth, bipolar shapes were observed.  In some cultures, melanocytes commonly formed 
clusters of up to 10-20 cells and a close contact was observed between the two melanocyte 
populations, by extending cytoplasmic processes.  In a couple of cases, melanocytes were 
observed to emerge from small fragments of tissues that attached to the bottom of culture 
dishes/plates. Primary cultures reached confluence after approximately 2- 3 weeks.  At this 
point of time, the predominant cell type was melanocytes and a small portion of keratinocytes 
and fibroblasts were absent from cu1tures after the second or third passage.  Melanocyte 
cultures were maintained up to at least 6 to 8 passages for further analysis. 
 
Melanocytes were isolated and cultured in melanocyte growth media (M254) with melanocyte 
growth supplements.  Cells were attached and continued to grow in this media having bipolar 
shape.  In later passages, dendritic cells were more and the culture needed slightly more time 
to establish bipolar, proliferative, pure melanocyte culture.  Another observed feature was, 
keratinocytes and fibroblasts could not attach and grow properly in this specific medium after 
2-3 passages.  Hence, the presence of keratinocytes and fibroblasts were less and could attain 
pure culture of melanocytes in minimum passages.  
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Figure 18: Isolation and morphology of melanocytes in explant culture (MEL1) 
 
 
A. Cells are emerging from the epidermal explant at day 10.  
B, C. Cells were attaining dendritic morphology on the 15th day of culture in basal MEM-
alpha medium supplemented with HMGS (Human melanocyte growth supplements).  
D. Human epidermal melanocytes after sub-passage.  
Images magnification- 10x 
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Figure 19: Isolation and morphology of melanocytes in explant culture (MEL5) 
 
 
A. Cells emerged from the epidermal explant at day 10.  
B, C. Cells were attaining dendritic morphology on the 15th day of culture in basal MEM-
alpha medium supplemented with HMGS (Human melanocyte growth supplements).  
D. Human epidermal melanocytes after sub-passage.  
Images magnification- 10x 
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Figure 20: Isolation and morphology of melanocytes in explant culture (MEL8) 
 
 
A, B, C: Cell line MEL8 suspension cultured cells showing attachment at P0.  
D, E, F: Adhered human melanocytes showed cobblestone (thin arrow-like) structure along 
with long bipolar and tripolar morphology and a few cells are with dendritic arms in 15 days 
of culture and passage 1.  
Images magnification- 10x 
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Figure 21: Isolation and morphology of melanocytes in suspension culture (MEL2 and 
MEL3) 
  
 
A. Cell line MEL2 on the 3rd day of seeding.  
B. A week after primary culture.  
C. Cells at Passage 1. 
D. Cell line MEL3 on the 3rd day of seeding after given wash with DPBS.  
E. Morphology of cells on day 7th of culture. 
F. At passage 1 reached 60% confluence. Melanocytes from both the samples showed spindle 
bipolar or multipolar dendritic processes.  
Images magnification- 10x 
 
 
204 
 
Figure 22: Isolation and morphology of melanocytes in suspension culture (MEL4 and 
MEL5) 
 
 
A, B, C: Cell line MEL4 suspension cultured cells showing attachment to the substratum 
coated with attachment factor at up to day 15 and there was a slow cell proliferation.  
D, E, F: Cell line MEL5. Suspension cultured human melanocytes showed bi, tri or 
multipolar structures indicating the melanocyte morphology.  
Images magnification- 10x   
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Figure 23: Isolation and morphology of melanocytes in suspension culture (MEL6 and 
MEL7) 
 
 
A, B, C: Cell line MEL6 suspension cultured cells showing attachment at P0.  
D, E, F: Cell line MEL7. Adhered human melanocytes showed cobblestone (thin arrow-like) 
structure along with long bipolar and tripolar morphology. A few cells are with dendritic 
arms in 15 days of culture and at passage 1.  
Images magnification- 10x 
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Figure 24: Isolation and morphology of melanocytes in suspension culture (MEL9 and 
MEL10). 
 
 
A. Cell line MEL9 on 4th day of seeding.  
B. A week after primary culture.  
C. Cells at passage 1.  
D. Cell line MEL10 on the 3rd day of seeding after given wash with DPBS.  
E. On day 7th and F. At passage 1 reached 60% confluence. Melanocytes from both the 
samples showed spindle bipolar or multipolar dendritic processes.  
Images magnification- 10x 
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4.4 Cellular, functional and phenotypic characteristics of melanocytes 
Established melanocytes were characterized based on their proliferation potential, viability, 
melanin content, tyrosinase activity and the expression of selected melanocyte markers.  In the 
present study, it was aimed to clarify the growth characteristics of melanocytes in vitro and 
understand the mechanisms of culturing autologous melanocytes for the potential treatment of 
vitiligo. 
 
4.4.1 Proliferation rate of melanocytes 
The proliferation rate of melanocytes is presented in this section and the numbers are depicted 
in Figure 25.  Melanocytes of passages 2 to 5 were employed for assessing their growth rate.  
Initially, the cells needed time for adherence to the plastic culture plates and hence the 
proliferation was slower.  By day 6 in culture, the cells started proliferating at higher rates and 
reached the peak of growth phase in a linear manner by day 9 and day 12 of the culture period.  
All the established melanocyte cell lines showed higher proliferation potential and without 
significant differences in their growth behaviour. However, the division time varied slightly 
between the three different melanocyte cell lines, particularly during the early stages of cell 
culture. 
 
In all the cell lines, cell number was significantly increased along with the time (P<0.0001). 
From day 9 to day 12 of culture, a significant difference in cell numbers was observed in all 
the cell lines. 
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Figure 25: Proliferation rate of melanocytes 
 
Total number is represented in terms of an increase in cell number during the culture period of 
12 days.    
 
In all the cell lines, the cell number was significantly increased along with the time (P<0.0001) 
except from day 0 to day 3.  From day 9 to day 12, a significant difference in cell numbers was 
observed in all the cell lines.  The differences in terms of P value were varied between P < 
0.0026 and P< 0.0001.  
 
Error bars indicate standard deviation (SD) for mean values obtained from triplicates.  Values 
on Y-axis denote cell number and x-axis denote the duration. 
 
Proliferation assay was performed in triplicates. 
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4.4.2 Viability assay of melanocytes 
Cell viability of cultured human melanocytes for a total of nine cell lines was assessed at 
different passages from one to six.  More than 98% viability was noticed in every passage in 
all the cell lines when analysed using trypan blue dye exclusion assay method (Figure 26, 
Figure 27 and Figure 28).  Melanocytes from all those passages had a proper morphology 
with dendritic structures and bipolar processes and remained proliferative with maintenance of 
high level of viability.  The percentage of viable cells at all examined passages was greater than 
90% and didn’t show major differences between the cell lines. 
 
All the cell lines showed more than 90% cell viability in every passage. Hence, there was no 
significant variation noticed in percentage cell viability except in MEL4, MEL7 and MEL10. 
In MEL 4, there was a significant difference in cell viability in P1 to P2 (p<0.0001), P1 to P5 
(p<0.0392), P2 to P3, P4, P5 (p<0.05).  In MEL, the differences were observed between P1 to 
P4 and P5 (p<0.05) and P3 to P4 and P5 (p<0.05).  In MEL10, significant variation was noticed 
between P2 to P4 and P5 (p<0.05). Between the cell lines, there was no significant difference 
observed except in P2 for MEL1 vs MEL4 (p<0.0001). 
  
210 
 
Figure 26: Cell viability of cultured human melanocytes (Total number=10) from passage 1 
to passage 6 
 
More than 98% viability was noticed in every passage in all the melanocyte cell lines when 
analysed using trypan-blue dye exclusion assay method. 
 
Viability assay was performed with minimum of triplicate experiments. 
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Figure 27: Cell viability of cultured human melanocytes (Total number=10) from passage 1 
to passage 6 
 
Percentage values of viability from passage 1 to passage 6 for every melanocyte cell line is 
presented in a single bar diagram. 
* indicates a significant difference in values between the cell lines (P<0.05).  
Viability assay was performed with minimum of triplicate experiments. 
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Figure 28: Average cell viability of cultured human melanocytes (n=10) from passage 1 to 
passage 6 
 
Average percentage viability values from passage 1 to passage 6 for melanocyte cell lines 
(n=10) is presented. 
a, b, c indicates a significant difference in values between the passages (P<0.05).  
Viability assay was performed with minimum of triplicate experiments. 
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4.4.3 Total melanin content assay 
Total melanin content assay was performed to estimate the melanin levels in melanocytes and 
absorbance was taken in 405 nm in ELISA reader.  A blank was taken without any cells and 
the dermal fibroblasts (DFs) were considered as a negative control for melanocytes.  Every 
melanocyte cell line showed higher absorbance than the negative control which indicated the 
production of melanin during culture expansion period (Figure 29).  A significant difference 
in absorbance values between the cell lines and blank or negative control (DFs) (P<0.05, 
P<0.0001) was observed. The melanin content was recorded at the absorbance at which both 
pheomelanin and eumelanin absorb light without the interference of pH from the cell culture 
medium. 
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Figure 29: Total melanin content assay 
 
 
Total melanin content assay was performed to estimate the melanin content in melanocytes 
and absorbance was taken in 405 nm in ELISA reader. A blank was taken without any cells 
and dermal fibroblasts (DFs) were considered as a negative control for melanocytes. Every 
melanocyte cell line showed higher absorbance than the negative control which indicated the 
production of melanin during culture expansion period. 
a & b indicate significant difference in values between the cell lines and blank or negative 
control (DFs) (P<0.05, P<0.0001). 
Melanin content assay was performed in triplicates. 
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4.4.4 Estimation of tyrosinase activity by L-DOPA assay 
Tyrosinase activity in melanocytes was carried out by following the L-DOPA assay method. A 
blank value was recorded without any cells and dermal fibroblast cells were considered as a 
negative control for melanocytes. Tyrosinase activity was found to be highest in melanocyte 
cell lines as compared to dermal fibroblast cell lines (Figure 30).  The results indicated that 
the established melanocytes were positive for the DOPA reaction. 
 
L-Dopa activity was significantly higher in melanocytes when compared to dermal fibroblast 
as well as blank (P<0.0001). Between the melanocyte cell lines, there was no significant 
variation recorded except for MEL3 Vs MEL-9 (p<0.0219). 
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Figure 30: Estimation of tyrosinase activity by L-DOPA assay 
 
 
 
Tyrosinase activity in melanocytes was carried out by following the L-dopa assay method. A 
blank was taken without any cells and dermal fibroblast (DFs) cells were considered as a 
negative control for melanocytes.  
Tyrosinase activity was found to be highest in melanocyte cell lines as compared to dermal 
fibroblast (DFs) cell lines.  
Between the melanocyte cell lines, there was no significant difference in L-DOPA recorded 
except for MEL3 Vs MEL-9 (p<0.0219). 
a, b & c indicate significant difference in values between the cell lines and blank or negative 
control (DFs) (P<0.05). L-DOPA assay was performed in triplicates. 
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4.4.5 Staining of melanocytes by L-DOPA 
The confirmation of melanocytes (MEL2, MEL3, MEL4 and MEL6 cell lines) by L-DOPA 
staining was examined by phase-contrast microscopy.  Cultured cells were fixed in 
paraformaldehyde and stained in L-DOPA for 30 min at 37°C.  Melanocytes were turned into 
dark brown after the staining procedures, and exhibited the positivity to the reaction (Figure 
31).  Melanocytes in the shape of dendritic structures were predominantly stained by DOPA 
and the nucleus was slightly smaller than dendritic features.  
Figure 31: Confirmation of melanocytes by L-Dopa staining  
 
 
A. MEL2 cell lines  
B. MEL3 cell lines 
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C. MEL4 cell lines 
D. MEL6 cell lines 
Cells were fixed in paraformaldehyde and stained in 1M L-DOPA for 30 minutes at 370C. 
Cells stained dark brown after staining.  
Image magnification- 10x. 
 
4.4.6 Melanin bleach assay 
In addition to the above, melanin bleach assay was also performed using different cell lines.  
Melanocytes as a control without bleach, and the cells bleached with oxalic acid that removed 
the melanin pigmentation were clearly observed after the assays (Figure 32).  These results 
confirmed that the cells isolated from the epidermal tissues were indeed melanocytes.  With a 
starting material of a very small amount of tissue, a good number of human melanocytes were 
established with a pure population by the stage they reached passage 3 or 4.  Although the 
melanocytes were isolated from various donors, significant differences in their morphological 
and proliferation rates were not observed.  Further, the functional features of melanocytes, such 
as melanin synthesis and tyrosinase activity were clearly demonstrated by specific assays in 
the cultured cells. 
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Figure 32: Melanin bleach assay 
 
 
A, B: Cell line MEL3. A is the control without bleach.  
B is cells bleached with oxalic acid which removes the melanin pigmentation   
C, D:  Cell line MEL9. C is the control without bleach. 
D is cells bleached with oxalic acid which removes the melanin pigmentation. 
Image magnification- 10x.  
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4.4.7 Expression of melanocyte specific markers analysed by flow cytometry 
The flow cytometry analysis of melanocytes (MEL1, MEL2, MEL3, MEL7 and MEL8 cell 
lines) was carried out to quantitatively examine the melanocyte-specific marker expression. 
Assay demonstrated the expression of S100, tyrosinase related protein 1 (TYRP1) and 
tyrosinase (TYR) markers against FITC (Fluorescein isothiocyanate) staining (Figure 33, 
Figure 34 and Figure 35). 
 
The expression of S100 was higher in all the cell lines examined.  However, the expression of 
other melanocyte-specific markers, such as TYRP1 and TYR showed varied levels of 
positivity.  Among the cell lines, MEL3 had a higher expression of these selected markers. 
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Figure 33: Representative results of flow cytometry analysis of melanocytes (MEL1 and 
MEL2 cell lines)  
 
 
Melanocyte-specific marker expression was quantitatively examined. Assay demonstrated the 
expression of S100, tyrosinase related protein 1 (TYRP1) and tyrosinase (TYR) markers 
against FITC (Fluorescein isothiocyanate) staining. The blue histograms represent the specific 
staining, and the red histograms indicate background staining of an isotype-matched control 
antibody. Samples were analysed in duplicates. 
 
 
 
222 
 
Figure 34: Representative results of flow cytometry analysis of melanocytes (MEL3 and 
MEL7 cell lines) 
 
 
Melanocyte-specific marker expression was quantitatively examined. Assay demonstrated the 
expression of S100, tyrosinase related protein 1 (TYRP1) and tyrosinase (TYR) markers 
against FITC (Fluorescein isothiocyanate) staining. The blue histograms represent the specific 
staining, and the red histograms indicate background staining of an isotype-matched control 
antibody. Samples were analysed in duplicates. 
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Figure 35: Representative results of flow cytometry analysis of melanocytes (MEL8 cell 
line)  
 
 
Melanocyte-specific marker expression was quantitatively examined. Assay demonstrated the 
expression of S100, tyrosinase related protein 1 (TYRP1) and tyrosinase (TYR) markers 
against FITC (Fluorescein isothiocyanate) staining. The blue histograms represent the specific 
staining, and the red histograms indicate background staining of an isotype-matched control 
antibody. Sample was analysed in duplicates.  
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4.5 Processing of skin for the isolation and establishment of keratinocytes 
The steps involved in the processing of skin samples for the isolation of keratinocytes are 
presented in Figure 36. 
 
Figure 36: Processing of split skin sample for the isolation of keratinocytes 
 
 
A, B: Washing with sterile DPBS with 2X penicillin and streptomycin followed by 2 μg/ml 
fungizone and 10 μg/ml gentamicin solution. Further, the skin tissue surface was sterilized with 
75% ethanol iodine solution.  
C, D: Skin tissue was minced using a sterile surgical blade.   
E: Minced tissue was incubated with 0.25% trypsin solution for 1.30 hrs.  
F. Epithelial cells were scraped using a sterile scalpel and kept in culture medium. 
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4.6 Isolation, establishment and morphological features of keratinocytes from skin 
sample 
An in vitro method followed for the establishment of primary culture of human keratinocytes 
was similar to that of melanocytes.  Keratinocytes were isolated from skin tissue samples using 
trypsin-EDTA digestion for collecting the cells in suspension.  In the present study, a total of 
10 keratinocyte cell lines were successfully established and designated as KRT1 to KRT10. 
Further, an explant culture method was tried for establishing KRT5 cell line.  The processing 
of skin tissue, primary culture establishment, and morphological characteristics of melanocytes 
of KRT1 to KRT10 cell lines are presented in this section. 
 
The keratinocytes established by explant culture, such as KRT5, KRT8, KRT9 and KRT10 are 
presented in Figures 37, 38 and 39, respectively. The remaining cell lines established by 
suspension culture are presented in Figure 40, Figure 41 and 42.  
 
Keratinocytes were first observed growing out of the tissue explant or the attached cells in 
suspension culture.  A monolayer of cells was formed between 48 and 96 hrs. By day 4, the 
outgrowth of cells surrounded the explants and over day 5 and 6, this outgrowth continued to 
expand.  After 6 days in suspension culture, cells with spindle-shaped fibroblast or melanocyte 
morphology were also visible along with the keratinocyte ring.  Sufficient numbers of cells for 
harvesting were attained in 2 to 3 weeks.  When subcultured in Epilife medium supplemented 
with growth factors, these cells exhibited exemplary attachment and growth capabilities. After 
2 to 3 days, cells were attached and were growing as a monolayer.  Under these conditions, 
cells were more adhesive and formed tight colonies of keratinocytes. The cells showed 
epithelial morphology resembling a ‘pavement stone’.  The presence of large and flat cells was 
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also noticed.  Importantly, no fibroblast contamination was observed in the cultures of later 
passages.  Confluent keratinocyte monolayers were generated in 2 weeks after passaging. 
 
Established keratinocytes were highly proliferative around 2 weeks of seeding cells in 
suspension culture.  Adhered keratinocytes had typical morphological characteristics and could 
be identified along with a small population of melanocytes and fibroblasts during the early 
stages of culture expansion.  From a small skin tissue, it was possible to obtain confluent dishes 
within 3 to 4 weeks of culture.  This was sufficient for sub-passaging and conducting the 
experiments at later passages.  When seeding keratinocytes after trypsinization, more than 90% 
of cells were attached and initiated the proliferation within 24 to 48 hrs. 
 
Direct outgrowth of keratinocytes from tissue explant was typically noticed within 3 to 4 days 
if successful.  After 14 days in primary culture, a colony of cells from a single tissue piece was 
observed.  For obtaining larger amounts of cells, subcultures were carried out as well as direct 
adaptation to EpiLife medium (at passage 0 or after).  They typically reached confluence and 
were ready for sub-culturing in 2 to 3 weeks. After this, they were split 1:4 once with medium 
changes every 3 days. 
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Figure 37: Isolation and morphology of keratinocytes in explant culture (KRT5) 
 
 
Under these conditions, cells were more adhesive and formed tight colonies of keratinocytes. 
The presence of large and flat cells was also noticed.  
Image magnification-10x 
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Figure 38: Isolation and morphology of keratinocytes in explant culture (KRT8)
 
 
Under these conditions, cells were more adhesive and formed tight clusters or colonies of 
keratinocytes.  
The presence of large and flat cells was also noticed.  
Image magnification-10x 
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Figure 39: Isolation and morphology of keratinocytes in explant culture (KRT8 and KRT10) 
 
 
Under these conditions, cells were more adhesive and formed tight clusters or colonies of 
keratinocytes.  
The presence of large and flat cells was also noticed.  
Image magnification-10x 
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Figure 40: Isolation and morphology of keratinocytes in suspension culture (KRT1 and 
KRT2) 
 
 
Phase-contrast microscopy revealed that the established keratinocytes formed a pavement-
like monolayer under in vitro culture conditions.   
Image magnification-10x 
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Figure 41: Isolation and morphology of keratinocytes in suspension culture (KRT3 and 
KRT4) 
 
 
Phase-contrast microscopy revealed that the established keratinocytes formed a pavement-
like monolayer under in vitro culture conditions.   
Image magnification-10x 
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Figure 42: Isolation and morphology of keratinocytes in suspension culture (KRT6) 
 
 
Phase-contrast microscopy revealed that the established keratinocytes formed a pavement-
like monolayer under in vitro culture conditions.   
Image magnification-10x 
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4.7 Cellular and phenotypic characteristics of keratinocytes 
In vitro established keratinocytes were characterized based on their proliferation potential, 
viability, and the expression of selected keratinocyte-specific markers.  In the present study, it 
was aimed to assess the growth characteristics of keratinocytes in vitro and understand the 
mechanisms of culturing autologous cells for establishing the optimal co-culture system with 
melanocytes. 
 
4.7.1 Proliferation rate of keratinocytes 
Proliferation rate of keratinocytes during the in vitro expansion for a period up to 12 days was 
examined.  The cells were trypsinized and counted using a hemocytometer on every 3rd day. 
Initially, the cell growth rate was slightly slower.  However, from day 6 onwards, there was a 
considerable increase in proliferation in all the cells cell lines was observed (Figure 43).  Some 
of the cell lines showed greater proliferation even after day 9 in culture. Significant difference 
(P<0.05) in the cell number was observed between the time points of analysis. 
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Figure 43: Proliferation rate of keratinocytes during the in vitro expansion period up to 12 
days 
 
 
All keratinocyte cell lines showed significant increase in cell number as the time increased 
(p<0.001) except from day 0 to day 3.  
From day 6 to day 12, a significant difference in cell numbers was observed in all the cell lines.  
The differences in terms of P value was <0.05.  
Error bars indicate standard deviation (SD) for mean values obtained from triplicates.  
Values on Y-axis denote cell number and x-axis denote the duration. 
 
Proliferation assay was performed in triplicates. 
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4.7.2 Viability assay of keratinocytes 
Viability of keratinocytes at different passages showed very high levels under in vitro culture 
conditions. Graphical representation of percentage values of viability of keratinocyte cell lines 
at different passages is made in Figure 44, Figure 45 and Figure 46. 
 
Amongst the keratinocyte cell lines, no significant difference was observed in percentage cell 
viability. But the KRT8 cell line showed significant variation in cell viability at (P1, 2, 3) vs P 
(5, 6) (p<0.005). Between the cell lines, few of the groups showed significant variation in 
percentage viability at P5 and P6. Those are at P5, KRT1 vs KRT8, KRT2 vs KRT8, KRT3 vs 
KRT7, KRT4 vs KRT8, KRT5 vs KRT8 and at P6, KRT1 vs KRT (7, 8) and KRT2 vs KRT 
(7, 8) at p<0.05.  Further, slightly lower viability values were noticed in keratinocytes of later 
passages (Passage 5 and 6). 
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Figure 44: Cell viability of cultured human keratinocytes (Total number=10) from passage 1 
to passage 6 
 
 
 
More than 96% viability was noticed in every passage in all the keratinocyte cell lines when 
analysed using trypan-blue dye exclusion assay method. 
Viability assay was performed with minimum of triplicate experiments. 
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Figure 45: Cell viability of cultured human keratinocytes (Total number=10) from passage 1 
to passage 6 
 
 
Percentage values of viability from passage 1 to passage 6 for every keratinocyte cell line is 
presented in a single bar diagram. 
* indicates a significant difference in values between the cell lines (P<0.05). 
Viability assay was performed with minimum of triplicate experiments. 
 
 
 
 
 
 
 
 
 
 
238 
 
Figure 46: Average cell viability of cultured human keratinocytes (n=10) from passage 1 to 
passage 6 
  
 
 
Average percentage viability values from passage 1 to passage 6 for keratinocyte cell lines 
(n=10) is presented. 
a, b, c & d indicate a significant difference in values between the passages (P<0.05).  
Viability assay was performed with minimum of triplicate experiments. 
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4.7.3 Expression of keratinocyte specific markers analysed by flow cytometry  
Keratinocyte-specific marker expression was quantitatively examined by flow cytometry.  
Assay demonstrated the expression of pan-cytokeratin (PanC), cytokeratin10 (CK10) and 
filaggrin (FLG) markers against FITC (Fluorescein isothiocyanate) staining (Figure 47, 
Figure 48 and Figure 49). 
 
The blue histograms represent the specific staining, and the red histograms indicate background 
staining of an isotype-matched control antibody. 
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Figure 47: Representative results of flow cytometry analysis of keratinocytes (KRT1 and 
KRT2 cell lines)  
 
 
Keratinocyte-specific marker expression was quantitatively examined. Assay demonstrated the 
expression of pan-cytokeratin (PanC), cytokeratin10 (CK10) and filaggrin (FLG) markers 
against FITC (Fluorescein isothiocyanate) staining. The blue histograms represent the specific 
staining, and the red histograms indicate background staining of an isotype-matched control 
antibody.  
Samples were analysed in duplicates. 
 
 
 
241 
 
Figure 48: Representative results of flow cytometry analysis of keratinocytes (KRT3 and 
KRT7 cell lines)  
 
 
 
Keratinocyte-specific marker expression was quantitatively examined. Assay demonstrated 
the expression of pan-cytokeratin (PanC), cytokeratin10 (CK10) and filaggrin (FLG) markers 
against FITC (Fluorescein isothiocyanate) staining. The blue histograms represent the 
specific staining, and the red histograms indicate background staining of an isotype-matched 
control antibody.  
Samples were analysed in duplicates. 
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Figure 49: Representative results of flow cytometry analysis of keratinocyte (KRT8 cell line)  
 
 
Keratinocyte-specific marker expression was quantitatively examined. Assay demonstrated 
the expression of pan-cytokeratin (PanC), cytokeratin10 (CK10) and filaggrin (FLG) markers 
against FITC (Fluorescein isothiocyanate) staining. The blue histograms represent the 
specific staining, and the red histograms indicate background staining of an isotype-matched 
control antibody.  
Sample was analysed in duplicates. 
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Objective 3: To establish and examine the co-culture methods for melanocytes and 
keratinocytes in different culture conditions. 
 
4.8 Co-culture of melanocytes and keratinocytes 
For optimization of the co-culture system, in vitro established and characterized the population 
of melanocytes and keratinocytes were employed.  The ratios of melanocytes to keratinocytes 
selected for optimization were 1:3, 1:5 and 1:10.  The parameters, such as morphology, melanin 
content and the expression of phenotypic markers were analysed in co-culture systems.  In 
Table 8 the media composition that was used for the various co-culture ratios is listed. 
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Table 8: Composition of media used for in vitro culture  
Culture Condition Medium FBS Non- 
essential 
amino acids 
Glutamax β-mercaptoethanol Pen-strep 
solution 
Growth factors 
Primary culture of 
keratinocytes 
MEM-α 20% 1% 1% 900µL 1% EGF 2 ng/mL + KGF 
2 ng/mL + HKGS 1X 
Primary culture of 
melanocytes 
MEM-α 20% 1% 1% 900µL 1% HMGS 1X 
Maintenance of 
Keratinocytes 
Epilife -- -- -- -- 1% EGF 2 ng/mL + KGF 
2 ng/mL + HKGS 1X 
Maintenance of 
melanocytes 
M254 -- -- -- -- 1% HMGS 1X 
Co-culture of 
melanocytes and 
keratinocytes (1:3) 
Above mentioned maintenance medium M254 and Epilife in the ratio 1:3 
Co-culture of 
melanocytes and 
keratinocytes (1:5) 
Above mentioned maintenance medium M254 and Epilife in the ratio 1:5 
Co-culture of 
melanocytes and 
keratinocytes (1:10) 
Above mentioned maintenance medium  M254 and Epilife in the ratio 1:5 
HKGS contents: 
Bovine pituitary extract (BPE): 0.2% v/v 
Recombinant human insulin-like growth factor-I: 0.01 µg/mL 
Hydrocortisone: 0.18 µg/mL 
Bovine transferrin: 5 µg/mL 
Human epidermal growth factor: 0.2 ng/mL 
HMGS contents: 
  Bovine pituitary extract (BPE): 0.2% v/v 
  Fetal bovine serum: 0.5% v/v 
  Recombinant human insulin-like growth factor-I: 0.01 µg/mL 
  Bovine transferrin: 5 µg/mL 
  Basic fibroblast growth factor: 3 ng/mL 
  Hydrocortisone: 0.18 µg/mL 
  Heparin: 3 µg/mL 
  Phorbol 12-myristate 13-acetate (PMA): 10ng/mL 
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4.8.1 Morphological features in co-culture of melanocytes and keratinocytes  
In this study, four cell lines of melanocytes and keratinocytes, such as MK2, MK3, MK4 and 
MK6 were employed for assessing the morphological changes at different ratios of 1:3, 1:5 
and 1:10 co-culture systems on days 3, 5 and 10 of culture. 
 
The differences in the morphological features were observed as per the ratios performed and 
the results are presented in Figure 50 to Figure 53. Higher number of melanocytes was 
observed at ratios 1:3 and 1:5. Further, the presence of cells in co-cultures was confirmed by 
hematoxylin staining (Figure 54). 
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Figure 50: Representative images of morphologies of melanocyte-keratinocyte co-cultures 
(MK2-CC) at 1:3, 1:5 and 1:10 ratios observed on days 3, 5 and 12 (A to I)  
 
 
Yellow arrows represent the melanocytes morphology and white arrows indicate keratinocyte 
cell clusters.  
Image magnification-10x 
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Figure 51: Representative images of morphologies of melanocyte-keratinocyte co-cultures 
(MK3-CC) at 1:3, 1:5 and 1:10 ratios observed on days 3, 5 and 12 (A to I)  
 
 
Yellow arrows represent the melanocytes morphology and white arrows indicate keratinocyte 
cell clusters.  
Image magnification-10x 
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Figure 52: Representative images of morphologies of melanocyte-keratinocyte co-cultures 
(MK4-CC) at 1:3, 1:5 and 1:10 ratios observed on days 3, 5 and 12 (A to I) 
 
 
Yellow arrows represent the melanocytes morphology and white arrows indicate keratinocyte 
cell clusters.  
Image magnification-10x 
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Figure 53: Representative images of morphologies of melanocyte-keratinocyte co-cultures 
(MK6-CC) at 1:3, 1:5 and 1:10 ratios observed on days 3, 5 and 12 (A to I)  
 
 
 
Yellow arrows represent the melanocytes morphology and white arrows indicate keratinocyte 
cell clusters.  
Image magnification-10x 
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Figure 54: Representative images of melanocyte-keratinocyte co-cultures (MK4-CC and 
MK6-CC) at 1:3, 1:5 and 1:10 ratios stained by hematoxylin for confirmation  
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4.8.2 Estimation of melanin content in melanocyte keratinocyte co-cultures 
Melanin content in the melanocyte-keratinocyte co-culture system at 1:3, 1:5 and 1:10 ratios 
was analysed in different cell lines. The results are presented in Figure 55. 
 
Figure 55: Estimation of melanin content in melanocyte keratinocyte co-cultures (MK2, 
MK3, MK4 and MK6) cultured at 1:3, 1:5 and 1:10 ratios   
 
 
Significantly higher secretion of melanin was observed in 1:3 and 1:5 ratio than 1:10 ratio 
(p<0005). Between the cell lines, MK4 cells showed significantly higher melanin content 
versus MK2 (p=0.0058) and MK3 (p=0.0403) cell lines in 1:3 ratio.  
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Melanin content was significantly higher in all the cell lines and all the ratios when compared 
to blank. In 1:3 ratio cultures, a significant difference in melanin content was observed 
between MEL2 vs MEL4 and MEL3 vs MEL4. In 1:5 and 1:10 ratios, there were no 
significant variations recorded in between the cell lines.   
Between ratios 1:3 vs 1:5, co-cultures did not show any significant difference in melanin 
content.  But, co-cultures in 1:3 vs 1:10 and 1:5 vs 1:10 showed highly significant variation in 
melanin content in all the cell lines. 
 
*, a and b indicate a significant difference in values between the co-culture ratios and cell 
lines as indicated (P<0.05).  
The samples were analysed in triplicates. 
 
Values on Y-axis indicate absorbance units (absolute values) 
 
Dermal fibroblasts (DFs) were initially used as 'Negative control cell lines' in Total melanin 
content and L-DOPA assays (Figure 29 & 30, p224 & p226). 
 
Later, for co-culture experiments, e.g. Figure 55 (p261), Figure 56 (p263) etc., only blanks 
were used. (Because DFs earlier showed very low melanin and tyrosinase, and the values 
were similar to blank values) 
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4.8.3 Analysis of tyrosinase activity in melanocyte keratinocyte co-cultures by L-DOPA 
Analysis of tyrosinase activity in melanocyte keratinocyte co-cultures was performed by L-
DOPA assay. The results are graphically presented in Figure 56. 
 
Figure 56: Analysis of tyrosinase activity was performed in melanocyte keratinocyte co-
cultures (MK2, MK3, MK4 and MK6) cultured at 1:3, 1:5 and 1:10 ratios 
 
 
L-dopa activity was present in co-cultured cells and it was highly significant when compared 
with blank values (p<0.0001).  
The increase in L-DOPA activity was not significant between the cells lines (P>0.05). But, 
between the different ratios of all the cell lines, the activity showed significant variation in 
1:3 vs 1:10 and 1:5 vs 1:10. But, 1:3 vs 1:5 groups did not show any significant difference in 
all the cell lines (P>0.05).  
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a and b indicate a significant difference in values between the co-culture ratios for each cell 
line as indicated (P<0.05).  
4.8.4 Expression of phenotypic markers by flow cytometry analysis 
Expression of selected melanocyte-specific markers was analysed in melanocyte-keratinocyte 
co-culture system using flow cytometer.  The marker expression was quantitatively examined 
and the results are presented in Figure 57. 
 
Analysis demonstrated the expression of S100, tyrosinase related protein 1 (TYRP1) and 
tyrosinase (TYR) markers against FITC (Fluorescein isothiocyanate) staining.  
 
Figure 57: Representative results of flow cytometry analysis of melanocytes and 
keratinocytes co-culture at 1:3 ratio (MK2 and MK6 cell lines)  
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The blue histograms represent the specific staining, and the red histograms indicate 
background staining of an isotype-matched control antibody. The samples were analysed in 
duplicates for each marker as indicated. 
 
Objective 4: To manipulate and assess the co-culture methods of melanocytes and 
keratinocytes by exposing to alpha melanocyte-stimulating hormone and UV light. 
 
4.9 Influence of α-MSH on melanocyte-keratinocyte co-cultures 
For further optimization of the co-culture system, the present study was aimed to assess the 
influence of α-MSH on melanocyte-keratinocyte at ratios 1:3, 1:5 and 1:10.   Three cell lines 
were selected for these experiments and they were, MK2, MK4 and MK6.  Further, α-MSH 
was tested at three different concentrations, such as 2.5 µg/ml, 5 µg/ml and 10 µg/ml.  The 
cellular and functional parameters, including morphological characteristics, melanin content 
and tyrosinase activity by L-DOPA assay were performed. 
 
4.9.1 Morphological features of melanocyte keratinocyte co-cultures at different ratios 
on days 3 and 7 after treatment with α-MSH at various concentrations 
In this study, three cell lines of melanocytes and keratinocytes, such as MK2, MK4 and MK6 
were employed for assessing the morphological changes at different ratios of 1:3, 1:5 and 
1:10 co-culture systems on days 3 and 7 after their exposure to α-MSH at 2.5 µg/ml, 5 µg/ml 
and 10 µg/ml. 
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The differences in the morphological features were observed as per the concentrations of α-
MSH used, and the results are presented for 1:3 ratio in Figures 58 to Figure 60, 1:5 ratio in 
Figures 61 to Figures 63 and 1:10 ratio in Figures 64 to Figures 66. In a dose dependent 
manner, the higher number of melanocytes was observed at ratios 1:3 and 1:5. Further, the 
day 0 images are also presented for ratios 1:3, 1:5 and 1:10 (Figure 67). 
 
In co-cultures, melanocytes showed bipolar with dendritic morphology, whilst the cells with 
well-defined contours and round shapes were keratinocytes. Melanocytes appeared normal in 
the perinuclear region and also based on the dendrite shapes. Both cells showed proper 
adherence as observed on days 3 and 7 of culture. 
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Figure 58: Representative images of morphology of melanocyte keratinocyte co-cultures at 
1:3 ratio (MK2-CC-1:3) on days 3 and 7 after treatment with α-MSH at different 
concentrations (2.5 µg/ml, 5 µg/ml and 10 µg/ml) 
 
 
Image magnification-10x 
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Figure 59: Representative images of morphology of melanocyte keratinocyte co-cultures at 
1:3 ratio (MK4-CC-1:3) on days 3 and 7 after treatment with α-MSH at different 
concentrations (2.5 µg/ml, 5 µg/ml and 10 µg/ml) 
 
Image magnification-10x 
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Figure 60: Representative images of morphology of melanocyte keratinocyte co-cultures at 
1:3 ratio (MK6-CC-1:3) on days 3 and 7 after treatment with α-MSH at different 
concentrations (2.5 µg/ml, 5 µg/ml and 10 µg/ml) 
 
Image magnification-10x 
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Figure 61: Representative images of morphology of melanocyte keratinocyte co-cultures at 
1:5 ratio (MK2-CC-1:5) on days 3 and 7 after treatment with α-MSH at different 
concentrations (2.5 µg/ml, 5 µg/ml and 10 µg/ml) 
 
Image magnification-10x 
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Figure 62: Representative images of morphology of melanocyte keratinocyte co-cultures at 
1:5 ratio (MK4-CC-1:5) on days 3 and 7 after treatment with α-MSH at different 
concentrations (2.5 µg/ml, 5 µg/ml and 10 µg/ml) 
 
Image magnification-10x 
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Figure 63: Representative images of morphology of melanocyte keratinocyte co-cultures at 
1:5 ratio (MK6-CC-1:5) on days 3 and 7 after treatment with α-MSH at different 
concentrations (2.5 µg/ml, 5 µg/ml and 10 µg/ml) 
 
Image magnification-10x 
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Figure 64: Representative images of morphology of melanocyte keratinocyte co-cultures at 
1:10 ratio (MK2-CC-1:10) on days 3 and 7 after treatment with α-MSH at different 
concentrations (2.5 µg/ml, 5 µg/ml and 10 µg/ml) 
 
Image magnification-10x 
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Figure 65: Representative images of morphology of melanocyte keratinocyte co-cultures at 
1:10 ratio (MK4-CC-1:10) on days 3 and 7 after treatment with α-MSH at different 
concentrations (2.5 µg/ml, 5 µg/ml and 10 µg/ml) 
 
Image magnification-10x 
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Figure 66: Representative images of morphology of melanocyte keratinocyte co-cultures at 
1:10 ratio (MK6-CC-1:10) on days 3 and 7 after treatment with α-MSH at different 
concentrations (2.5 µg/ml, 5 µg/ml and 10 µg/ml) 
 
Image magnification-10x 
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Figure 67: Representative images of morphology of melanocyte keratinocyte co-cultures at 
1:3, 1:5 and 1:10 ratio on day 0 after treatment with α-MSH at 2.5 µg/ml concentration 
  
Image magnification-10x  
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4.9.2 Melanin content assay in melanocyte keratinocyte co-cultures at different ratios 
Melanin content was analysed in melanocyte keratinocyte co-cultures at different ratios and 
exposed to α-MSH at various concentrations.  All the three ratios of co-culture with 3 different 
concentrations of α-MSH (2.5, 5 and 10 µg/mL) showed significant increase in melanin content 
after treatment with α-MSH when compared to blank (p<0.0001) (Figure 68, Figure 69 and 
Figure 70).  Hence, after α-MSH treatment, all the cell lines showed increased secretion of 
melanin.   
 
Figure 68: Melanin content assay in melanocyte keratinocyte co-cultures at different ratios 
(1:3, 1:5 and 1:10) in MK2, MK4 and MK6 cell lines after treatment with α-MSH at 2.5 µg/ml 
concentration 
 
There was a significantly increased melanin content in 1:3 and 1:5 ratios (p<0.0334). 
The samples were analysed in triplicates. a and b indicate a significant difference in values 
between the co-culture ratios for each cell line as indicated (P<0.05).  
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Figure 69: Melanin content assay in melanocyte keratinocyte co-cultures at different ratios 
(1:3, 1:5 and 1:10) in MK2, MK4 and MK6 cell lines after treatment with α-MSH at 5 µg/ml 
concentration  
 
No significant differences (P>0.05) in melanin content were recorded between the various 
ratios and the cell lines analysed.  
The samples were analysed in triplicates. 
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Figure 70: Melanin content assay in melanocyte keratinocyte co-cultures at different ratios 
(1:3, 1:5 and 1:10) in MK2, MK4 and MK6 cell lines after treatment with α-MSH at 10 
µg/ml concentration 
 
There was no significant difference (P>0.05) observed between the ratios of co-culture 
systems.  But, between the cell lines, MK2 showed significantly lower secretion of melanin 
compared to MK4 and MK6 cell lines, when co-cultured cells were treated with 10 µg/mL α-
MSH (P<0.02). 
The samples were analysed in triplicates. 
* indicates a significant difference in values between the cell lines as indicated (P<0.05).  
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4.9.3 Estimation of tyrosinase activity by L-DOPA assay in α-MSH (2.5, 5 and 10 
µg/mL) treated co-cultured cell lines 
Tyrosinase activity by L-DOPA assay in melanocyte keratinocyte co-cultures at different ratios 
(1:3, 1:5 and 1:10) in MK2, MK4 and MK6 cell lines was evaluated after treatment with α-
MSH at 2.5, 5 and 10 µg/ml concentrations. The results are presented in Figure 71, Figure 72 
and Figure 73. 
 
Figure 71: Tyrosinase activity by L-DOPA assay in melanocyte keratinocyte co-cultures at 
different ratios (1:3, 1:5 and 1:10) in MK2, MK4 and MK6 cell lines evaluated after treatment 
with α-MSH at 2.5 µg/ml concentration 
 
After α-MSH treatment all the cell lines showed increased tyrosinase activity. The tyrosinase 
activity was significantly high in 1:5 and 1:10 ratio in comparison with 1:3 ratio (p< 0.05).  
Between the cell lines, MK2 showed a significant increase in tyrosinase activity than MK4 in 
1:10 ratio (p=0.0273). The samples were analysed in triplicates. *, a and b indicate a significant 
difference in values between the co-culture ratios for each cell line as indicated (P<0.05).  
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Figure 72: Tyrosinase activity by L-DOPA assay in melanocyte keratinocyte co-cultures at 
different ratios (1:3, 1:5 and 1:10) in MK2, MK4 and MK6 cell lines after treatment with α-
MSH at 5 µg/ml concentration 
 
L- DOPA activity was recorded in all the cell lines. But, between the cell lines, its activity 
was not significantly different (P>0.05). Also, in between different ratios, the L-DOPA 
activity was not significant (P>0.05). 
The samples were analysed in triplicates.  
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Figure 73: Tyrosinase activity by L-DOPA assay in melanocyte keratinocyte co-cultures at 
different ratios (1:3, 1:5 and 1:10) in MK2, MK4 and MK6 cell lines after treatment with α-
MSH at 10 µg/ml concentration 
 
L- DOPA activity was recorded in all the cell lines and was higher than blank. But, between 
the cell lines, its activity was not significantly different (P>0.05). Further, between different 
ratios also, the L-DOPA activity was not statistically significant (P>0.05). 
The samples were analysed in triplicates.  
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4.10 Exposure of melanocyte keratinocyte co-cultures to UVB 
With an objective of further optimization of the co-culture system, the effect of UVB exposure 
on melanocyte-keratinocyte at ratios 1:3, 1:5 and 1:10 was also assessed.  Three cell lines 
including, MK2, MK4 and MK6 were used for these experiments.  Further, UVB exposure was 
tested at three different doses, such as 10 mJ/cm2, 20 mJ/cm2 and 30 mJ/cm2.  The cellular and 
phenotypic characteristics of melanocytes and keratinocytes, such as morphology, melanin 
content, tyrosinase activity and the expression of selected markers were analysed in co-culture 
systems.   
 
4.10.1 Morphological features of melanocyte keratinocyte co-cultures at 1:3 ratio exposed 
to UVB at different doses observed post-exposure, on day 5 and day 10 
In this study, three cell lines of melanocytes and keratinocytes, such as MK2, MK4 and MK6 
were employed for assessing the morphological changes at 1:3 ratio co-culture systems on days 
5 and 10 after their exposure to UVB at 10 mJ/cm2, 20 mJ/cm2 and 30 mJ/cm2. 
 
The differences in the morphological features were observed as per the doses of UVB used, 
and the results are presented for 1:3 ratio in Figures 74 to Figure 76.  In a dose dependent 
manner, the reduced number of cells with alterations in morphologies was observed in the co-
culture system. 
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 Figure 74: Representative images of morphologies of melanocyte keratinocyte co-cultures 
(MK2, MK4 and MK6 cell lines) at 1:3 ratio exposed to UVB at 10 mJ/cm2 observed after  
exposure, on day 5 and day 10
 
Very moderate changes in morphologies were observed in melanocyte keratinocyte co-
cultures after UVB exposure at 10 mJ/cm2. 
Image magnification-10x 
 
 
 
 
 
 
 
 
275 
 
Figure 75: Representative images of morphologies of melanocyte keratinocyte co-cultures 
(MK2, MK4 and MK6 cell lines) at 1:3 ratio exposed to UVB at 20 mJ/cm2 observed after 
exposure, on day 5 and day 10 
 
 
Noticeable changes in morphologies were recorded in melanocyte keratinocyte co-cultures 
after UVB exposure at 20 mJ/cm2. The cells formed clusters by day 5 and 10, and the number 
was reduced drastically in all the cell lines. 
Image magnification-10x 
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Figure 76: Representative images of morphologies of melanocyte keratinocyte co-cultures 
(MK2, MK4 and MK6 cell lines) at 1:3 ratio exposed to UVB at 30 mJ/cm2 observed after 
exposure, on day 5 and day 10 
 
 
Drastic changes in morphologies were noticed in melanocyte keratinocyte co-cultures after 
UVB exposure at 30 mJ/cm2. The cells formed clusters prominently by day 5 and 10, and the 
number of both melanocytes and keratinocytes was reduced considerably in all the cell lines. 
Image magnification-10x 
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4.10.2 Melanin content assay in melanocyte keratinocyte co-cultures at 1:3 ratio exposed 
to UVB at different doses observed after exposure, on day 5 and day 10 
Melanin content was analysed in melanocyte keratinocyte co-cultures at 1:3 ratio and exposed 
to UVB radiation at different doses.  1:3 ratio of co-culture with 3 different doses of UVB (10 
mJ/cm2, 20 mJ/cm2 and 30 mJ/cm2) showed significant increase in melanin content after 
exposure when compared to blank (p<0.05) (Figure 77).  Hence, after UV radiation exposure, 
all the cell lines showed increased production of melanin.  
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Figure 77: Melanin content assay in melanocyte keratinocyte co-cultures (MK2, MK4 and 
MK6 cell lines) at 1:3 ratio exposed to UVB at 10 mJ/cm2, 20 mJ/cm2 and 30 mJ/cm2 observed 
after exposure, on day 5 and day 10 
 
 
There was a significant increase in melanin content in all the three cell lines when compared 
with a blank.  In 10 mJ/cm2 and 30 mJ/cm2, between the cell lines, there was no significant 
difference noticed. But, in 20 mJ/cm2 significant difference in melanin content was observed 
in MK2 vs MK6 and MK4 vs MK6 (p<0.009). Statistical significant difference was observed 
only in MK6 cells between 10 mJ/cm2 vs 20 mJ/cm2 and 20 mJ/cm2 vs 30 mJ/cm2 (p=0.0378). 
The samples were analysed in triplicates.  
*, a, b and c indicate a significant difference in values between the UVB exposure doses for 
each cell line as indicated (P<0.05).   
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4.10.3 Tyrosinase activity by L-DOPA assay in melanocyte keratinocyte co-cultures 
(MK2, MK4 and MK6 cell lines) at 1:3 ratio exposed to UVB at 10 mJ/cm2, 20 mJ/cm2 
and 30 mJ/cm2 observed after exposure, on day 5 and day 10 
Tyrosinase activity by L-DOPA was analysed in melanocyte keratinocyte co-cultures at 1:3 
ratio and exposed to UVB radiation at different doses.  1:3 ratio of co-culture with 3 different 
doses of UVB (10 mJ/cm2, 20 mJ/cm2 and 30 mJ/cm2) showed significant increase in tyrosinase 
activity after exposure when compared to blank (p<0.05) (Figure 78).  
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Figure 78: Tyrosinase activity by L-DOPA assay in melanocyte keratinocyte co-cultures 
(MK2, MK4 and MK6 cell lines) at 1:3 ratio exposed to UVB at 10 mJ/cm2, 20 mJ/cm2 and 30 
mJ/cm2 observed after exposure, on day 5 and day 10 
 
 
Tyrosinase activity by L-DOPA assay was observed in all the cell lines exposed to various 
doses of UVB.  However, a significant difference in L-DOPA activity was observed in MK4 
cell line Vs MK6, MK2 (p<0.0139) in 20 mJ/cm2.  A significant difference was also noticed in 
the MK6 cell line between 10mj Vs 20mj (p<0.0345).  Remaining exposure groups did not 
show any significant difference (P>0.05). 
The samples were analysed in triplicates.  
*, a and b indicate a significant difference in values between the UVB exposure doses for each 
cell line as indicated (P<0.05). 
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4.10.4 Phenotypic marker expression by flow cytometry analysis 
Flow cytometric assay demonstrated the expression of S100, tyrosinase related protein 1 
(TYRP1) and tyrosinase (TYR) markers against FITC (Fluorescein isothiocyanate) staining in 
melanocyte keratinocyte co-cultures (MK2 and MK4 cell lines) at 1:3 ratio after exposure to 
UVB at 10 mJ/cm2, 20 mJ/cm2 and 30 mJ/cm2. Melanocyte-specific marker expression was 
quantitatively examined, and the results indicated that the exposure of UVB slightly enhanced 
the melanocyte markers expression (Figure 79, Figure 80 and Figure 81). In addition, the 
expression of these selected markers was higher in MK2-CC-1:3 cells exposed at 20 mJ/cm2. 
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Figure 79: Representative results of flow cytometry analysis of melanocyte keratinocyte co-
cultures (MK2 and MK4 cell lines) at 1:3 ratio after exposure to UVB at 10 mJ/cm2 
 
 
Melanocyte-specific marker expression was quantitatively examined by acquiring 10,000 
cells per sample. Assay demonstrated the expression of S100, tyrosinase related protein 1 
(TYRP1) and tyrosinase (TYR) markers against FITC (Fluorescein isothiocyanate) staining. 
The blue histograms represent the specific staining, and the red histograms indicate 
background staining of an isotype-matched control antibody. 
The samples were analysed in duplicates. 
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Figure 80: Representative results of flow cytometry analysis of melanocyte keratinocyte co-
cultures (MK2 and MK4 cell lines) at 1:3 ratio after exposure to UVB at 20 mJ/cm2 
 
Melanocyte-specific marker expression was quantitatively examined by acquiring 10,000 cells 
per sample. Assay demonstrated the expression of S100, tyrosinase related protein 1 (TYRP1) 
and tyrosinase (TYR) markers against FITC (Fluorescein isothiocyanate) staining. The blue 
histograms represent the specific staining, and the red histograms indicate background staining 
of an isotype-matched control antibody. 
The samples were analysed in duplicates. 
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Figure 81: Representative results of flow cytometry (PARTEC) analysis of melanocyte 
keratinocyte co-cultures (MK2 and MK4 cell lines) at 1:3 ratio after exposure to UVB at 30 
mJ/cm2 
 
 
Melanocyte-specific marker expression was quantitatively examined by acquiring 10,000 cells 
per sample. Assay demonstrated the expression of S100, tyrosinase related protein 1 (TYRP1) 
and tyrosinase (TYR) markers against FITC (Fluorescein isothiocyanate) staining. 
The blue histograms represent the specific staining to the marker indicated.  
The samples were analysed in duplicates. 
 
 
  
285 
 
4.11 Summary of results 
Split-skin grafting (SSG) and full-thickness grafting (FTG) samples were obtained from 
subjects/patients undergoing routine graft surgery procedures with an informed consent. 
Digestion with collagenase type I and trypsin was employed to obtain epidermal cells by 
explant and suspension culture methods, respectively. Cell morphology, viability, proliferation 
and markers expression were assessed.  Further, the co-culture system of melanocytes and 
keratinocytes at different rations (1:3, 1:5 and 1:10) was established and assessed various 
parameters, such as morphological changes at different days of culture duration, melanin 
content, tyrosinase activity and the expression of selected markers.  Later, the same co-culture 
system of melanocytes and keratinocytes at different ratios were exposed to various 
concentrations of α-MSH (2.5 µg/ml, 5 µg/ml and 10 µg/ml) and examined for their 
morphological characteristics during culture duration along with melanin content assays and 
tyrosinase activity.  Finally, the co-culture system of melanocytes and keratinocytes at different 
ratios were exposed UVB (10 mJ/cm2, 20 mJ/cm2 and 30 mJ/cm2) and the cells were evaluated 
for changes in morphology, melanin content, tyrosinase activity and the expression of selected 
markers. 
 
The primary cultures of melanocytes and keratinocytes from different human skin samples 
were successfully established (n=10) with highly proliferative features. Cells had a typical 
morphology with high viability and could be identified using specific markers, such as 
tyrosinase, S100, TYRP1, TYR, pan-cytokeratin, cytokeratin 10 and filaggrin. Further, the 
maintenance of cell cultures in vitro was carried out by employing cell specific media for 
further analyses. 
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After successfully establishing and culturing melanocytes and keratinocytes, the co-culture 
model was prepared at different ratios, such as 1:3, 1:5 and 1:10. These co-cultures were 
maintained up to 12 days. Morphological features were recorded at different timings and 
showed the higher population of melanocytes at ratios of 1:3 and 1:5. These results were 
supported by the higher synthesis of melanin content as well as the activity of tyrosinase in co-
cultured cells.   
 
The proliferation, melanin content and tyrosinase activity were increased in the co-culture 
model of melanocytes and keratinocytes when supplemented with different concentrations of  
α-MSH (2.5 µg/ml, 5 µg/ml and 10 µg/ml). The dose dependent response was observed in the 
cells with these parameters when compared to untreated controls. 
 
The co-culture system of melanocytes and keratinocytes at different ratios when exposed to 
UVB at levels of 10 mJ/cm2, 20 mJ/cm2 and 30 mJ/cm2 resulted in stimulated effects on 
melanocytes and melanin production. 
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CHAPTER FIVE: DISCUSSION 
 
There is a need for reliable techniques to isolate high quality melanocytes and keratinocytes, 
and expand them under in vitro culture systems to examine co-culture models for treating 
vitiligo subjects.  Therefore, the present study was conducted to isolate and establish primary 
cultures of melanocytes and keratinocytes in vitro with a potential to prepare the appropriate 
skin co-culture model for replenishment.  
 
The theory behind autologous transplantation is that melanocytes were harvested as an 
autologous melanocyte rich cell suspension from a donor split thickness graft. Melanocyte 
culture was performed in selected cases where the melanocyte cell count was insufficient to 
meet the requirement of the recipient area. These cells were then transplanted to the recipient 
area that had been superficially dermabraded. 
 
A limitation of autologous transplantation is that it is unknown if the normal appearing non-
lesional skin of vitiligo patients is in fact normal, therefore we cannot be sure if the melanocytes 
from non-lesional skin of vitiligo patients would in fact be impaired in their ability to produce 
melanin.  Moretti et al. (2006) states that cultured melanocytes (showing an impaired growth) 
can only be obtained from pigmented (non lesional) skin of vitiligo patients and not from 
depigmented (lesional) vitiligo skin.  One paper that investigated this further was Yu et al. 
(2012). 
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The conclusion of Yu et al. (2012) was that markers of heightened immune response were 
found to be upregulated in non-lesional as well as lesional skin of vitiligo patients.  This 
suggests that melanocytes from non-lesional skin of vitiligo patients would in fact have an 
impaired functionality in comparison to those from a normal unaffected individual. 
 
It should definitely be explored further if melanocytes from non lesional skin of vitiligo patients 
have an impaired ability to produce melanin.  However, what must also be taken into 
consideration is the fact that the whole purpose of using autologous melanocytes as a treatment 
is that using cells from the same patient reduces the likelihood of rejection due to immune 
rejection.  If we were to start using cells from a normal donor instead then this fact must be 
remembered. 
 
Split-skin grafting (SSG) and full-thickness grafting (FTG) samples were obtained from 
patients undergoing routine graft surgery procedures with an informed consent. Digestion with 
collagenase type I and trypsin was employed to obtain epidermal cells by explant and 
suspension culture methods, respectively.  The important factors required for establishing in 
vitro culture of melanocytes include the usage of appropriate enzymes and culture conditions.  
In vitro culture of adult human melanocytes was first successfully reported by Nielson and Don 
(1984).  The improvement in the culture system was attempted by the supplementation of 
tumour promoting phorbol ester 12-O-tetradecanoyl phorbol-13-acetate (TPA) (Eisinger and 
Marko, 1982).  TPA was found to enhance the proliferation and attachment of melanocytes 
under in vitro culture.  Moreover, the use of cyclic AMP (cAMP)-inducers, such as cholera 
toxin (CT) and isobutyl-methylxanthine (IBMX), observed to induce a mitogenic effect on 
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melanocytes, could be used to promote melanocyte cell proliferation in cell culture system 
(Eisinger and Marko 1982).   
In the last two decades, the advancements in culture systems, especially by adding the selected 
growth factors in the medium have resulted in the enhanced yield of skin melanocytes.  It has 
been demonstrated that basic fibroblast growth factor (bFGF), nerve growth factor (NGF), and 
endothelin-1 (ET-1) enhance the melanocyte proliferation, tyrosinase activity and dendricity 
(Akio et al. 2004; Tang et al., 2013).  Collectively, it is now established that either TPA or ET-
1 is essential for the successful culture of melanocytes and hence, most of the commercially 
available melanocyte specific media consists of these supplements to support the culture of 
skin melanocytes. 
 
In the present study, M254, a commercially available complete medium manufactured by 
GIBCO-INVITROGEN was employed for the culture of melanocytes after the initial usage of 
MEM-α. M254 medium contains essential and nonessential amino acids, vitamins, other 
organic substances, trace elements and salts to support the cell adherence and proliferation, but 
does not contain antibiotics, antifungal drugs, hormones, growth factors or other proteins. 
While establishing the culture, antibiotics (Penicillin-streptomycin) and antifungal 
(Amphotericin-B) were added to prevent the contamination. M254 medium also contains 
HEPES and bicarbonate buffers to maintain the optimal osmolality. After the initial primary 
culture establishment, supplementation of M254 medium with human melanocyte growth 
supplement (HMGS) is required for maintaining the long-term cultures of melanocytes. HMGS 
contains bovine pituitary extract (BPE), fetal bovine serum (FBS), bovine insulin, bovine 
transferrin, bFGF, hydrocortisone, heparin and phorbol esters, including phorbol 12-myristate 
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13-acetate (PMA), TPA, all of which are required for the growth of melanocytes under in vitro 
culture system (Swope et al. 1995; Tang et al., 2013). 
 
As explained previously, isolated epidermal tissue remnants were pooled in a trypsin/EDTA 
solution and single-cell suspensions were prepared by filtering and pipetting.  Separated cells 
were collected in serum to stop enzymatic action of trypsin.  The pooled epidermal cell 
suspensions were centrifuged at low speed to harvest the cells and resuspended in growth 
medium.  Cell suspensions were placed in tissue culture dishes in growth medium containing 
HMGS.  After 48 hours of seeding cells, the medium was changed and unattached cells were 
removed.  From day 3 onwards till the cells reached confluence, the attachment patterns and 
morphological features of melanocytes with dendritic features were observed regularly during 
their culture expansion.  The cellular properties, such as proliferation ability and viability were 
analysed during their early culture system.  Melanocytes were highly proliferative and did not 
show any noticeable differences in their cell number between the cell lines.  Further, the 
viability values were also >98% at all cell passages (P1 to P6) analysed, and thus indicated 
their healthy status during the in vitro culture expansion. 
 
Establishment of a pure population of melanocyte cultures facilitates the development of 
suitable co-culture models with keratinocytes and helps to study the factors controlling the 
pigmentation process.  In this study, melanocytes derived from normal skin tissues showed 
bipolar structures with circular nucleus, and dendritic features. Similar morphological 
characteristics of melanocytes were observed in earlier studies (Tang et al., 2013; Zhang et al., 
2018).  However, Kumar et al. (2012) recorded some significant differences in the morphology 
of melanocytes between control skin and samples from unstable vitiligo patients.  Melanocytes 
291 
 
from control samples were normal in perinuclear region and size. Whereas melanocytes from 
unstable vitiligo patients showed a bigger perinuclear region and the dendrites of perilesional 
unstable vitiligo patients were small with clubbed ends.  In comparison, the results of the 
present study demonstrated that melanocytes from early passages (P1 to P6) exhibit key 
phenotypic characteristics of normal skin samples and possess relatively higher proliferative 
activity.  
 
Apart from morphological and cellular characteristics, the conformation of melanocytes was 
carried out by melanin synthesis assay, L-DOPA staining and the expression of melanocyte 
specific markers, such as S100, TYRP1 and TYR.  Established melanocytes were stained dark 
after L-DOPA incubation. L-DOPA positive staining confirms the presence of DOPA oxidase 
(tyrosinase) activity in the melanosomes as evidenced by previous reports (Munoz–Munoz et 
al. 2010; Tang eta l., 2013). This parameter is employed to positively identify melanocytes, 
and they are the only DOPA oxidase-positive cells in the cultures. L-DOPA functions as a 
second messenger subsequent to tyrosine hydroxylase activity, promoting the pigmentation 
through co-ordinated action with TYR (Stominski et al., 1988). Further, in melanocytes, L-
DOPA activity enables the activation of TYR in vitro (Shi et al., 2016). In accordance with 
these observations, the results of this study showed strong reactivity in melanocytes, which 
corresponds with the expression of TYR marker in subsequent analysis. 
 
The expressions of melanocyte specific markers, including S100, TYRP1 and TYR were 
analysed to validate that the cells possess functional features of normal melanocytes.  S100 is 
a highly sensitive marker for melanocytes and is widely distributed in cells of neural crest 
origin and tumour cells.  The observation of positive staining using both L-DOPA and S-100 
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proves that the cells established and cultured were indeed melanocytes (Petersson et al. 2009; 
Shi et al., 2016).  TRP1 and TYR are related enzymes expressed in melanocytes and involved 
in melanin synthesis, which can also be employed to identify melanocytes (Tang et al., 2014).  
The expression of TRP1 has been closely related to melanin synthesis and its level of detection 
confirmed the purity and melanogenic capacity of melanocytes at different passages. Similarly, 
high expression of TYR is associated with increased melanin synthesis and its level of 
expression affects melanogenesis (Shi et al., 2016).  Further, TYR catalyzes the rate of 
melanogenesis, and has been functionally correlated with the expression of a pigmented 
phenotype of melanocytes (Yamaguchi and Hearing, 2009). The results of the present study 
with the expression of these markers in established melanocyte cell lines showed that they have 
relatively higher melanogenic activity. 
 
The present study attempted to establish and culture keratinocytes from normal skin tissue 
samples for developing suitable co-culture models with melanocytes.  Previous reports have 
showed that keratinocytes can be cultured based on the traditional feeder-dependent method 
(Rheinwald and Green, 1975) or by other alternative methods using defined serum-free, low-
calcium media, that do not require any feeder cells for cultivation (Tenchini et al., 1992).  The 
current study succeeded in establishing keratinocyte subcultures without using feeder layers.  
Similar to melanocyte cell preparation, the cell suspension obtained after enzymatic digestion 
was filtered through a cell strainer and washed twice in DPBS.  The harvested cells were 
resuspended in defined keratinocyte medium (EpiLife, GIBCO-INVITROGEN) supplemented 
with keratinocyte growth factor (KGF) and epidermal growth factor (EGF), and allowed for 
the establishment of primary culture with the medium being changed every third day.  
Microscopic observations revealed that the confluent keratinocytes formed a pavement-like 
monolayer and most importantly, no fibroblast contamination was observed in the cultures of 
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later passages.  These cells could be sub-cultured to passage 6 without significant loss of 
morphological features.  Established keratinocytes were highly proliferative around one week 
of seeding the cells and maintained their typical morphology. In agreement with these 
observations, isolation of primary keratinocytes was accomplished by enzymatic dissociation 
or with explant culture method using murine and human skin samples (Yano and Okochi, 2005; 
Aasen and Belmonte, 2010; Kumar et al., 2012; Zhang et al., 2017). In comparison with some 
cell types, such as fibroblasts, keratinocytes require more attention and issues such as apoptosis 
in low density and specifically, differentiation and senescence after reaching confluence have 
been observed as more prominent features (Aasen and Belmonte, 2010). However, in this 
study, these characteristics were not noticed, and obtained large numbers of keratinocytes for 
further analysis. Here, the role of EGF supplementation in culture media was evident as its 
positive effects on keratinocyte culture have been previously investigated (Yano and Okochi, 
2005). Although the culture protocol followed in this study employed neither feeder layer nor 
any coating material, the supplementation of KGF and EGF was indispensable for the 
maintenance of keratinocyte cultures. 
 
During the culture expansion of keratinocytes from skin tissues, fibroblast contamination poses 
a common challenge.  Therefore, to determine the purity of the culture expanded keratinocytes, 
markers, such as pan-cytokeratin (PanC), cytokeratin10 (CK10) and filaggrin (FLG) 
expression was analysed by FACS method.  Established keratinocytes at early passages were 
positive for the above markers indicating a high level of cell population in cultures.  With this, 
the morphological analysis of keratinocytes was complemented by marker expression of basal 
cell markers (PanC and CK10) and the terminal differentiation marker, FLG.  Earlier reports 
too demonstrated the expression levels of selected markers in keratinocytes using similar 
techniques (Yano and Okochi, 2005; Alkhilaiwi et al., 2018; Zhang et al., 2018).  Collectively, 
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it is inferred that the keratinocyte cultures were established using a defined media and the 
supplementation of growth factors, such as KGF and EGF. A larger number of keratinocytes 
were obtained with normal morphology and proliferative features. Further, the purity of 
keratinocytes was ascertained by the expression of specific markers, which play a critical role 
in regulating the cellular and biological functions. 
The melanocytes and keratinocytes would be a suitable co-culture model for different 
applications in vitiligo patients. Hence, the co-culture system of melanocytes and keratinocytes 
at different ratios (1:3, 1:5 and 1:10) was established and assessed on various parameters, such 
as morphological changes at different days of culture duration, melanin content, tyrosinase 
activity and the expression of selected markers.  Later, the same co-culture system of 
melanocytes and keratinocytes at different ratios were exposed to various concentrations of α-
MSH (2.5 µg/ml, 5 µg/ml and 10 µg/ml) and examined for their morphological characteristics 
during culture duration along with melanin content assays and tyrosinase activity.  Finally, the 
co-culture system of melanocytes and keratinocytes at different ratios were exposed UVB (10 
mJ/cm2, 20 mJ/cm2 and 30 mJ/cm2) and the cells were evaluated for changes in morphology, 
melanin content, tyrosinase activity and the expression of selected markers. 
 
It is known that melanocytes in epidermis exist in close contact with keratinocytes which are 
shown to affect melanocyte morphology and growth, and hence, the present study developed a 
co-culture system of melanocytes and keratinocytes at different ratios.  In a co-culture system 
of different ratios (melanocytes: keratinocytes of 1:3, 1:5 and 1:10), melanocytes and 
keratinocytes from skin tissue samples were morphologically different, and the number in both 
types of cells varied at different time points of culture as observed on day 3, day 5 and day 12. 
Melanocytes are specialized epidermal cells, originated from the neural crest, with a 
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representation of 2-5% of the epidermal cells in the skin (Cooper and David, 2009).  It has been 
showed that melanocytes, being pigment producing cells, transfer melanin pigment within their 
cytoplasmic melanosomes to surrounding keratinocytes.  Further, their proliferation and 
melanogenic activities are stimulated by keratinocytes, fibroblasts and other regulatory factors 
(Liu et al., 2008; Zhang et al., 2018).  This evidence indicates the existence of some complex 
interactions between melanocytes and keratinocytes through the secretion of a wide variety of 
molecules.  To ascertain this, the melanin content and the tyrosinase activity by L-DOPA 
assays were performed in an established co-culture system. The results demonstrated that there 
was an increase in melanin secretion and also tyrosinase activity in melanocyte keratinocyte 
co-cultures at 1:3 and 1:5 ratios.  An earlier study by Kumar et al. (2012), successfully cultured 
melanocytes and keratinocytes at 1:5 ratio from control and vitiligo patients and after that co-
culture models were prepared.  After treatment of a co-culture model with melanogenic 
stimulator, they recorded increased tyrosinase activity, cell proliferation and melanin content.  
In contrast, after treatment with melanogenic inhibitors, tyrosinase activity, cell proliferation 
and melanin content were decreased. Finally, the study concluded that the use of primary 
melanocytes and keratinocytes is more appropriate over the use of transformed cells for 
assessing the regulators of pigmentation.  In a recent study, the number of melanocytes co-
cultured with keratinocytes in vitro reached the maximum on the 20th day of culture (Zhang et 
al., 2018).  The authors opined that this co-cultured model might contribute to the growth of 
melanocytes which could be employed in the treatment of vitiligo.  These collective facts 
demonstrate the existence of interactions and communicatory links between melanocytes and 
keratinocytes in co-cultures, resulting in modulated secretion of melanin and pigmentation 
process (Decean et al., 2013). 
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The increase in proliferation and migration of melanocytes is expected in mixed melanocyte 
and keratinocyte cultures (Duval et al., 2001; Kim et al., 2012; Zhang et al., 2018). With this 
interactive phenomenon, a study examined the effects of adipose-derived stem cells (ADSCs) 
on in vitro proliferation, differentiation, and migration of melanocytes, and compared with 
those of keratinocytes (Kim et al., 2012).  The data showed that co-culturing with ADSCs 
stimulated both proliferation and migration of melanocytes although this was to a lesser degree 
compared with co-culturing with keratinocytes.  In addition, ADSC co-culturing also increased 
the number of melanocyte precursor cells.  These findings could be used to improve treatments 
of pigmentation disorders associated with the loss of melanocytes (Kim et al., 2012).  
Therefore, applications of co-cultured epidermis cells rather than just melanocytes to treat 
conditions, such as vitiligo have many advantages.  This includes the regulation by 
keratinocytes on the growth and differentiation of the melanocytes (Zhang et al., 2018).  
Further, co-culturing will maintain the normal physiology characteristics of melanocytes, 
which mean melanocytes, could communicate with keratinocytes and dermal fibroblasts by 
secreted factors and cell contacts.  Finally, culturing with keratinocytes is easier than 
melanocytes alone in a short time to obtain an autologous epidermis, and this method may not 
pose any serious adverse effects (Zhang et al., 2018). 
 
Co-culturing of melanocytes with keratinocytes induced enhanced expression of melanocyte 
markers, such as S100, TYRP1 and TYR.  The expression of TYRP1 showed a correlation with 
enhanced melanin content in a co-culture system.  In a study by Kim et al. (2012), migration 
assay showed that co-culturing with ADSCs stimulated the melanocyte migration less than co-
culturing with keratinocytes, although both cell types significantly stimulated migration 
compared with melanocyte monocultures.  The report also demonstrated the expression of N-
cadherin and E-cadherin proteins as they are transmembrane glycoproteins connected to the 
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actin cytoskeleton, and mediate haemophilic adhesion between neighbouring cells.  In addition 
to this, the keratinocyte-derived growth factors, such as NGF, ET-1, and BFGF, promote 
melanocyte migration (Ma et al., 2006; Kim et al., 2012).  However, additional studies are 
warranted to decipher the mechanisms by which mediators affect the melanocyte migration 
and melanogenic functions. 
 
In the present research work, the effect of an important melanogenic stimulator compound, 
such as α-MSH was examined by supplementing different concentrations (2.5 µg/ml, 5 µg/ml 
and 10 µg/ml) on the melanocyte-keratinocyte co-culture system (1:3, 1:5 and 1:10).  The 
results confirmed that proliferation, melanin content and tyrosinase activity based on L-DOPA 
assay increased in dose dependent manner in the established co-culture model. During the 
melanocyte culture, it has been observed that the cell-culture techniques yield heterogeneous 
cell populations and lead to eventual overgrowth by keratinocytes and fibroblasts (Zhang et al., 
2018).  
 
Thus, studies of in vitro characteristics of human melanocytes have been made difficult by the 
presence of contaminating populations of rapidly multiplying cells other than melanocytes. On 
the other hand, biosynthesis of melanin is initiated by multiple stimuli including hormonal 
signaling, UV irradiation and secretion of inflammatory cytokines (D’Mello et al., 2016). 
Particularly, α-MSH released from UV-exposed keratinocytes can stimulate melanin 
biosynthesis in epidermal melanocytes by activating the cAMP-PKA-CREB (cyclic adenosine 
monophosphate-protein kinase A-cAMP response element binding protein) axis (D’Mello et 
al., 2016). In the present study, it has been noticed that α-MSH directly influenced the melanin 
synthesis in a dose dependent manner, and this might have resulted in enhanced tyrosinase 
298 
 
activity that is independent of the transcriptional machinery associated with melanogenesis. 
These results suggest that α-MSH may be a potential component for the management of 
melanocytes and keratinocytes co-culture systems. This is supported by the fact that this 
neuropeptide was primarily known as melanogenic hormone. But, later its immunomodulatory 
role has been discovered and its anti-inflammatory effects have been implicated in the cure of 
many inflammatory conditions (Singh and Mukhopadhyay, 2014). 
 
In the present study, the stimulatory effects of different concentrations of α-MSH were 
examined on the tyrosinase enzyme activity using cellular and cell-free tyrosinase activity 
assays and also based on L-DOPA assay.  Based on the findings of melanocyte proliferation, 
melanin content and tyrosinase activity, the positive effect of α-MSH was demonstrated. 
However, the study did not look into a precise molecular mechanism as to how α-MSH 
enhances tyrosinase activity or melanin synthesis in melanocytes.  This mechanism should be 
further explored to elucidate whether α-MSH directly interacts with tyrosinase and stimulates 
its oxidase activity or whether it has indirect effects that lead to increased tyrosinase activity. 
 
In this study, the established co-culture model of melanocytes and keratinocytes was allowed 
to UVB exposure at different sub-cytotoxic doses, such as 10 mJ/cm2, 20 mJ/cm2 and 30 
mJ/cm2.  Later, the exposed cells were cultured for 10 days and assessed for any changes in 
cellular and biological characteristics.  The treatment resulted in features of enhanced number 
of melanocytes accompanied by hyperpigmentation as evidenced by enhanced melanin 
content. Additionally, increased tyrosinase activity was recorded by L-DOPA assay following 
UVB exposure.  Further, the expression of markers, such as S100, TYRP1 and TYR was 
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considerably enhanced in melanocyte and keratinocyte co-culture of 1:3 ratio after UVB 
exposure to 20 mJ/cm2. 
 
It is well established that, upon exposure to UV-radiation, melanin produced by epidermal 
melanocytes is transferred to neighbouring keratinocytes and thus, permitting their absorption 
of UV-radiation to protect the cells from UVR-induced damage (Lin and Fisher, 2007).  With 
this, it displays the role of photoprotection and thermoregulation activity. Under in vitro 
conditions, the epidermal melanin unit could be established as a co-culture system or as in 
tissue-engineered epidermis.  These models are constructed to resemble the anatomical 
structure of human epidermis including the interaction between melanocytes and keratinocytes 
that ultimately results in macroscopically visible alterations.  This pigmented reconstructed 
human epidermis may be employed as an alternative to animal model testing in cosmetic, 
pharmaceutical and medical research. However, no study has demonstrated yet a direct 
quantitative correlation between melanin content and the capacity to withstand natural UV-
radiation under in vitro conditions. In a recent report by Choi et al. (2018), human epidermal 
melanocytes were exposed twice with 20 mJ/cm2 UVB over a 24 hrs interval and subsequently 
cultivated for 2 weeks. The exposure induced melanocyte senescence, and senescent 
melanocytes were accompanied hyperpigmentation through the prolonged p53 expression. 
This study primarily examined the long-term effects of UV-radiation exposure in human 
epidermal melanocytes, the subsequent phenomena and key mediators of this process. 
 
A distinct melanogenic response to UV exposure by human melanocytes in monoculture, in 
co-culture with keratinocytes and in reconstructed epidermis was documented (Duval et al., 
2001).  The study concluded that keratinocytes play an important role in mediating UVB-
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induced pigmentation, but do not seem to be involved in the process of UVA stimulated 
pigmentation.  This research further suggested that reconstructed pigmented epidermis is the 
most appropriate model to study UV-induced pigmentation under in vitro conditions.  Thus, 
there is an increasing interest to study these processes in a standardized co-culture model of 
melanocytes and keratinocytes that mimics the in vivo situation as closely as possible. 
Moreover, melanin is detectable within the cytoplasm of keratinocytes and hence, a functional 
epidermal melanin unit, can be created in this model (Schmid et al., 2018). 
 
In the current study, the effect of upper dose of UVB exposure at 30 mJ/cm2 was noticeable in 
melanocytes and keratinocytes co-cultured at 1:3 ratios.  Importantly, the reduction in the 
number of both the cells was observed at a dose of 30 mJ/cm2.  These observations indicate 
that doses of 10 mJ/cm2 and 20 mJ/cm2 might allow desirable cellular reactions in both 
melanocytes and keratinocytes, but higher UVB exposure might result in unfavourable 
changes, such as immediate cell death.  These findings are in accordance with previous studies 
that indicated a connection between the functional properties of melanin unit and keratinocyte 
properties after UVB exposure (Duval et al., 2001; Choi et al. 2018; Schmid et al., 2018).  
 
To summarize, the successful isolation and culture expansion of melanocytes and keratinocytes 
separately will enable trying out various ratios of these cells in a different medium as a co-
culture method for potential therapy in vitiligo patients. Based on the findings, it is drawn the 
conclusion that the positive rate of melanocytes co-cultured with keratinocytes in vitro reached 
the maximum on the 12th  day, and this co-culture model may be capable of being used in the 
treatment of vitiligo patients. 
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CHAPTER SIX: CONCLUSION 
6.1 Scientific outcomes of my doctoral work 
6.1.1 Developing a method to prepare skin tissue 
A major revelation from my experimental work before the skin was processed in any way was 
just how susceptible the skin samples were to contamination.  Although sorting this problem 
might seem relatively trivial it would actually be accurate to describe it as a rate limiting step 
and solving it completely was actually more complex than might originally be thought.  When 
samples were initially received from the patient some were lost to contamination before any 
experimental work had begun and it seems that the location of the skin being on the surface of 
the body makes it particularly vulnerable.  In summary it was found that the ideal way to reduce 
infection was to immediately place the sample, following extraction, into medium (DMEM or 
DPBS) containing penicillin, streptomycin and fungizone.  Once the sample was received in 
the lab it was washed in 10ml of DPBS and disinfected with 10-30ml of 75% medical alcohol 
for 30 sec followed by washing with 30ml DPBS three times.   
 
The effects of using different enzymes and digestion times to isolate cells from the skin sample 
was investigated and the best options were found to be to either perform a short incubation 
with enzyme at the warmer temperature of 370C for about 4 hours or a longer overnight 
incubation at 40C. The ideal isolation of cells from the skin sample occurred when a 
combination of enzymes was used.  The preferred method to isolate cells from the skin sample 
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was found to be to first separate the epidermis from the dermis by placing the skin in 0.25% 
trypsin-EDTA followed by incubation in 0.1% collagenase to isolate the cells from this.  
 
In conclusion as a result of my doctoral work an optimised procedure was developed for the 
isolation of melanocytes and keratinocytes from skin samples and the establishment of their 
subsequent monocultures.  Cells isolated from skin are a mixed population of melanocytes, 
keratinocytes and fibroblasts and the population was encouraged to being of either a 
melanocyte or keratinocyte lineage by transferring the mixed culture, once established, to a cell 
specific medium that supported the growth of either melanocytes or keratinocytes.   
 
6.1.2 Isolation and characterisation of melanocytes based on their cellular, biological 
and phenotypic properties. 
Established melanocytes were characterized based on their proliferation potential, viability, 
melanin content, tyrosinase activity and the expression of selected melanocyte markers. All the 
melanocytes exhibited a proliferation potential that was initially slow but later occurred at 
higher rates whilst cell viability was consistently more than 90% amongst all cell lines.  
Melanocytes can be distinguished morphologically from other cells by their bipolar or 
polydendritic features.  Melanin levels in the melanocyte cells were measured via ELISA 
reader at absorbance 405nm and compared to blank and dermal fibroblasts, used as controls, 
which confirmed the production of melanin during the culture expansion period.   An L-DOPA 
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assay confirmed tyrosinase (enzyme of melanin synthesis) activity and these both gave a 
positive result in comparison to the controls at an absorbance of 470nm.  The positive dark 
brown staining of cells by L-DOPA and their ability to be bleached in the melanin bleach assay 
also confirmed these cells were melanocytes.  A positive result for expression of melanocyte 
specific markers S100, TYRP1 and TYR used via flow cytometry also identified that the cells 
in culture were melanocytes. 
 
6.1.3 Isolation and characterisation of keratinocytes based on their cellular and 
phenotypic features 
Morphologically keratinocytes in monoculture formed a pavement like monolayer/cells had a 
round polygonal shape.  Established keratinocytes were highly proliferative and they exhibited 
high levels of viability in culture.  Flow cytometry using the keratinocyte specific markers 
PanC, CK10 and FLG also confirmed keratinocyte presence. 
 
6.1.4 Establishment and examination of co-culture methods for melanocytes and 
keratinocytes in different culture conditions 
For the co-culture of melanocytes with keratinocytes the melanocyte to keratinocyte seeding 
densities of 1:3, 1:5 and 1:10 were used so that the growth of both cell types could be supported 
at the same time.  Measuring absorbance in the co-cultures at 405nm using an ELISA reader 
showed that the best results for melanin content was at seeding ratios of 1:3 and 1:5, there was 
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not much difference in outcomes between them but both showed markedly superior results to 
culturing at 1:10.  This result was confirmed by measuring L-DOPA via absorbance at 470nm.  
Presence of melanocytes was further confirmed using cell specific markers via flow cytometry 
in the 1:3 co-culture ratio. 
 
6.1.5 Manipulation of culture conditions with alpha-melanocyte-stimulating hormone 
An attempt was made to manipulate the melanin content in all three different co-culture ratios 
by exposing them to α-MSH at three different concentrations (2.5, 5 and 10 µg/mL).  
Proliferation, melanin content and tyrosinase activity were increased in co-culture upon 
supplementation with α-MSH.  Exposing melanocytes to α-MSH in increasing concentrations 
stimulated melanin production in these cells in a dose dependent manner. 
 
6.1.6 Manipulation of culture conditions with UV light 
The effect of UV light as a stimulator of melanin production in melanocytes was observed and 
cells in all three co-culture ratios were exposed to UVB at 10mJ/cm2, 20mJ/cm2 and 30mJ/cm2.  
The results of doing this confirmed that exposing the cells in co-culture to all three 
concentrations of UVB did have a stimulatory effect on melanocytes and melanin production 
in cells regardless of the seeding ratio. 
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6.2 Contribution of my work to future research 
As an in vitro study my doctoral work has provided a vital first step towards the development 
of a treatment for vitiligo vulgaris.  The aim of my doctoral study is that the outcomes of this 
serve to provide us with the ability to accurately estimate the actual number of participants 
required for a much larger full-scale study to obtain results that are statistically significant.  
Any scientific investigation requires that enough participants are recruited so that precise 
statistical analysis can be done.  The aim of conducting a pilot study such as mine is if it can 
be used to design further work then significant results can be generated without the need for 
repetition of experiments and the consequent requirement for in this case the use of a more than 
necessary number of animals for in vivo work.  Studies are usually undertaken in vitro first for 
ethical reasons since in vitro studies allow a potential treatment to be studied safely, without 
subjecting humans or animals to the possible side effects or toxicity of a new treatment.  After 
the in vitro stage of development has been completed it is usually the case that this is followed 
by in vivo experimentation in animals (normally mammals such as mice) before any human 
clinical trials are performed.  Non-animal techniques such as the one I developed in my doctoral 
work do obviously have inherent limitations however they are extremely useful for preliminary 
work before the necessary animal testing stage, of treatment development, however 
unfortunately one of the main disadvantages of using in vitro tests is that they can produce false 
or unreliable results with regards to applying these findings to an in vivo setting.   
 
6.3 Future directions 
6.3.1 The use of exosome technology as an improvement to the co-culture method 
The use of co-culture systems is invaluable in molecular biology for investigating the 
interactions that occur between different cell populations.  At its most simplistic level a co-
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culture can be described as a setup where two or more different cell populations are grown with 
an element of contact between them.  However, co-culture systems are not without their 
limitations and there is a requirement for the development of other methods to study cell 
interactions outside of the co-culture system.  One major disadvantage of the co-culture system 
is that it is seriously limited with regards to system complexity.  As far as high complexity 
systems are concerned these are often few and far between for reasons including that using 
multiple cell populations seriously complicates the procedure.  This can be attributed to the 
fact that studying the interactions of any more than three populations at a time can lead to a 
complexity that is difficult to manage with regards to how they interact.  Another disadvantage 
of using co-culture media is that creation of a media that is suitable for supporting the growth 
of multiple cell types at once can be extremely time consuming, requires a great deal of 
technical skill and can be very expensive.   
 
An alternative to co-culture media that has been proposed is the development of a synthetic 
media that has a ‘co-culture affect.’  A suggestion for how this can be done is to completely 
step away from the concept of growing two cell types in the same media at the same time.  
Instead it has been suggested that a much simpler option would be to grow the two (or multiple) 
cell types in their own specific media.  At its essence a co-culture media was thought to be 
important because when cells are grown together, they secrete factors that can impact the 
growth of neighbouring cell types.  A possible useful extension to this project and alternative 
to co-culture could be to grow cells individually in their own specific media and then isolate 
the important influencing factors that they secrete during their growth (e.g. exosomes) directly 
from the media.  Once these secreted factors have been isolated from the media they can be 
added to the specific media/culture for the cell type we want to investigate that it is believed to 
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be influencing, thus removing the entire need for developing a co-culture media and what could 
be a complex protocol for enabling the growth of multiple cells types at once. 
 
The scientific theory behind developing a media with a ‘co-culture’ effect starts with the fact 
that extracellular vesicles, specifically exosomes, have a significant function with regards to 
enabling communication between various types of cells.  The human body is obviously not 
composed of cells existing in isolation but rather it is made up of many different cell types 
existing and communicating with each other, all contributing to the in vivo system.  Until 
recently it was thought that intercellular communication occurred via direct interactions and 
soluble molecules such as cytokines that are secreted by cells.  However, more recent studies 
have identified that extracellular vesicles are important for communication between cells.  
Extracellular vesicles such as exosomes were once viewed as cellular waste but as of 
2006/2007 it was discovered that exosomes contain microRNA (miRNA) and RNA 
highlighting that they have the capability for transmitting genetic information between cells 
(Shimasaki et al., 2018). 
 
The procedure behind a media enriched with exosomes would be loosely: 
Step 1, Grow cell type A as normal in its specific media 
Step 2, Expose cell type A to growth inhibiting or secreting factors e.g., UV light, MSH 
Step 3, Extract exosomes from this media (the standard extraction method is ultracentrifugation 
of the media with exosomes existing in the resulting pellet) 
Step 4, Administer the isolated exosomes to cell type B, growing in their specific media 
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Step 5, Analyse the effect of exosomes on the growth of cells growing in exosome enriched 
media. 
 
A 2018 study (Shimasaki et al., 2018) found that as of this date the number of papers published 
on the topic of exosomes and co-culture research totalled less than 180 but the number of 
publications has shown a dramatic increase in present times.  Both exosome administration and 
co-culture analysis are techniques that can be used for studying cell interactions and the use of 
each has their own advantages and disadvantages.  With exosome administration it is possible 
to study the effect of the exosomes on cells and the results are reasonably simple to interpret 
however cell interactions are not observed and the results might be artificial.  With co-culture 
on the other hand it is possible to study the natural effect of cells on each other, there is no need 
to extract exosomes and the exchange, manufacture and secretion of exosomes can be evaluated 
by exosome surface marker with a fluorescent dye however the setback of this is that the results 
are not so simple to analyse. 
 
6.3.2 Three dimensional skin models 
However useful a two-dimensional melanocyte keratinocyte cell co-culture model might be, it 
is still limited in its ability to recapitulate the cellular complexity of human skin.  Currently 
most cell-based studies are composed of the traditional set up of a 2D monolayer of cells that 
are grown on a substrate that is flat or rigid and whilst this was a useful arrangement for cell 
work the limitations of it are becoming increasingly acknowledged.  In the in vivo situation 
cells are found surrounded by many other types and as such three-dimensional skin equivalents 
provide a much better representation of the complex architecture that is the human skin tissue.  
Current three-dimensional models consist of keratinocytes that are cultured on a dermal 
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substitute but with the work conducted with my melanocyte keratinocyte co-culture system 
there is a hope that there is much scope for the improvement of current skin models to make 
scientific systems that are a much more realistic representation of the system that exists in the 
human body.  A result of this is that 3D skin models provide a much better scientific model 
than a two-dimensional cell culture model does and as such the creation of three-dimensional 
skin models would be a useful extension to my doctoral work.   It can even be inferred that due 
to their lack of complexity the outcomes of tests using 2D cultures are not completely reliable 
and are a misleading representation of the in vivo response.   (Edmondson et al., 2014). 
 
The two most commonly used types of 3D cell culture models are 3D spheroids and cells that 
are embedded into a 3D matrix.  The principle behind cellular spheroids is that they are formed 
by aggregations of cell-cell adhesion when interactions at the cell-surface are interrupted.  
Spheroids can be a preferable alternative to artificial skin and animal models which can be 
comparatively more expensive and time consuming (Chung et al., 2019).  Multicellular 
spheroids have even been used in the treatment of vitiligo where they have been transplanted 
into the dermabraded skin lesions of vitiligo skin and repigmentation of the skin occurs when 
cells migrate from the transplanted spheroids.  The use of spheroids is preferable over cell 
suspension for several reasons such as during the preparation of cell suspension melanocytes 
are easily damaged and they are subject to apoptosis when maintained in suspension medium 
(Hsiao and Young, 2019).   
 
The creation of accurate three-dimensional models is so important for several reasons which 
include that the regulatory restrictions regarding the use of animal testing are getting 
increasingly stricter, with the use of animal testing for cosmetic being completely banned by 
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the European Union in 2013, whilst almost important to consider is that the availability of 
excised human skin is limited.  Therefore, such models are crucial as a tool to reliably assess 
the safety and functionality of new cosmetic products with reliable skin models also being 
important in medical research and to the pharmaceutical industry where they can be used to 
evaluate drug formulations. These models give results that can be reproduced and are often 
translated to humans, reducing the reliance on animals whilst at the same time they give a 
fundamental insight into the cellular interactions that happen within tissue-like structures.  
Unfortunately at present the cost and technical requirements, such as a lack of standardisation 
of composition and construction, of multicellular human skin models are presenting as major 
limitations for their industrial use. 
 
6.3.3 Further melanocyte/keratinocyte proliferation stimulating factors 
A thorough literature search has identified basic fibroblast growth factor (bFGF) as being vital 
to the proliferation and survival of human melanocytes in pure culture.  I did not investigate 
the use of this in my doctoral thesis however if my study was to be extended in the future the 
results of my literature search suggest that it would be useful to investigate how bFGF impacts 
melanocyte growth. A study published as early as 1988 (Halaban et al., 1998) identified that 
the presence of basic fibroblast growth factor is crucial to the survival and proliferation of 
human melanocytes and without it the cells die.   
 
When melanocytes are cultured with keratinocytes without the addition of bFGF the cells can 
survive for several weeks suggesting that this growth factor is in fact produced by human 
keratinocytes.  The release of bFGF is thought to be as a result of the stimulation of 
keratinocytes by UVB (Lee et al., 2017) and since UVB was one of the growth factors that was 
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investigated in my doctoral work studying bFGF directly would be the next logical step.  Other 
factors that are secreted by UV-B exposed keratinocytes and could be investigated in future 
studies include: nitric oxide, interleukin-1, interleukin-6, tumour necrosis factor, granulocyte 
macrophage colony stimulating factor (GM-CSF), endothelin-1, alpha- melanocyte 
stimulating hormone (this has already been investigated) and stem cell factor (Lee et al., 
2017).    Agents that could be investigated for inhibiting the functions of melanocytes are: 
Arbutin, Kojic acid and Niacinamide. 
 
6.3.4 Using different cell types for co-culture 
A worthwhile future study would be to compare if alternative cell types to keratinocytes can 
be used in melanocyte co-culture to support their growth.  Studies have already been conducted 
where adipose cells have been used in melanocyte co-culture instead of keratinocytes.  An 
advantage of using adipose cells is that for experimental work the cells are easy to isolate and 
culture from adipose tissue that can be obtained by liposuction from a small incision.  This is 
in comparison to using keratinocytes where there is a need to take a large amount of skin, the 
by-product of doing so is often scarring (Kim et al., 2012).  Therefore a balance must be 
obtained when considering cell types for co-culture between practicality and the quality of 
outcomes that are achieved. 
 
6.4 Personal reflections on completing my PhD 
The aim of my doctoral work was to successfully answer a research question and three research 
objectives which has been done.  My work has raised several future research questions and this 
study has contributed towards future research.  My study has also contributed new knowledge 
in the fields of cell co-culture, co-culture manipulation, in vitro cell technologies, vitiligo 
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research and aims to assist with the development of three-dimensional skin models for 
scientific testing in the future. 
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CHAPTER EIGHT: APPENDICES 
 
Appendix 1 Research ethics approval – England 
 
London - City & East Research Ethics Committee 
Bristol Research Ethics 
Committee Centre 
WhitefriarsLevel 3,Block 
B Lewins Mead 
Bristol 
BS1 2NT 
Telephone: (020) 71048033 
 
Please note: This is the favourable opinion of the REC only and does not allow you to start your study at 
NHS sites in England until you receive HRA Approval. 
 
05 August 2016 
Miss N Shetty 
295 Hempstead Road 
Hempstead 
Kent ME73QJ 
 
Dear Miss Shetty 
Study title: Developing methods of measuring and manipulating 
melanocyte/keratinocyte ratios to inform potential treatment 
of vitiligo vulgaris. 
REC reference: 16/LO/1395 
IRAS project ID: 206446 
Thank you for your letter of 4 August 2016, responding to the Proportionate Review 
Sub-Committee’s request for changes to the documentation for the above study. 
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The revised documentation has been reviewed and approved by the sub-committee. 
 
We plan to publish your research summary wording for the above study on the HRA website, 
together with your contact details. Publication will be no earlier than three months from the date of 
this favourable opinion letter.  The expectation is that this information will be published for all 
studies that receive an ethical opinion but should you wish to provide a substitute contact point, wish 
to make a request to defer, or require further information, please contact the REC Manager Mr Raj 
Khullar, nrescommittee.london-cityandeast@nhs.net. Under very limited circumstances (e.g. for 
student research which has received an unfavourable opinion), it may be possible to grant an 
exemption to the publication of the study. 
 
Confirmation of ethical opinion 
 
On behalf of the Committee, I am pleased to confirm a favourable ethical opinion for the above research on 
the basis described in the application form, protocol and supporting documentation as revised. 
Management permission must be obtained from each host organisation prior to the start of the  
study at the site concerned. 
Management permission should be sought from all NHS organisations involved in the study in accordance 
with NHS research governance arrangements. Each NHS organisation must confirm through the signing of 
agreements and/or other documents that it has given permission for the research to proceed (except where 
explicitly specified otherwise). 
Guidance on applying for HRA Approval (England)/ NHS permission for research is available in the 
Integrated Research Application System, www.hra.nhs.uk or at http://www.rdforum.nhs.uk. 
Where a NHS organisation’s role in the study is limited to identifying and referring potential participants to 
research sites (“participant identification centre”), guidance should be sought from the R&D office on the 
information it requires to give permission for this activity. 
For non-NHS sites, site management permission should be obtained in accordance with the procedures 
of the relevant host organisation. 
Sponsors are not required to notify the Committee of management permissions from host 
organisations. 
Registration of Clinical Trials 
All clinical trials (defined as the first four categories on the IRAS filter page) must be registered on a publically 
accessible database. This should be before the first participant is recruited but no later than 6 weeks after 
recruitment of the first participant. 
 
There is no requirement to separately notify the REC but you should do so at the earliest opportunity e.g. 
when submitting an amendment.  We will audit the registration details as part of the annual progress reporting 
process. 
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To ensure transparency in research, we strongly recommend that all research is registered but for non-clinical 
trials this is not currently mandatory. 
 
If a sponsor wishes to request a deferral for study registration within the required timeframe, they should 
contact hra.studyregistration@nhs.net. The expectation is that all clinical trials will be registered, however, in 
exceptional circumstances non registration may be permissible with prior agreement from the HRA. Guidance 
on where to register is provided on the HRA website. 
 
It is the responsibility of the sponsor to ensure that all the conditions are complied with before the 
start of the study or its initiation at a particular site (as applicable). 
Ethical review of research sites 
The favourable opinion applies to all NHS sites taking part in the study, subject to management 
permission being obtained from the NHS/HSC R&D office prior to the start of the study (see 
“Conditions of the favourable opinion” above). 
 
Approved documents 
The documents reviewed and approved by the Committee are: 
Document Version Date 
Covering letter on headed paper [IRAS Covering Letter Neha 
Shetty 
12.07.2016] 
1 12 July 2016 
Evidence of Sponsor insurance or indemnity (non NHS 
Sponsors only) [2016-17 PI TWIMC Letter Neha Shetty 
12.07.2016] 
1 12 July 2016 
GP/consultant information sheets or letters [Consultant 
Information 
Letter Neha Shetty 12.07.2016] 
1 12 July 2016 
IRAS Application Form [IRAS_Form_04082016]  04 August 2016 
342 
 
IRAS Application Form XML file [IRAS_Form_04082016]  04 August 2016 
IRAS Checklist XML [Checklist_04082016]  04 August 2016 
Letter from sponsor [Sponsor Letter Neha Shetty] 1 12 July 2016 
Other [Email from Neha Shetty ]  12 July 2016 
Other [RESEARCH STUDY PROTOCOL02.08.16final] 2 02 August 2016 
Other [IRAS cover letter v2030816] 2 03 August 2016 
Other [Patientinfosheetwithcomments] 1 04 August 2016 
Other [patientconsentformtrackchanges] 1 04 August 2016 
Participant consent form [Participant Consent Form Neha Shetty 
02.08.2016final] 
2 02 August 2016 
Participant information sheet (PIS) [Participant Information Sheet 
Neha Shetty 12.07.2016] 
2 02 August 2016 
Referee's report or other scientific critique report [Referee Report 
Neha Shetty 12.07.2016] 
1 12 July 2016 
Research protocol or project proposal [Research Study Proposal 
FINAL Neha Shetty 12.07.2016] 
1 12 July 2016 
Summary CV for Chief Investigator (CI) [CV for Neha Shetty 
12.07.2016] 
1 12 July 2016 
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Summary CV for student [2nd Research Supervisor CV Prof Kim 
for 
Neha Shetty 12.07.2016] 
2 03 August 2016 
Summary CV for supervisor (student research) [Dr. S. Plummer 
CV 
2016 re Neha Shetty ] 
1 12 July 2016 
Statement of compliance 
The Committee is constituted in accordance with the Governance Arrangements for Research Ethics 
Committees and complies fully with the Standard Operating Procedures for Research Ethics Committees in 
the UK. 
 
After ethical review 
Reporting requirements 
The attached document “After ethical review – guidance for researchers” gives detailed guidance 
on reporting requirements for studies with a favourable opinion, including: 
∙  Notifying substantial amendments 
∙  Adding new sites and investigators 
∙  Notification of serious breaches of the protocol 
∙  Progress and safety reports 
∙  Notifying the end of the study 
 
The HRA website also provides guidance on these topics, which is updated in the light of changes in reporting 
requirements or procedures. 
 
Feedback 
 
You are invited to give your view of the service that you have received from the National Research Ethics 
Service and the application procedure.  If you wish to make your views known please use the feedback form 
available on the HRA website: 
http://www.hra.nhs.uk/about-the-hra/governance/quality-assurance 
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We are pleased to welcome researchers and R & D staff at our NRES committee members’ 
training days – see details at http://www.hra.nhs.uk/hra-training/
 
 
16/LO/1395 Please quote this number on all correspondence 
 
With the Committee’s best wishes for the success of this project. Yours 
sincerely  
PP Dr John Keen 
Chair 
Email: nrescommittee.london-cityandeast@nhs.net 
Enclosures: “After ethical review – guidance for researchers” 
 
Copy to: Miss Neha Shetty 
 
 
 
 
345 
 
Appendix 2 Research ethics approval – India 
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Appendix 3 Consultant information letter 
 
Mr M. Jones 
Consultant plastic surgeon 
Spire Alexandra Hospital 
Impton Lane 
Walderslade 
Kent 
ME5 9PG 
 
Dear Mr. Jones 
Re: Research study 
 
I am undertaking a research study for a PhD.  The title of my study is: “Developing methods of measuring and 
manipulating melanocyte/keratinocyte ratios to inform potential treatments of Vitiligo Vulgaris.”  In this study I 
will be isolating cells from skin that is surplus to cosmetic procedures.  This skin will be harvested and cells 
cultured.  The purpose of my study is to culture cells from skin and manipulate them.  The research questions that 
I will be attempting to address are: 
 
1) Can a new method be created that will be reliable and reproducible for measuring ratios of different cell types 
during standard cell culture process using image processing. 
 
2) Can ratios of cell populations in in vitro co-culture can be altered using environmental, biochemical or physical 
methods.   
 
Patients who can be included in this study will be: 
All patients who: 
1. are undergoing surgery which will result in discarded skin that would normally be destroyed  
       in routine practice of procedure 
2. have agreed to take part - have capacity to give consent 
3.    are between 18-60 years’ old 
 
Patients who are excluded in this study will be: 
All patients who: 
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1. are aged less than 18 years old and who are aged above 60 
2. do not agree to take part in the study 
3. do not have the capacity to give informed consent. 
4. do not speak & understand fluent English 
 
I would like to ask if you would agree to allow me to have surplus skin from the patients who consent to take part 
in this study so that I can use it as part of my research.  If you do agree I would be extremely grateful.   
 
When a patient who meets the above inclusion criteria attends your clinic would you please tell them that a study 
is being undertaken involving growing skin cells and that excess skin from their forthcoming surgery may be 
helpful in this study.  Please could you give them an information pack which I will provide you with.  This 
information pack consists of a patient information leaflet and three copies of a consent form.   It is necessary that 
the patient takes the information pack home with them so that they have time to consider whether they wish to 
take part.  It is important that no pressure is put on the patient to agree to take part.   In the information pack, the 
patient is asked to  return two signed copies of the consent form in the stamped addressed envelope that 
is also included in the pack.  The envelope is addressed to you at the Spire Alexandra Hospital.  Please would you 
put the two consent forms into the patient’s notes.  The patient will keep the third copy of the consent form for 
themselves. 
  
I will provide you with transport medium and container. I will also provide your secretary with specimen form 
stickers to put into the patient’s notes.  Each sample will be given a unique reference number which will be written 
on the stickers.   After the patient’s surgery, whilst in theatre, please can you then complete the stickers with the 
information requested.  Please put one sticker on the transport tube and one sticker on each of the two copies of 
the consent form.  Please can you place these consent forms into the patient’s notes.  When I collect the skin 
sample I will also take one of the patient’s consent forms with me in order that it can be kept in the study notes 
within locked cabinets in the University’s secure laboratory.  The Data Protection Act of 1998 will be followed.   
 
It might be the case that the patient wants to ask more questions about the study.  In this instance the patient has 
been asked to contact you. If you need any further information, please let me know. 
 
Thank you for taking the time to read this letter and your cooperation would be highly appreciated. 
 
Best wishes, 
Neha Shetty   
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Appendix 4 Consent form – England 
                               Unique Patient Identification No:  …….. 
 
Faculty of Health and Wellbeing 
Institute of Medical Sciences 
CONSENT FORM FOR PARTICIPATION IN RESEARCH STUDY : “DEVELOPING METHODS 
OF MEASURING AND MANIPULATING MELANOCYTE/KERATINOCYTE RATIOS TO 
INFORM POTENTIAL TREATMENT OF VITILIGO VULGARIS”. 
In the operation you will shortly have, some skin tissue will be removed. Normally this would be thrown away. 
Scientists and surgeons at Canterbury Christ Church University (CCCU) may be able to use this skin to develop 
new techniques which will be used to help us to understand how best to potentially treat a skin condition called 
Vitiligo Vulgaris. 
1. We are asking for your permission to take a small sample – no more than 2 square centimetres (3.4 of 
an inch) of this surplus skin after your operation and use it for research purposes. 
2. No additional skin will be taken during the operation other than that required as part of your routine 
surgery. 
3. The skin will only be used for this research project which has been ethically approved by a Research 
Ethics Committee. 
4. The skin will be destroyed after use in this study. 
5. The skin will not be subject to any diagnostic testing. 
6. The skin will not be used for the treatment of any patients.  It is for laboratory based research only. 
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7. Your skin sample will be given a unique identification number to make it anonymous during this 
research 
8. To comply with the Human Tissue Act (2004) to ensure all donated human tissues are used only for 
the purposes for which consent was given, a secure record will link your identity with the anonymous 
identification number. This will be made prior to the sample being used for research and will be 
identified thereafter by only the code number. 
9. After being used, any remaining skin will be disposed of in a dignified manner in accordance with the 
University policy for the disposal of human tissue which is informed by the Human Tissue Act 
(2004) 
10. If you do not wish to take part in this study and donate your surplus skin, this will not affect your 
current or future treatment in any way. 
11. If you are willing to donate your surplus skin, please tick the “Agree” box below. 
12. If you are not sure, please discuss with your Consultant. 
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Faculty of Health and Wellbeing 
            Institute of Medical Sciences  
     CONSENT FORM 
Centre Number:                                                                               Study Number: 
Participant Identification Number for this trial: 
Title of Project: “DEVELOPING METHODS OF MEASURING AND MANIPULATING 
MELANOCYTE/KERATINOCYTE RATIOS TO INFORM POTENTIAL TREATMENT OF 
VITILIGO VULGARIS”.  
Name of Researcher: Miss Neha Ananthram Shetty 
  Please  initial        
1. I confirm that I have read the information sheet dated.......02/08/16............. (version....3........) for the above 
study. I have had the opportunity to consider the information, ask questions and have had these answered 
satisfactorily.  
2. I understand that my participation is voluntary and that I am free to withdraw without giving any reason, 
without my medical care or legal rights being affected. 
3. I agree to take part in the above study. 
Name of Participant  Date    Signature 
            
Name of Person taking consent Date    Signature 
_____________________  _____________________  _____________________               
Please sign each of the three copies.  Please keep one for yourself and return the other two to your Consultant in the stamped 
addressed envelope     provided.Version 3 02.08.2016 
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Appendix 5 Patient information leaflet 
 
Faculty of Health and Wellbeing  
Institute of Medical Sciences  
Can you help us in our skin research?  
Patient Information Leaflet 
Dear Sir/Madam,   
 
We would like to invite you to take part in a research study that is being undertaken at Canterbury Christ Church 
University.   This research study is an educational project for a PhD which is an advanced higher degree.  
 Purpose of study  
The purpose of this study is to look at different ways of growing skin cells so that we can contribute to the current 
information about a skin disorder called Vitiligo Vulgaris.  We hope that the results of this research study will 
help us and our colleagues around the world to have more understanding on how to potentially treat this distressing 
condition.   
Vitiligo Vulgaris is a condition where pale white patches develop on the skin. It is due to a lack of colour (pigment) 
in the affected areas of skin. Vitiligo does not make someone feel ill, but the appearance of the white patches of 
skin can be very distressing and embarrassing. This is particularly so for darker-skinned people where white 
patches are noticeable.  
Our Research  
 In order to study different ways of growing skin cells we need to have small samples of human skin so that we 
can remove the pigment cells and work on them in our laboratory.  When someone has a routine cosmetic 
procedure that involves removing part of their skin, this excess skin is disposed of at the end of the operation by 
the hospital.  With your permission, we would like to take a small part of this skin which will be no more than 2 
square centimetres (3/4 of an inch).  We would only take a sample from skin that would normally be disposed of.     
Do I have to take part?  
 No, you don’t have to take part.  Participation is voluntary and if you choose not to take part this will not affect 
your current or future treatment and care in any way.   
   
Why have I been chosen?  
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You have been approached for this study because you are going to have routine surgery that involves removing 
part of your skin.  At the end of your operation, this excess skin would normally be discarded. Please be assured 
that you have not been chosen for this study because we are concerned that you might have vitiligo.  By taking 
part in this study we are not confirming that you may or might have vitiligo.  You have been selected purely 
randomly.  
What do I have to do?  
 You do not have to do anything.  Your operation would not be altered at all.    
 What are the potential benefits of taking part?  
 You will be providing us with skin cells which we can use to undertake scientific research on.  Ultimately you 
will be contributing to research which will aid in potentially developing treatment of Vitiligo Vulgaris.  
 Will my participation in this study be kept confidential?  
Yes.  The only people that will know of your involvement are yourself and your Consultant.  The skin sample that 
we take from you that would normally be discarded at the end of your operation will be coded and we will not 
know who it belongs to.  
 How will this affect my treatment?  
 There will be no change to your surgery and it will not affect your treatment at all.  
 What is the likelihood of discovering an illness or disease from my sample?  
 The sample we take from your excess skin will not be subject to diagnostic tests so any identification of illnesses 
or disease will not occur.  
 What risks are there in participation?  
 There are no risks to you in taking part in this study.  It is important that we use only skin that would normally 
be discarded.  We do not want any additional skin nor will any steps of the procedure be altered at all for the 
purpose of this research study.  
 How is my privacy protected?  
Consent forms: One copy of your signed consent form will be kept in your medical notes in the Spire Alexandra 
Hospital.  The only people who will access your medical notes will be your Consultant and the health care team 
at the hospital.  A second copy of your signed consent form will be kept in a sealed envelope and stored in a 
locked cabinet in our secure laboratory at the Medway Campus of the University.  Your skin sample will be given 
a unique identification number and this number will be put onto your consent forms.  Your identity (your name) 
and your skin sample unique identification number will only be matched if you contact us having decided to 
withdraw from this study.  This will enable us to remove your skin sample and any results we have on your skin.  
The only people who will have access to your consent form stored within the University will be the research study 
supervisor.  
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Skin sample:  Your skin sample will be given a unique identification number.  It will be stored and used within 
our secure laboratory at the Medway Campus of the University.  Access to the laboratory is highly restricted.  
Results of our scientific work on your skin sample will be stored on our data base within the University’s secure 
server.  Access to these results are also highly restricted.   
 Will you sell to, or give other people my skin sample?  
 No, cells will only be used for this study.  
How will the skin sample be disposed of?  
 Your skin sample will be disposed of in a dignified manner and within the strict laboratory regulations. No skin 
sample will be kept in the laboratory once the work on your cells is completed.  
 Can I withdraw from this study if I change my mind?  
 If, after you have signed and returned your consent forms, you decide that you no longer want to take part in the 
study please contact your Consultant - Mr. Martin Jones - who will let us know.  Please be assured that if you 
decide to do this, it will not affect your current or future care in any way.     
 However, it will not be possible to withdraw you from the study after the point at which your skin cells have been 
used in our research and they have been analysed.  This also means that results from your cells would be included 
in the overall analysis of all patients’ skin cells and at that point would not be identifiable.  The results of these 
analyses would be included in future studies.  
 Who has reviewed this study?  
 This study has been reviewed by the University, experts in skin cell culture and it has been approved by a Research 
Ethics Committee.  
 I am not sure whether I want to take part in this study. Where can I find more information?   
 If you are not sure, please contact your Consultant – Mr. Martin Jones – who will be able to give you some more 
information.  
 Will I be informed about the outcomes of the study?  
 Yes.  At the end of this study, which we expect to take at least two years, you will be contacted by letter to inform 
you of the results of the study.     
What do I do now?  
 If you would like to take part in this study, please sign each of the consent forms (three copies) that are enclosed 
in this pack.  Please keep one copy for yourself.  Then send the remaining two consent forms back to Mr. Martin 
Jones in the prepaid envelope that is also enclosed in this pack.  When it is time for you to attend the hospital for 
your operation, Mr. Jones will know that you have agreed to take part in this study.  
 Thank you  
 Thank you for taking the time to read this information sheet, it is much appreciated.  
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 If you have any complaints please contact Dr Susan Plummer at:  
susan.plummer@canterbury.ac.uk  
 Research Team,  
Institute of Medical Sciences  
Canterbury Christ Church University  
Version 3 020816 
Appendix 6 Patient information sheet and consent form – India 
01. Nature and purpose of study stating it as  
      research 
 
DEVELOPING METHODS OF 
MEASURING AND MANIPULATING 
MELANOCYTE/KERATINOCYTE 
RATIOS TO INFORM POTENTIAL 
TREATMENT OF VITILIGO VULGARIS  
02. Duration of participation with number of  
      participants:  
Cells isolated from a part of the skin sample which is 
collected for the treatment of  patients who 
are undergoing skin treatment will only be 
used for this research study:. 
No. of samples: 10 
 
03. Procedures to be followed: Collection, isolation, processing, in vitro 
expansion of cells, characterization, and 
storage of cells collected from the tissue  
04. Investigations, if any, to be performed Not Applicable  
05. Foreseeable risks and discomforts  
      adequately described and whether project 
      involves more than minimal risk 
NO 
06. Benefits to participant, community or  
      medical profession as may be applicable 
NO direct benefit 
 (Tissue and Cells will only be used for 
research studies) 
07. Policy on compensation No compensation is given 
08. Availability of medical treatment for such  
      injuries or risk management 
Treatment facilities are available if any 
injuries or risks occur 
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09. Alternative treatments if available 
 
Not applicable 
10. Steps taken for ensuring confidentiality Identity of patients, tissues and cells 
obtained from the harvested tissues from 
the patients will not be shared with third 
parties. 
 
11. No loss of benefits on withdrawal No 
12. Benefit sharing in the event of 
      commercialization 
No commercialization as tissue and cells will be used only for 
research activity in this study. 
13. Contact details of PI or local PI/Co-PI in  
      multicentric studies for asking more 
      information related to the research or  
      in case of injury 
Ms. Neha Shetty/Dr. B. Mohana Kumar 
NUCSReM, 3rd Floor, K. S Hegde Medical Academy 
Email ID: mohanakumar@nitte.edu.in 
Mobile number: 9480504462 
14. Contact details of Chairman of the IEC  
      for appeal against violation of rights 
Member Secretary/Chairperson 
Central Ethics Committee 
Nitte (Deemed to be University) 
Deralakatte, Mangaluru. 
Ph: 0824-2204300/01/02 
 
15. Voluntary participation Tissues will be collected from patients coming voluntarily for 
their skin treatment. 
16. IIf test for genetics and HIV is to be done,  
      counseling for consent for testing must be  
      given as per national guidelines 
Not applicable 
17. Storage period of biological sample and  
      related data with choice offered to 
      participant regarding future use of 
      sample, refusal for storage and receipt of 
      its results 
Successfully cultured cells after being used for this research 
study only, and the remaining stock of cells if any left would be 
stored frozen until the study is completed. 
Maximum storage period is 5 years.   
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Nitte (Deemed to be University) 
JUSTICE K. S. HEGDE CHARITABLE HOSPITAL 
(Unit of K. S. Hegde Medical Academy) 
Medical Sciences Complex, Deralakatte, Mangaluru-575018, Karnataka 
Ph.: 0824-2204471-76, Fax: 0824-2204016 
Website: www.nitte.edu.in, E-mail: kshegde_hospital@nitte.edu.in 
 
Patient Informed Consent Form 
Study 
Title______________________________________________________________________________________
_ 
Study Number 
____________________________________________________________________________________ 
 
Subject’s Full Name (with father’s name) ______________________________________________________ 
 
Date of Birth/Age 
________________________________________________________________________________ 
 
Address of subject 
_______________________________________________________________________________ 
 
__________________________________________________________________________________________
___________ 
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Qualification of subject 
_________________________________________________________________________ 
 
 
Name and address of nominee(s) and his relation to subject 
 
__________________________________________________________________________________________
___________ 
 
__________________________________________________________________________________________
___________ 
 
1. I/We confirm that I have read and understood the information document dated _________________for the 
above study and have had the opportunity to ask questions. 
OR I/We have been explained the nature of the study by the Investigator and had the opportunity to ask 
questions. 
 
2. I/We understand that my participation in the study is voluntary and that I am free to withdraw at any time, 
without giving any reason and without my medical care or legal rights being affected. 
 
3. I/ We understand that no payment is made to me/us to carry out the above study. 
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4. I/We understand that the sponsor of the clinical trial/project, others working on the Sponsor’s behalf, the 
Ethics Committee and the regulatory authorities will not need my permission to look at my health records 
both in respect of the current study and any further research that may be conducted in relation to it, even if I 
withdraw from the study. However, I/We understand that my Identity will not be revealed in any 
information released to third parties or published. 
 
5. I/We agree not to restrict the use of any data or results that arise from this study provided such a use is only 
for scientific purpose(s). 
 
6. I/We agree to use collected/stored skin tissue sample to isolate keratinocytes and melanocytes, and grow 
them in laboratory to study the characteristics including DNA, RNA and protein analysis without any major 
modifications.  
 
7. I/we agree that part of skin tissue collected for my treatment purpose will be used for above titled research. 
 
8. I/we understand that my denial of participation in this study will not influence my treatment plan and 
outcome. 
 
9. I/we understand that my health records and reports are stored for five years as per ICMR guidelines. 
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10. I /We agree to take part in the above study. 
 
Signature (or Thumb impression) of the Subject/Legally Acceptable Representative: 
 
_____________________________________________________________________ 
 Date_______________ 
 
Signatory’s Name_________________________________________________  
 Date_______________ 
 
Signature of the Investigator_____________________________________  
 Date_______________ 
 
Study Investigator’s Name _______________________________________  
 
Signature of the Witness ________________________________________  Date_____________ 
Name of the Witness __________________________________________________ 
 
 
 
Nitte University  
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Appendix 7 Media, reagents and chemicals 
LIST OF MEDIA, REAGENTS, CHEMICALS AND OTHER ITEMS 
Item Catalogue No. Company 
Dulbecco’s phosphate buffer saline 
(DPBS) 
21300-025 Gibco-Invitrogen, Thermo 
Fisher Scientific 
Penicillin-streptomycin solution 15140-122 Gibco-Invitrogen, Thermo 
Fisher Scientific 
Dulbecco’s modified eagle’s medium 
(DMEM) 
11995-065 Gibco-Invitrogen, Thermo 
Fisher Scientific 
Attachment factor protein S-006-100 Gibco-Invitrogen, Thermo 
Fisher Scientific 
Alpha-melanocyte stimulating 
hormone (α-MSH) 
M4135-1 mg Sigma-Aldrich 
Ethyl alcohol (Ethanol) F204325 Haymankimia 
Collagenase, Type 1 17100-017 Gibco-Invitrogen, Thermo 
Fisher Scientific 
Minimum Essential Medium-alpha 
(MEM-α) 
12561-072 Gibco-Invitrogen, Thermo 
Fisher Scientific 
Fetal bovine serum (FBS) 10270106 Gibco-Invitrogen, Thermo 
Fisher Scientific 
0.4% Trypan blue 15250-061 Gibco-Invitrogen, Thermo 
Fisher Scientific 
Epilife growth medium MEPI500CA Gibco-Invitrogen, Thermo 
Fisher Scientific 
Epidermal growth factor (EGF) 585506 Biolegend 
Medium 254 M254500 Gibco-Invitrogen, Thermo 
Fisher Scientific 
Human melanocyte growth 
supplement (HMGS) 
S-002-5 Gibco-Invitrogen, Thermo 
Fisher Scientific 
Human keratinocyte growth 
supplement (HKGS) 
S-001-5 Gibco-Invitrogen, Thermo 
Fisher Scientific 
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Keratinocyte growth factor (KGF) 100-19-02 Peprotech 
0.25% trypsin/EDTA 25200-072 Gibco-Invitrogen, Thermo 
Fisher Scientific 
Paraformaldehyde P6148 Sigma-Aldrich 
Sodium hydroxide (NaOH) TCL002 Himedia 
L-DOPA (L-3, 4- 
dihydroxyphenylalanine) 
333786 Sigma-Aldrich 
Triton X-100 X-100 Sigma-Aldrich 
Fungizone (Amphotericin B) 15290-018 Gibco-Invitrogen, Thermo 
Fisher Scientific 
Non-essential amino acid 
 
11140-050 
 
Gibco-Invitrogen, Thermo 
Fisher Scientific 
S100 NBP2-45267SS Novus Biologicals 
TRP1  NBP2-32907 Novus Biologicals 
TYR NBP2-25238 Novus Biologicals 
Cell staining buffer 420201 Biolegend 
FITC-conjugated secondary antibody 11-4010-82 e-Bioscience, Thermo Fisher 
Scientific 
FITC-conjugated secondary antibody sc-516140 Santa Cruz Biotechnology 
Normal mouse IgG sc-3877 Santa Cruz Biotechnology 
Filaggrin NBP2-53245 Novus Biologicals 
Pancytokeratin (K1) NBP2-29429 Novus Biologicals 
Keratin 10 (K10 NBP2-32962 Novus Biologicals 
Glutamax (100X) 35050-061 Gibco-Invitrogen, Thermo 
Fisher Scientific 
Phosphate buffered saline (PBS) 
solution 
14190-144 Gibco-Invitrogen, Thermo 
Fisher Scientific 
Fungizone (Amphotericin B) 15290-018 Gibco-Invitrogen, Thermo 
Fisher Scientific 
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Non-essential amino acid 
 
11140-050 
 
Gibco-Invitrogen, Thermo 
Fisher Scientific 
2-Mercaptoethanol 21985-023 Gibco-Invitrogen, Thermo 
Fisher Scientific 
Dimethyl sulphoxide (DMSO) TC185 Himedia 
Thermo Fisher Scientific, Gibco-Invitrogen, Life Technologies, Grand Island, NY, USA 
Sigma-Aldrich, St. Louis, MO, USA 
Biolegend, San Diego, CA, USA 
Peprotech, NJ, USA 
Novus Biologicals, Centennial, CO, USA 
Himedia, Mumbai, India 
Haymankimia, Chargen Life Sciences, Mumbai, India 
Santa Cruz Biotechnology, San Diego, CA, USA 
 
ITEMS 
 
COMPANY CATALOGUE NUMBER 
MEDIA/REAGENTS   
DPBS Powder w/o calcium, 
magnesium 
Gibco -Invitrogen 21300-025 
Penicillin-streptomycin solution Gibco -Invitrogen 15140-122 
Fungizone (Amphotericin B) Gibco -Invitrogen 15290-018 
0.25% Trypsin-EDTA Gibco -Invitrogen 25200-072 
Collagenase Type 2, powder Gibco -Invitrogen 17101-015 
Gentamycin solution Gibco -Invitrogen 15750060 
Iodine solution Himedia R044 
Ethanol Hayman F204325 
364 
 
Fetal bovine serum FBS (South 
America Origin) 
Gibco -Invitrogen 10270106 
MEM Alpha No nucleoside Gibco -Invitrogen 12561072 
Epilife growth medium Gibco -Invitrogen MEPI500CA 
Human Keratinocyte growth 
supplement 
Gibco -Invitrogen S0015 
Medium 254 Gibco -Invitrogen M254500 
Human melanocyte growth 
supplement (HMGS) 
Gibco -Invitrogen S-002-5 
Keratinocyte growth factor 
(KGF) 
Peprotech 100-19-2 
EGF Recombinant human 
protein 
Biolegend 585506 
Attachment factor protein Gibco -Invitrogen S-006-100 
Cell staining buffer Gibco -Invitrogen 004222-26 
Paraformaldehyde Sigma-Aldrich P6148 
Glutamax (100X) Gibco-Invitrogen 35050-061 
MEM nonessential amino acids 
(100x) 
Gibco-Invitrogen 11140-050 
2-Mercaptoethanol Gibco Invitrogen 21985-023 
   
CHEMICALS/MARKERS 
 
  
 
L-DOPA-(Phenyl-D3) Sigma-Aldrich 333786 
a-Melanocyte stimulating 
harmone 
Sigma-Aldrich M4135 
DMSO Sigma-Aldrich D-2650-100 
Sodium hydroxide solution Himedia TCL002 
Triton X-100 Sigma-Aldrich X100-100ML 
Tyrosinase Antibody Novus Biologicals NBP2-25238 
Anti tyrp1 Novus Biologicals NBP2-32907 
Anti-S100B Novus Biologicals NBP2-45267SS 
mIgkBP-FITC SantaCruz sc-516140 
F(ab)2 Anti mouse IgG FITC E-bioscience 11-4010-82 
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PAN Cytokeratin Antibody 
(K1) 
Novus Biologicals NBP2-29429 
Cytokeratin 10 Antibody (k10) Novus Biologicals NBP2-32962 
Filaggrin Antibody Novus Biologicals NBP2-53245 
 
Appendix 8 Plastic wares, culture dishes and items 
Company: Thermo Fisher Scientific, Roskilde, Denmark 
Items Catalogue No. 
25 cm2 flask (T25 flask 156367 
75 cm2 flask (T75 flask) 
 
156499 
Conical tube- 15 ml LSCT15BS 
Conical tube- 50 ml LSCT50BS 
6-well plate-TC treated 
 
140675 
12-well plate-TC treated 150628 
24-well plate-TC treated 142475 
48-well plate-TC treated 150687 
96-well plate-TC treated 167008 
35 mm culture  dish 153066 
60 mm culture  dish 150288 
100 mm culture  dish 150350 
Bacteriological Petri Dish- Non Treated sterile 157150 
Serological pipette-5 mL 170355 
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Serological pipette-10 mL 170356 
Cryo chill vial-1.5 mL 523182 
(Tarsons) 
Cell Strainer-Nylon-40 µm 22363547 
 
Cell Strainer-Nylon-70 µm 22363548 
 
Cell Strainer-Nylon-100 µm 
 
22363549 
 
Syringe Filter Unit, 0.22 µm (PVDF), individually packed PVSY02225-100 
Syringe Filter Unit, 0.45 µm (PVDF), 
individually packed 
PVSY04525-100 
Syringe Filter Unit, 0.88 µm (PVDF), 
individually packed 
PVSY08825-100 
Filter unit 250 mL PES membrane 
50mm, 0.20 µm 
568-0020 
Filter unit 500 mL PES membrane 
50mm, 0.20 µm 
566-0020 
Cell scraper 62407-141 
 
ITEMS 
 
COMPANY CATALOGUE NUMBER 
PLASTIC WARES 
 
  
35 mm dish Thermoscientific 153066 
60 mm dish Thermoscientific 150288 
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6-well plate-TC treated Thermoscientific 140675 
12-well plate-TC treated Thermoscientific 150628 
24-well plate-TC treated Thermoscientific 142475 
25 cm2 flask (25T flask) Thermoscientific 156367 
Pipette tips- 1000µL Tarsons 521020 
Pipette tips- 200µL Yellow Tarsons 521010Y 
Pipette tips- 10µL Tarsons 521000 
Serological pipette-5ml Thermoscientific 170355 
Serological pipette-10ml Thermoscientific 170356 
Syringe Filter Unit, 0.22 µm 
(PVDF) 
Thermoscientific PVSY02225-100 
Cell Strainer-Nylon-70µM Thermoscientific 22363548 
Cell Strainer-Nylon-100µM Thermoscientific 22363549 
Conical tube- 15 ml Thermoscientific LSCT15BS 
Conical tube- 50 ml Thermoscientific LSCT50BS 
Microcentrifuge tubes- 0.5 ml, 
colourless 
Tarsons 500000 
Microcentrifuge tubes- 1.5 ml, 
colourless 
Tarsons 500010 
Microcentrifuge tubes- 2.0 ml, 
colourless 
Tarsons 500020 
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Appendix 9 List of equipment  
K. S. HEGDE MEDICAL ACADEMY 
Deralakatte, Mangaluru – 575 018 
A constituent College of Nitte (Deemed to be University) 
List of Equipments/Instruments for Research Purpose 
Nitte University Centre for Stem Cell Research and Regenerative Medicine 
(NUCSReM) 
 
Instrument 
Company 
Institute 
Centre/Dept. 
Contact 
Person  
 
 
Applications 
Centrifuge (incl. 15/50 ml adapters) 
Eppendorf, 5810R 
KSHEMA 
NUCSReM (Stem cell lab) 
Dr. B. Mohana Kumar 
M: 9480504462 
E: mohanakumar@nitte.edu.in 
 
1) Remove cellular elements from blood or body 
fluids 
2) Concentration of cellular elements for microscopy 
3) Isolation of macro- and micromolecules, such as 
DNA, RNA, proteins or lipids 
4) Applicable to 15ml/50ml conical tube 
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Instrument 
Company 
Institute 
Centre/Dept. 
Contact 
Person  
 
 
Applications 
Centrifuge (Refrigerated 24 tubes) 
Eppendorf,  5418R 
KSHEMA 
NUCSReM (Stem cell lab) 
Dr. B. Mohana Kumar 
M: 9480504462 
E: mohanakumar@nitte.edu.in 
 
1) Remove cellular elements from blood or body 
fluids 
2) Concentration of cellular elements for microscopy 
3) Isolation of macro- and micromolecules, such as 
DNA, RNA, proteins or lipids 
4) Applicable to 1.5ml/2ml micro centrifuge tube 
 
 
 
Instrument 
Company 
Institute 
Centre/Dept. 
Contact 
Person  
 
 
Applications 
Centrifuge 
Eppendorf,  5427R 
KSHEMA 
NUCSReM (Stem cell lab) 
Dr. B. Mohan Kumar 
M:9480504462 
E: mohanakumar@nitte.edu.in 
 
1) Remove cellular elements from blood or body 
fluids 
2) Concentration of cellular elements for microscopy 
3) Isolation of macro- and micromolecules, such as 
DNA, RNA, proteins or lipids 
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4) Applicable to 1.5ml/2ml micro centrifuge tube 
 
Instrument 
Company 
Institute 
Centre/Dept. 
Contact 
Person  
 
 
Applications 
Centrifuge, Minispin plus 
Eppendorf,  5453 
KSHEMA 
NUCSReM (Stem cell lab) 
Dr. B. Mohana Kumar 
M: 9480504462 
E: mohanakumar@nitte.edu.in 
 
1) Isolation of macro- and micromolecules, such as 
DNA, RNA, proteins or lipids 
2) Applicable to 1.5ml/2ml micro centrifuge tube 
       
 
 
Instrument 
Company 
Institute 
Centre/Dept. 
Contact 
Person  
 
CO2 Incubator 
Eppendorf,  Galaxy 170S 
KSHEMA 
NUCSReM (Stem cell lab) 
Dr. B. Mohana Kumar 
M: 9480504462 
E: mohanakumar@nitte.edu.in 
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Applications 
 
1) Used in scientific research to grow and maintain 
cell lines 
2) High temperature disinfection system 
 
Instrument 
Company 
Institute 
Centre/Dept. 
Contact 
Person  
  
 
Applications 
CO2 Incubator 
Eppendorf,  Galaxy 170R 
KSHEMA 
NUCSReM (Stem cell lab) 
Dr. B. Mohana Kumar 
M: 9480504462 
E: mohanakumar@nitte.edu.in 
 
1) Used in scientific research to grow and maintain 
cell lines 
2) Option of oxygen control for hypoxia experiments 
3) Availability of tri-gas monitoring option 
4) High temperature disinfection system 
 
     
  
 
Instrument 
Company 
Institute 
Centre/Dept. 
Contact  
 
-80ºC Ultra freezer 
Eppendorf  U570, New Brunswick 
KSHEMA 
NUCSReM (Stem cell lab) 
Dr. B. Mohana Kumar 
M: 9480504462 
E: mohanakumar@nitte.edu.in 
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Applications 
 
1) Cryostorage of tissue/cell samples at -80ºC for 
long term storage 
2) Shelves for keeping samples in cryoboxes 
  
Instrument 
Company 
Institute 
Centre/Dept. 
Contact 
Person  
  
 
Applications 
Vertical autoclave 
Panasonic, MLS-3751  
KSHEMA 
NUCSReM (Stem cell lab) 
Dr. B. Mohana Kumar 
M: 9480504462 
E: mohanakumar@nitte.edu.in 
 
1) Provides a safe, reliable high pressure steam 
sterilization environment 
2) Applicable in culture media preparation, labware 
sterilization, etc. 
  
 
 
Instrument 
Company 
Institute 
Centre/Dept. 
Contact 
Person  
  
 
Applications 
Cryogenic Storage Vessel 
Thermoscientific,8246 Locator 4w/monitor 
KSHEMA 
NUCSReM (Stem cell lab) 
Dr. B. Mohana Kumar 
M: 9480504462 
E: mohanakumar@nitte.edu.in 
 
1) Cryogenic storage vessel for storage of tissue 
samples or cell lines in liquid nitrogen 
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2) Cryopreservation accessories to meet the rigorous 
storage requirements of cryogenic samples 
 
Instrument 
Company 
Institute 
Centre/Dept. 
Contact 
Person  
  
 
Applications 
Electric Oven 
Panasonic, MOV-112-PK 
KSHEMA 
NUCSReM (Stem cell lab) 
Dr. B. Mohana Kumar 
M: 9480504462 
E: mohanakumar@nitte.edu.in 
 
1) Sterilization and drying of glass wares, microtips, 
surgical items etc. 
 
  
 
 
Instrument 
Company 
Institute 
Centre/Dept. 
Contact 
Person  
  
 
Applications 
Pharmaceutical refrigerator with freezer (-30ºC) 
Panasonic, MPR-414F-PE 
KSHEMA 
NUCSReM (Stem cell lab) 
Dr. B. Mohana Kumar 
M: 9480504462 
E: mohanakumar@nitte.edu.in 
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1) It provides exact and strict storage temperature for 
keeping cell culture essentials, such as media, 
reagents etc. 
2) Storage of materials at 4°C and -30°C 
Instrument 
Company 
Institute 
Centre/Dept. 
Contact 
Person  
  
 
Applications 
-30ºC Deep freezer 
Panasonic, MDF-U537D-PK 
KSHEMA 
NUCSReM (Stem cell lab) 
Dr. B. Mohana Kumar 
M: 9480504462 
E: mohanakumar@nitte.edu.in 
 
1) It provides exact and strict storage temperature for 
keeping cell culture essentials, such as media, 
reagents etc. and other biological materials 
 
 
 
Instrument 
Company 
Institute 
Centre/Dept. 
Contact 
Person  
  
 
Applications 
Pharma refrigerator (4ºC) 
Thermo Scientific, 288R AEV-TS 
KSHEMA 
NUCSReM (Stem cell lab) 
Dr. B. Mohana Kumar 
M: 9480504462 
E: mohanakumar@nitte.edu.in 
 
1) Storage of cell culture essentials, such as media, 
reagents etc. and other biological materials 
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2) Storage of research consumables 
 
Instrument 
Company 
Institute 
Centre/Dept. 
Contact 
Person  
  
 
Applications 
Biosafety cabinet with base stand, Class II Type A2 
Labconco, No. 302681170, 6 ft width 
KSHEMA 
NUCSReM (Stem cell lab) 
Dr. B. Mohana Kumar 
M: 9480504462 
E: mohanakumar@nitte.edu.in 
 
1) Workplace for safe handling and working with 
materials requiring a defined biosafety level 
2) With high efficiency particulate air (HEPA) filters, 
cabinets are designed to protect against exposure 
to particulates, including biological agents 
 
  
Instrument 
 
Company 
Institute 
Centre/Dept. 
Contact 
Person  
  
Applications 
Liquid nitrogen container and accessories 
Taylor Wharton, LS6000  
KSHEMA 
NUCSReM (Stem cell lab) 
Dr. B. Mohana Kumar 
M: 9480504462 
E: mohanakumar@nitte.edu.in 
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1) Cryogenic vessel for storage of cell/tissue samples 
in liquid nitrogen at -196°C 
2)  Cryopreservation accessories are designed to meet 
the rigorous storage  requirements of cryogenic 
samples 
 
Instrument 
Company 
Institute 
Centre/Dept. 
Contact 
Person  
  
 
Applications 
Liquid nitrogen withdrawal device 
Taylor Wharton, LD35 
KSHEMA 
NUCSReM (Stem cell lab) 
Dr. B. Mohana Kumar 
M: 9480504462 
E: mohanakumar@nitte.edu.in 
 
1) Provides convenient pressure transfers of  liquid 
nitrogen from LD35 
 
  
 
Instrument 
Company 
Institute 
Centre/Dept. 
Contact 
Person  
  
 
Applications 
Countess- automated cell counter 
Life Technologies, Thermo Scientific, AMQAF1000 
KSHEMA 
NUCSReM (Stem cell lab) 
Dr. B. Mohana Kumar 
M: 9480504462 
E: mohanakumar@nitte.edu.in 
 
1) Performs cell count and viability measurement by 
using trypan blue stain 
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2) Eliminate the subjectivity of manual cell counting 
and user-to-user variability 
3) Operated using an intuitive user interface 
 
Instrument 
Company 
Institute 
Centre/Dept. 
Contact 
Person  
  
 
Applications 
Water bath 
Grant, JBN5 
KSHEMA 
NUCSReM (Stem cell lab) 
Dr. B. Mohana Kumar 
M: 9480504462 
E: mohanakumar@nitte.edu.in 
 
1) Incubate samples in water at a constant 
temperature over certain period of time 
2)  Also suitable for use with heat transfer beads 
 
  
 
Instrument 
Company 
Institute 
Centre/Dept. 
Contact 
Person  
  
 
pH meter 
EUTECH, ECION27004GS 
KSHEMA 
NUCSReM (Stem cell lab) 
Dr. Shama Rao 
M: 8095239355 
E: shamarao.88@nitte.edu.in 
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Applications 1) To measure pH values in media and buffer 
solutions employed in cell culture activities 
2) This is a micro-processor based instrument 
 
Instrument 
Company 
Institute 
Centre/Dept. 
Contact 
Person  
  
 
Applications 
Electronic balance, 220G, 0.0001G 
Sartorious, BSA224S-CW 
KSHEMA 
NUCSReM (Stem cell lab) 
Dr. Shama Rao 
M: 8095239355 
E: shamarao.88@nitte.edu.in 
 
1) To measure weight with accuracy 
 
  
 
Instrument 
 
Company 
Institute 
Centre/Dept. 
Contact 
Person  
 
Applications 
Trinocular inverted research microscope 
Nikon, Japan, TS100LED-F-MV 
KSHEMA 
NUCSReM (Stem cell lab) 
Dr. B. Mohana Kumar 
M: 9480504462 
E: mohanakumar@nitte.edu.in 
 
1) To observe and investigate small objects and their 
structure 
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Instrument 
Company 
Institute 
Centre/Dept. 
Contact 
Person  
  
 
Applications 
Haemocytometer complete set 
Neubauer  
KSHEMA 
NUCSReM (Stem cell lab) 
Dr. Shama Rao 
M: 8095239355 
E: shamarao.88@nitte.edu.in 
 
1) Used for  manually counting the cells under 
microscope 
 
  
 
 
Instrument 
Company 
Institute 
Centre/Dept. 
Contact 
Person  
 
 
Applications 
MilliQ Direct 8 ultrapure water purification System 
Merck Millipore, Direct 8 Reservoir(TANKPE030) 
KSHEMA 
NUCSReM (Stem cell lab) 
Dr. B. Mohana Kumar 
M: 9480504462 
E: mohanakumar@nitte.edu.in 
 
1) Water purification system providing lab with pure 
and ultrapure water directly from tap water with 
RO facility 
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Instrument 
Company 
Institute 
Centre/Dept. 
Contact 
Person  
  
 
Applications 
Cryo 1ºC freezing containers, System 
Thermo Scientific, Nalgene 
KSHEMA 
NUCSReM (Stem cell lab) 
Dr. Shama Rao 
M: 8095239355 
E: shamarao.88@nitte.edu.in 
 
1) To store cells at the rate of cooling-1ºC/minute 
prior to cryopreservation at ultralow temperatures 
 
 
  
 
Instrument 
Company 
Institute 
Centre/Dept. 
Contact 
Person  
  
 
Applications 
Autoclave- vertical type 
Rotek, RAV-04 
KSHEMA 
NUCSReM (Stem cell lab) 
Dr. Shama Rao 
M: 8095239355 
E: shamarao.88@nitte.edu.in 
 
1)  Used in culture media preparation, lab wares and 
dissection items sterilization etc. 
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Instrument 
Company 
Institute 
Centre/Dept. 
Contact 
Person  
  
 
Applications 
Magnetic stirrer 
Remi, 5MLH 
KSHEMA 
NUCSReM (Stem cell lab) 
Dr. Shama Rao 
M: 8095239355 
E: shamarao.88@nitte.edu.in 
 
1) Employs a rotating magnetic field to cause stir bar 
spin quickly to dissolve chemicals or particulates 
 
  
 
Instrument 
Company 
Institute 
Centre/Dept. 
Contact 
Person  
  
 
Applications 
Vortex mixture 
Remi, CM101 
KSHEMA 
NUCSReM (Stem cell lab) 
Dr. Shama Rao 
M: 8095239355 
E: shamarao.88@nitte.edu.in 
 
1) Used in proper mixing of  liquids in small vials 
 
   
 
Instrument 
Company 
Institute 
Centre/Dept. 
Contact 
Person  
Vortex mixture 
Labnet, Z5030327 
KSHEMA 
NUCSReM (Stem cell lab) 
Dr. Shama Rao 
M: 8095239355 
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Applications 
E: shamarao.88@nitte.edu.in 
 
1) Used in proper mixing of  liquids in small vials 
 
Instrument 
Company 
Institute 
Centre/Dept. 
Contact 
Person  
  
 
Applications 
Hot air oven 
Rotek, RHOM-18HSP 
KSHEMA 
NUCSReM (Stem cell lab) 
Dr. Shama Rao 
M: 8095239355 
E: shamarao.88@nitte.edu.in 
 
1) Drying of glass wares, microtips, surgical items 
etc. 
 
  
 
Instrument 
Company 
Institute 
Centre/Dept. 
Contact 
Person  
  
 
Applications 
Water bath 
Rotek, RPTB-02SP 
KSHEMA 
NUCSReM (Stem cell lab) 
Dr. Shama Rao 
M: 8095239355 
E: shamarao.88@nitte.edu.in 
 
1) Used to incubate sample in water at a constant 
temperature over certain period of time 
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Instrument 
Company 
Institute 
Centre/Dept. 
Contact 
Person  
  
 
Applications 
Cryocan- for liquid nitrogen  
IOC, TA-55  
KSHEMA 
NUCSReM (Stem cell lab) 
Dr. B. Mohana Kumar 
M: 9480504462 
E: mohanakumar@nitte.edu.in 
 
1) For safe transportation of liquid nitrogen 
 
  
 
Instrument 
Company 
Institute 
Centre/Dept. 
Contact 
Person  
 
 
Applications 
Centrifuge (incl. 15/50 ml adapters) 
Eppendorf, 5804R 
KSHEMA 
NUCSReM (Stem cell lab) 
Dr. B. Mohana Kumar 
M: 9480504462 
E: mohanakumar@nitte.edu.in 
 
1) Remove cellular elements from blood or body 
fluids 
2) Concentration of cellular elements for microscopy 
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3) Isolation of macro- and micromolecules, such as 
DNA, RNA, proteins or lipids 
4) Applicable to 15ml/50ml conical tube 
 
Instrument 
Company 
Institute 
Centre/Dept. 
Contact 
Person  
  
 
Applications 
Freezer- High efficiency -86ºC 
Eppendorf, New-Brunswick, U101 
KSHEMA 
NUCSReM (Stem cell lab) 
Dr. B. Mohana Kumar 
M: 9480504462 
E: mohanakumar@nitte.edu.in 
 
1) Cryostorage of tissue/cell samples at -80ºC for 
long term storage 
2) Shelves for keeping samples in cryoboxes 
 
  
Instrument 
Company 
Institute 
Centre/Dept. 
Contact 
Person  
Microbiological incubator 
Bio-Bee 
KSHEMA 
NUCSReM (Stem cell lab) 
Dr. Shama Rao 
M: 8095239355 
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Applications 
E: shamarao.88@nitte.edu.in 
 
1) Microbial culture incubation for sterility testing 
2) Detection of bacterial and fungal contamination in 
cell culture media 
 
 
Instrument 
 
Company 
Institute 
Centre/Dept. 
Contact 
Person  
 
Applications 
Biosafety cabinet with base stand, class II Type A2 
Thermo Scientific, 1300 series 
KSHEMA 
NUCSReM (Stem cell lab) 
Dr. B. Mohana Kumar 
M: 9480504462 
E: mohanakumar@nitte.edu.in 
 
1) Workplace for safe handling and working with 
materials requiring a defined biosafety level 
2) With high efficiency particulate air (HEPA) filters, 
cabinets are designed to protect against exposure 
to particulates, including biological agents 
 
  
Instrument 
 
Company 
Institute 
Centre/Dept. 
Contact 
Person  
Deep freezer -20ºC, ES series lab freezer 
Thermo Scientific, 232F-AEV-TS 
KSHEMA 
NUCSReM (Stem cell lab) 
Dr. B. Mohana Kumar 
M: 9480504462 
E: mohanakumar@nitte.edu.in 
 
 
 
386 
 
 
Applications 
1) For general-purpose lab storage and routine 
sample protection 
 
Instrument 
 
Company 
Institute 
Centre/Dept. 
Contact 
Person  
 
Applications 
Electrophoresis system- Midi sub system 
Bioworld-03-02 
KSHEMA 
NUCSReM (Stem cell lab) 
Dr. Shama Rao 
M: 8095239355 
E: shamarao.88@nitte.edu.in 
 
1) To separate charged molecules, such as DNA, 
RNA etc on electrophoretic gels 
 
  
 
Instrument 
Company 
Institute 
Centre/Dept. 
Contact 
Person  
  
 
Applications 
Heat block with digital temperature 
ADJ Single block, D1100-230V 
KSHEMA 
NUCSReM (Stem cell lab) 
Dr. Shama Rao 
M: 8095239355 
E: shamarao.88@nitte.edu.in 
 
1) Holds individual containers, such as test tubes, 
microtubes, or PCR tubes, for constant heating 
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Instrument 
Company 
Institute 
Centre/Dept. 
Contact 
Person  
 
 
Applications 
Olympus-Trinocular inverted microscope with Q 
imaging 
Olympus, CKX41 
KSHEMA 
NUCSReM (Stem cell lab) 
Dr. B. Mohana Kumar 
M: 9480504462 
E: mohanakumar@nitte.edu.in 
 
1)  Suitable for regular cell observations 
2)  Software with digital camera is connected for 
efficient documentation tasks and archiving in a 
computer 
 
 
 
 
 
Instrument 
Company 
Institute 
Centre/Dept. 
Contact 
Person  
  
 
Applications 
Mixmate with 3 tube holders (0.5ml/1.5ml/2.0ml) 
Eppendorf, 5353000.014 
KSHEMA 
NUCSReM (Stem cell lab) 
Dr. Shama Rao 
M: 8095239355 
E: shamarao.88@nitte.edu.in 
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1) High speed instrument provides complete mixing 
of samples in seconds 
2) Applicable to 0.5ml/1.5ml/2.0ml tubes 
 
Instrument 
Company 
Institute 
Centre/Dept. 
Contact 
Person  
  
 
Applications 
Master cycler Pro S, 230v (6325000.510) 
Eppendorf, PRO-S 
KSHEMA 
NUCSReM (Stem cell lab) 
Dr. Shama Rao 
M: 8095239355 
E: shamarao.88@nitte.edu.in 
 
1) PCR thermocycler is commonly used in molecular 
biology for amplifying single copy or few copy 
segments of DNA  to generate thousand to 
millions of copies 
2) Applications in the field of cell/stem cell biology, 
genetic research, medicine, forensic science etc. 
3)  Heated lid with integrated Thermal Sample 
Protection (TSP) technology 
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Instrument 
Company 
Institute 
Centre/Dept. 
Contact 
Person  
  
 
Applications 
Mini centrifuge 10000rpm including accessories 
FBS-MINI-10K 
KSHEMA 
NUCSReM (Stem cell lab) 
Dr. Shama Rao 
M: 8095239355 
E: shamarao.88@nitte.edu.in 
 
1) Concentrate and remove cellular elements from 
biological fluids 
2) Applicable to 1.5ml/2ml micro centrifuge tube 
 
  
 
Instrument 
Company 
Institute 
Centre/Dept. 
Contact 
Person  
  
 
Applications 
Liquid nitrogen container, Locator 4 with level 
monitor 
Thermo Scientific, CY509107 Locator 4 
KSHEMA 
NUCSReM (Stem cell lab) 
Dr. B. Mohana Kumar 
M: 9480504462 
E: mohanakumar@nitte.edu.in 
1) Cryogenic vessel for storage of cell/tissue samples 
in liquid nitrogen at -196°C 
2) Cryopreservation accessories are designed to meet 
the rigorous storage  requirements of cryogenic 
samples 
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Instrument 
Company 
Institute 
Centre/Dept. 
Contact 
Person  
  
 
Applications 
Vacuum pressure pump kit 
Millipore, Vacuum pump kit 
KSHEMA 
NUCSReM (Stem cell lab) 
Dr. Shama Rao 
M: 8095239355 
E: shamarao.88@nitte.edu.in 
 
1) Cell culture media aspiration  
2) Filter sterilization of medium and other cell culture 
solutions 
 
 
Instrument 
Company 
Institute 
Centre/Dept. 
Contact 
Person  
  
 
Applications 
Incubator shaker 
Bio-Bee 
KSHEMA 
NUCSReM 
Dr. Shama Rao 
M: 8095239355 
E: shamarao.88@nitte.edu.in 
 
1) Equipment is used to mix, blend and agitate 
substance in a tube or flask 
2) It is mainly used in the field of chemistry and 
biology 
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Appendix 10 List of conferences/meetings participated as a DELEGATE  
1.  The 2nd Biennial National Conference on “Advances in Stem Cell Research and Cell 
Based Therapy with Emphasis on Orthopedic, Dermatological and Dental 
Applications” held at K. S. Hegde Medical Academy (KSHEMA) from 22nd to 23rd 
December, 2017. This conference was jointly organized by Nitte University Centre for 
Stem Cell Research & Regenerative Medicine (NUCSReM) and Department of 
Orthopaedics, KSHEMA. 
  
2.  National Symposium on “Regenerative and Cancer Stem Cells” organized by Stem Cell 
and Regenerative Medicine Division of Yenepoya Research centre, Yenepoya (Deemed 
to be University) at Mangaluru on 1st February 2018. 
  
3.  Two days lecture series in ‘Molecular Genetics’ organized by K. S. Hegde Medical 
Academy (KSHEMA) in association with Karnataka Science and Technology 
Academy (KSTA) at Deralakatte, Mangaluru on 24th and 25th August 2018. 
  
4.  PIKNIKH Series XXVIII Indo-Japan symposium on ‘Molecular Medicine’ organized 
by School of Life Sciences (SLS), Manipal Academy of Higher Education (MAHE), 
Manipal on 19th September 2018. 
  
5.  International Conference on Radiation Biology (ICRB-2018) and 14th biennial meeting 
of Indian Society of Radiation Biology (ISRB) organized by K. S. Hegde Medical 
Academy (KSHEMA) from 4th to 6th October 2018 at Deralakatte, Mangaluru. 
  
6. Presentation of part of PhD work at 87th Annual Conference of Society of Biological 
Chemists (India) with a theme on “Genome Biology in Health and Diseases” organized 
by School of Life Sciences (SLS), Manipal Academy of Higher Education (MAHE), 
Manipal from 25th to 27th  November 2018. 
 
Poster abstract presented and published in proceedings: 
Title: DERIVATION AND CULTIVATION OF HUMAN MELANOCYTES AND 
KERATINOCYTES IN VITRO 
Authors: Neha A. Shetty, Shama Rao, Vinutha E, Nikhil S. Shetty, Veena Shetty A, 
Jayaprakasha Shetty K, Mohana Kumar B. 
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Appendix 11 Departmental seminars, journal clubs presented during period 
 
1. Regularly participated in the weekly meetings/seminars at Nitte University Centre for Stem 
Cell Research & Regenerative Medicine (NUCSReM) and Journal Club meetings of 
KSHEMA-CRL, Genetics and NUCSReM.  
2. Presented the research articles related to PhD dissertation as a part of meetings/seminar. 
3. Attended the guest/invited lectures organized at K. S. Hegde Medical Academy 
(KSHEMA). 
 
 
 
 
 
 
 
